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Mucormycosis is a life-threatening mold infection with overall mortality rates of 50%, yet 
fatality levels reach 100% in patients with disseminated disease, prolonged neutropenia, or 
brain involvement. The disease is caused by a group of filamentous fungi, the mucorales and 
particularly targets patients with immunosuppression due to diabetic ketoacidosis (DKA), iron 
overload, severe trauma, neutropenia, corticosteroid treatment, or organ transplantation.  
 
These predisposing conditions are linked to defects in key aspects of the innate immunity, 
particularly defects in phagocytic effector functions by macrophages and neutrophils, 
suggesting phagocytic activity is crucial to disease control.  Yet, we currently have a very 
limited understanding of the interaction between mucormycete infecting spores and 
phagocytes.  
 
In this thesis, we show that the early events during phagocyte- spore interaction may determine 
infection by R. microsporus.  We report that spore metabolism modulates macrophage effector 
functions including phagocytic uptake of spores, phagosome acidification following uptake 
and cytoskeletal organisation via a secreted factor.  
 
We also demonstrate the secreted factor is not produced by R. microsporus but a bacterial 
endosymbiont Ralstonia pickettii. This is a close relative of Paraburkholderia species belonging 
to the family Bukholderiaceace that produce rhizo-toxins already characterised and implicated 
in plant pathology but not yet in human disease. However, although the secreted compound 
here shares chemical and functional attributes with the rhizo-toxins, it is not a rhizo-toxin. 
 xvi  
Thesis Overview  
Infections due to invasive opportunistic moulds such as the mucormycetes continue to emerge 
especially in patients with various immunosuppressive threats including but not limited to 
organ transplants, HIV/AIDS, haematological malignancies, metabolic acidosis, iron overload, 
corticosteroid therapy, neutropenia, and trauma.  Mucormycosis is now the second most 
invasive mould infection after aspergillosis. It presents with hallmark symptoms of angio-
invasion, thrombosis and necrosis. These infections are difficult to manage because of 
challenges associated with poor diagnosis, expensive yet unsuccessful therapy and anti-fungal 
drug resistance. Among the risk factors is a defect in phagocytic effector functions which seems 
crucial for disease progression. Bettering our understanding of the mechanisms underlying 
spore-phagocyte interactions is key if we are to improve prognosis. This thesis is written in a 
traditional style including chapter 1(introduction), chapter 2 (methods and materials) and 
chapters 3-6 (results and discussion). Three projects are presented and a discussion for each 
chapter follows immediately to explain the data. The work presented in this thesis is mainly 
focused on R. microsporus but data from other mucoralean fungi is also included for 
comparisons. 
 
Chapter 3 explores spore-macrophage interactions, describing some of the key approaches 
developed in this project. A major of the chapter is a finding that metabolic spores inhibit 
phagocytic uptake by macrophages via a secreted factor. 
 
Chapter 4 is a follow up on the observations made in chapter 3 where further characterisation 
of the secreted factor is made, highlighting that the factor is secreted by a bacterial 
endosymbiont rather than the fungus.  
 
Chapter 5 is also a build-up on chapters 3 and 4, mainly exploring bacterial symbiosis and its 
impact on pathogenicity of R. microsporus both in vitro and in vivo.  
 
Chapter 6 is additional work and possible hypotheses for future directions. 
 
















1.1 Mucorales and Mucormycosis  
1.1.1 Overview  
Fungi have increasingly gained medical importance in recent times and are now known to cause 
a range of diseases worldwide (Skiada et al., 2012, Blyth et al., 2014, Roden et al., 2005).  
However, this is in parallel with the increasing numbers of at-risk individuals.  Clinically, 
manifestations of diseases due to fungi have ranged from mild superficial to aggressively fatal 
and disseminated infections. Nevertheless, the taxonomic diversity of the disease-causing 
agents continues to expand as fungi that were primarily known to be saprobes like the 
mucorales, are now regarded major and emerging aetiological agents (Skiada et al., 2012, de 
Hoog et al., 2014, Mohindra et al., 2014).  
Indeed, mucoralean fungi are the causative agents of a fatal disease called mucormycosis. The 
disease is characterized by hallmark symptoms of angio-invasion, thrombosis and tissue 
necrosis (Chayakulkeeree et al., 2006, Neblett Fanfair et al., 2012, Ribes et al., 2000). The 
infection is very aggressive, hard to treat and individuals with a defect in phagocytic effector 
functions show increased susceptibility (Ribes et al., 2000).  
 
1.2 The mucorales  
The mucorales are a group of traditional fungi that together with chytridiomycetes diverged 
early in the fungal kingdom and thus are regarded as basal fungi (Lee et al., 2010, Mendoza et 
al., 2015). They are best known environmentally as agricultural produce spoilers and clinically 
as laboratory contaminants especially some members of the Rhizopus genus (de Hoog et al., 
2014).  
They form a sub-family within the phylum mucormycotina (formally zygomycotina) that is 





fungi) and higher fungi (i.e. the ascomycota, basidiomycota and deuteromycetes groups) 
(Grigoriev et al., 2014, Spatafora et al., 2016, de Hoog et al., 2014) (Figure 1).  
Mucoralean fungi are non-motile and are morphologically characterized by formation of thalli 
networks of coenocytic (a septate) mycelia with root like structures called rhizoids, aerial 
sporangiophore on which sporangia and spores are formed asexually; or non-enveloped 
zygospores during sexual reproduction (Lee et al., 2010, Lee and Heitman, 2014, Mendoza et 
al., 2015, Hoffmann et al., 2013, Spatafora et al., 2016).  
The phylum mucormycotina contains nine orders with mucorales as the most studied among 
them (Lee et al., 2010).  Majority of these fungi are saprophytic in nature and propagate by 











Figure 1: The Mucoromycotina is sandwiched between lower and higher fungal phyla. 
The Mucoromycota fungi are phylogenetically sandwiched between lower slime and flagellate 
fungi and higher fungi such as the dikaryon, ascomycota and basidiomycotina.  This family is 
composed of several orders including Rhizopodaceae, Mucorineae and Cunninhamellaceae 
among others as indicated. Under these are several species as indicated.  The phylogenetic tree 






1.3 Reproduction in mucorales  
The term zygomycotina has been used interchangeably to describe mucorales in the past and 
this is also reflected in their sexual reproductive cycle as mentioned above. However, 
mucorales reproduce by both sexual and asexual means. These concepts of reproduction in 
mucoralean fungi have been described since the 1800 particularly in Syzygites megalocarpus 
(Blakeslee, 1904, Lee and Heitman, 2014). 
 
1.3.1 Asexual reproduction  
During asexual reproduction, offspring arise from a single parent. Spores germinate under 
suitable conditions to form a thallus network of mycelia. From these, aerial hyphae emerge 
from which sporangia form. This is now called a sporangiophore. It is on the sporangia that 
mitospores called sporangiospores later develop via mitosis (Figure 2). Mitospores are formed 
inside sporangioles and released when mature by disintegration of the sporangium wall or as a 
whole sporangiole that breaks off the Sporangiospore. It has been suggested that this form of 
reproduction is more rapid in development and drives dispersal and perhaps infection (Lee et 














Figure 2: Mucoralean fungi reproduce by both sexual and asexual means. 
Diagrammatic representation of asexual and sexual reproduction in mucormycetes. 
Mucormycetes reproduce by both sexual and asexual means.  Asexual reproduction yields the 
ubiquitous sporangiospores responsible for dispersal and infection while sexual reproduction 














1.3.2 Sexual reproduction  
Sexual reproduction is by physical blending or fusion of morphologically similar gametangia 
tips to form a thick and ornamented wall called a zygo-sporangium following a mixture of 
multinucleated contents. This is also called the teleomorphic phase. The Greek term, Zygos   
which means balance of scales is used to describe the resultant joining (the yoke) (Lee and 
Heitman, 2014, Johannes Wöstemeyer, 2007, Alexander Idnurm, 2007). In mucoralean fungi, 
sexual reproduction can be homo or hetero-thallic. Whilst homothallism requires conjugation 
of mating hyphal types (gametangia) from a single thallus, two different but sexually 
compatible thalli are required during heterothallism. Zygosporangia develop thick walls and 
are the equivalent of resting spores (Figure 2) (Lee and Heitman, 2014).  
 
1.3.2.1 The sex loci in mucorales  
The sex locus in mucoralean fungi was first discovered in Phycomyces blakesleeanus and is 
still poorly characterized when compared with the two dikaryon lineages, Ascomycetes and 
Basidiomycetes (Idnurm et al., 2008, Lee and Heitman, 2014, Poggeler et al., 2011, Coelho et 
al., 2017, Gryganskyi et al., 2010, Wetzel et al., 2012).  Unlike in animals and some plants 
where sex identity is determined by large sex specific chromosomes, genomic studies reveal 
sexual reproduction in fungi to be controlled by a small, specialized region of the genome 
called the mating type (MAT) or sex locus (Idnurm et al., 2008, Lee et al., 2010, Lee and 
Idnurm, 2017).   
The MAT locus may contain two or more alleles that encode key domain transcription factors 
including homeodomain or the high mobility group (HMG) proteins (Idnurm et al., 2008, Lee 
and Heitman, 2014, Lee et al., 2010). Studies on P. blakesleeanus show that the sex locus of 
mucoralean fungi comprise a single HMG gene flanked at both ends by conserved putative 





helicase gene cluster (TPT/HMG/RNA) (Figure 3) (Idnurm et al., 2008, Lee and Idnurm, 
2017). Each of these mating types encodes an allelic HMG gene: sexP for the (+) and sexM for 
the (-) mating types (Idnurm et al., 2008).  
This seems to be a bona fide sex locus in P. blakesleeanus because haploid strains contain 
either the sexP or sexM in the genome and only expressed through mating the two mating types 
resulting into formation of zygospores. Secondly, sexP strains will only mate with (-) mating 
types and sexM strains with (+) mating types and no mating occurs between strains of the same 
mating type. Lastly, strains with chromosomes represented twice for the sexP and sexM genes 
appear to be self-fertile. Similar observations have been made in M. circinelloides and R. 
delemar (Idnurm et al., 2008, Gryganskyi et al., 2010, Lee and Idnurm, 2017, Lee et al., 2008).   
The overall structure of the sex locus in mucorales is highly conserved but genomic studies on 
other mucoralean fungi seem to show that specific differences may exist as demonstrated in 
Figure 3. Particularly, the direction of transcription of the sexP and sexM genes differs in some 
species such as P. blakesleeanus (Idnurm et al., 2008). In addition, the presence of repetitive 
elements on the sexP locus like with P. blakesleeanus, presence of an additional open reading 
frame (ORF) arbA that encodes an Ankyrin –RCC1-BTB-POZ domain protein such as in R. 
oryzae (sex P) and S. megalocarpus (-) sex locus), and a partial gene inversion in the rnh A 
gene (S. megalocarpus) have been identified by bioinformatics and genomic mapping (Figure 









Figure 3: Mucoralean fungi sex locus encodes sexP (+) and sexM (-). 
The sex loci of four different mucoralean fungi is shown. The (+) sex locus encode the sexP 
gene whilst (-) encodes the sexM gene. Both of these are flanked by tptA and rnhA genes. 
There are key defining features that differentiates between loci of the different mucoralean 
fungi: including the direction of sexP and sexM, the presence and absence of repetitive element 
and an additional ORF encoding 10nkyrin-RCC1-BTP-POZ; and partial rnhA gene inversion. 













1.3.2.2 Sex and infection in mucoralean fungi 
Asexual spores are ubiquitously available in the environment and are the main source of 
dispersion and infection usually through inhalation (Mendoza et al., 2015, Kennedy et al., 
2016). Infection by other modes such as traumatic implantation and ingestion are also common. 
In regard to sexual zygospores, a particular mating type may skew their ability to elicit an 
infection. This has been noted among Mucor species. For instance, Mucor amphibiorum, a 
causative agent of ulcerative mucormycosis, a (+) mating type is more virulent than the (-) 
mating type species (Lee and Heitman, 2014, Stewart and Munday, 2005). Similar observations 
have been made with Mucor piriformis, the causative agent of Mucor rot in plants (Stewart and 
Munday, 2005, Lee and Heitman, 2014, Kennedy et al., 2016).  
Mating types are also linked to spore dimorphism and virulence in M. circinelloides, where (+) 
types are more virulent than their (-) counterparts. However, further investigations now show 
that the sexM gene may not solely be responsible for dimorphism in spores as mutants for this 
gene can still produce large spores (Lee and Heitman, 2014, Li et al., 2011, Lee et al., 2010). 
We can perhaps suggest that spore size may be controlled by the SexP gene or other genetic 
loci acting either independently or in concert with the sexM gene. 
The sex paradigm here can easily be related to that of the basidiomycete, Cryptococcus 
neoformans where the alpha mating type predominates both in the environment and clinical 
niches. Whether this unisexual bias in Cryptococcus can be extrapolated to explain the 
virulence predominance expressed by (+) mating type in the mucorales remains to be explored. 
Nonetheless, as efforts are made to understand virulence dynamics of mucormycetes, it is 
apparent to note that sex types may significantly influence aetiology by mucoralean fungi and 
such implications should be keenly looked for in future studies. However, for this study we 






1.4 Clinical features of mucormycosis 
1.4.1 Epidemiology of mucormycosis  
Mucoralean fungi are the aetiological agents of an infection called mucormycosis. This is a 
rare but emerging opportunistic invasive filamentous fungal disease. Mucormycosis is fatal 
and is associated with high (30-90 %) mortality rates worldwide (Table 1) (Brown et al., 2012). 
Fatality rates of the disease are increased if not diagnosed early enough to allow aggressive 
treatment and management (Lewis and Kontoyiannis, 2013).  
Individuals at risk include a cohort of immunosuppressed patients, particularly those with 
uncontrolled hyperglycaemic ketoacidosis, trauma, malignancies (haematological (HM) and 
non-HM), iron overload, neutropenia or organ transplant. The disease can also target healthy 
individuals, especially those inoculated via traumatic injuries (Petrikkos et al., 2014, Lewis and 
Kontoyiannis, 2013, Kyriopoulos et al., 2015, Brown et al., 2012). 
Mucormycosis can manifest in at least six different forms, including rhino-cerebral, 
disseminated, pulmonary, cutaneous and gastrointestinal forms (Petrikkos et al., 2012, Singla 
et al., 2018). Clinical manifestations are often unique and aggressive, with gruesome and 
almost irreversible complications, which usually occur during late stages of the infection 
(Figure 4). Early signs of  the infection can be non-specific and almost indistinguishable from 
other invasive fungal infections (IFIs) (Lewis and Kontoyiannis, 2013).  
Although the disease is associated with severe clinical consequences, its epidemiology is still 
poorly documented. So far, only a handful of surveillance studies exist, and these places 
incidence of mucormycosis (including cases by entomophthorales) at 1.2 to 1.7 cases per 
million persons per year (Rees et al., 1998, Petrikkos et al., 2014). The caveat with these 
statistics is that majority of the studies have been done in Europe which is only about a fifth of 
the world’s population. Indeed, more studies are needed if the worldwide incidences of 





Table 1: Worldwide distribution of mycoses  
Disease Location Estimated life-
threatening 
infections / year 
at that location 
Mortality rates 
(% in infected 
populations) 
Opportunistic invasive mycoses 
Aspergillosis (A. fumigatus) 
Candidiasis (C. albicans) 
Cryptococcosis (C. neoformans) 




































































Figure 4: Mucormycosis manifests clinical symptoms characteristic of tissue death. 
Clinical manifestations of mucormycosis are characterised by angio-invasion which culminates 
into tissue necrosis and manifestations range from superficial to disseminated infections. (a 
and d) Depict cutaneous presentation, one of the most prevalent forms of mucormycosis. (b 
and c) Depict gross presentation of invasive mucormycosis in a patient infected via traumatic 













Review of literature reporting incidence of mucormycosis from the past 10-15 years generally 
shows an increase in mucormycotic cases. Some of which highlight similar predisposing 
factors as mentioned earlier while others report new risks for mucormycosis. For instance, 
recently the exposure to drugs such as voriconazole with limited or no anti-mycotic activity is 
reported as being a major and new emerging risk factor for mucormycosis (Petrikkos et al., 
2014, Mendoza et al., 2015, Moreira et al., 2016, Riley et al., 2016, Kontoyiannis et al., 2000, 
Kontoyiannis et al., 2016, Petrikkos and Drogari-Apiranthitou, 2011, Bonifaz et al., 2012, 
Saegeman et al., 2010, Bitar et al., 2009, Ambrosioni et al., 2010, Meis and Chakrabarti, 2009, 
Roden et al., 2005).  
In addition to the forms mentioned above, soft tissue involvement is also a common 
presentation of mucormycosis. The aetiological agents of this and the afore mentioned forms 
are predominantly Rhizopus, Lichtheimia, and Mucor species (Petrikkos et al., 2014, Mendoza 
et al., 2015, Moreira et al., 2016, Riley et al., 2016, Kontoyiannis et al., 2000, Kontoyiannis et 
al., 2016, Petrikkos and Drogari-Apiranthitou, 2011, Bonifaz et al., 2012, Saegeman et al., 
2010, Bitar et al., 2009, Ambrosioni et al., 2010, Meis and Chakrabarti, 2009, Roden et al., 
2005). Other aetiological agents such as Cunninghamella bertholletiae are also occasionally 
reported but predominantly in health individuals.  
This background clearly highlights the clinical relevance of mucormycosis; and the need to 
better our understanding of epidemiological impact, aetiology, pathogenesis, diagnosis and 
treatment is now apparent in order to improve prognosis.  
 
1.4.2 Aetiology of mucormycosis 
Mucoralean fungi are a group of rapidly growing, heterotrophic, terrestrial thermotolerant 





as opportunists, some may infect immunocompetent individuals (Chayakulkeeree et al., 2006, 
Mendoza et al., 2015).  
Rhizopus species are the most prevalent, responsible for about half of the reported cases (Roden 
et al., 2005, Petrikkos et al., 2014). Common examples include, Rhizopus arrhizus, R. 
16icrospores, and R. oryzae. Other genera often implicated include Mucor, Lichtheimia 
(formally Absidia), Cunninghamella, Rhizomucor, Apophysomyces, Mortierella, Saksenaea, 
Syncephalastrum and Cokeromyces (Figure 5) (Roden et al., 2005, Zaki et al., 2014, 
Antoniadou, 2009). Lichtheimia and Mucor are the second and third most frequent causes of 
mucormycosis. Cunninghamella, Lichtheimia and Apophysomyces species cause disease in 
immunocompetent individuals (Simitsopoulou et al., 2010, Lake et al., 1988). R. pusillus is the 
most common member of the Rhizomucor genus, and debate as to of whether Mortierella is a 
true mucoralean fungus continues, as members of this genus are unable to sporulate like 

















Figure 5: The Common aetiological agents of mucormycosis. 
Aetiology of mucormycosis is dominated by members of the Rhizopus, Mucor and Lichtheimia 
genera but occasionally infections due to members of Cunninghamella, Mortierella and 
Rhizomucor are also reported. Images were taken from Mycology Online-University of 
























1.4.2.1 Rhizopus microsporus as an aetiological agent of mucormycosis. 
R. microsporus is among the emerging aetiological agents of mucormycosis. This agent falls 
within the most prevalent genera in Rhizopus, with R. oryzae as the commonest cause of 
mucormycosis (Roden et al., 2005, Ribes et al., 2000). However, recent clinical reports 
particularly from middle income countries such as India show a changing trend in the aetiology 
of mucormycosis, importantly highlighting the increasing incidences due to R. microsporus 
(Pandey et al., 2018, Ribeiro et al., 2012, Lyskova et al., 2013). It has so far been implicated 
in patients with but not limited to diabetis, haemopoetic stem cell transplantation (HST) and 
traumatic cases (West et al., 1995, Pandey et al., 2018, Wang et al., 2018, Ville et al., 2016). 
The commonly implicated strains of R. microsporus are R. microsporus var microsporus, R. 
microsporus var oligoporus, R. microsporus var rhizopodoformis and R. microsporus var 
azygosporus (Pandey et al., 2018, West et al., 1995, Ribeiro et al., 2012, Sato et al., 2016). 
Thus, this changing trend shows how relevant it is to explore virulence attributes of R. 
microsporus. In this project, we focus mainly on a clinical isolate of R. microsporus as the 
model organism for this study.  
 
1.4.3 Pathogenesis mucormycosis 
Normally the immune system will recognize, contain, and selectively eliminate threats posed 
by infecting particles such as mucormycete propagules. However, this ability is impaired under 
certain conditions facilitating colonization by the pathogens. For mucormycosis, development 
heavily depends on underlying factors which can be host or pathogen based. Examples of host-
based are mentioned (Section 1.4.1) above whereas pathogen-based factors will be detailed 
later on.  
It appears that most of the host factors are highly linked to defective phagocytic effector 





therapy and iron overload affect the ability of macrophages to contain and prevent spore 
germination following uptake (Mendoza et al., 2015, Gebremariam et al., 2016, Gebremariam 
et al., 2014, Andrianaki et al., 2018b, Ibrahim et al., 2012).  
 
1.4.4 Host factors for mucormycosis 
1.4.4.1 Diabetes and metabolic acidosis 
Until recently, diabetes and metabolic acidosis were regarded the most prevalent risk factors 
for mucormycosis, estimated in about 36-88% of mucormycosis cases. This has recently been 
overshadowed by an over-representation of haematological malignancies, especially in Europe 
(Mendoza et al., 2015, Nithyanandam et al., 2003, Ibrahim and Kontoyiannis, 2013, 
Kontoyiannis et al., 2012, Petrikkos et al., 2014, Chen et al., 2017, Anane et al., 2009). As far 
as diabetes is concerned though, its role in disease progression is usually associated with 
elevation of serum ketone levels, a condition known as diabetic ketoacidosis (Nithyanandam 
et al., 2003, Gebremariam et al., 2016, Petrikkos et al., 2014, Ribes et al., 2000, Roden et al., 
2005, Gen et al., 2013, Chen et al., 2017, Trabelsi et al., 2005, Anane et al., 2009). The 
condition results in acidification with subsequent decline of blood pH (Mendoza et al., 2015, 
Gebremariam et al., 2016, Boelaert et al., 1988). The shift in pH impacts on a series of 
physiological events; most notably the deposition of iron from its carrier proteins such as ferrin, 
transferrin and lactoferrin (Mendoza et al., 2015, Boelaert et al., 1989, Artis et al., 1982, 
Boelaert et al., 1993).  
Iron is an essential nutrient for both the host and fungus. Its release increases its availability to 
the pathogen, promoting pathogenicity by enhancing fungal growth (de Locht et al., 1994, 
Verdonck et al., 1993, Mendoza et al., 2015, Weinberg, 1971, Weinberg, 1994, Boelaert et al., 
1993, Ibrahim et al., 2008c, Gebremariam et al., 2016). Under normal conditions, the ferrin 
proteins are responsible for physiological iron homeostasis, regulating its availability and 





clinically be managed by iron chelating agents such as deferoxamine and deferasirox. 
However, whilst deferasirox is a potent chelator, deferoxamine is a xeno-siderophore of iron 
as explained in the next section below (Windus et al., 1987).  
 
1.4.4.2 Iron overload  
Iron is an essential metal and the second most abundant after aluminium. It exists in two 
ionization states of Fe2+ or Fe 3+ (Howard, 1999). The metal is required for a range of biological 
systems as a cofactor for several enzymes involved in redox processes (Howard, 1999, 
Johnson, 2008, Condon et al., 2014, Zhang et al., 2013). In context, iron is essential to both the 
host and fungal pathogens and thus it is apparent that both compete for the nutrient for survival 
(Nairz et al., 2010, Nevitt, 2011, Condon et al., 2014).  
 
Human hosts are able to limit the availability and access to micronutrients by pathogens 
through a process called nutritional immunity (Leon-Sicairos et al., 2015, Condon et al., 2014). 
In regard to iron homeostasis, the host has evolved mechanisms such as expression of 
glycoproteins like ferrin, transferrin and ferritin that physiologically bind and transport iron. In 
order to circumvent host iron chelation, pathogens including fungi have evolved subtle 
mechanisms such as non-ribosomal secreted iron chelators (siderophore), reductive iron 
assimilation or possession of ferritin-like proteins that enable them access host reserves 
(Howard, 1999, Weinberg, 1971, Frederick et al., 2009, Condon et al., 2014).  
To the contrary though, opportunistic fungal pathogens such as mucormycetes demonstrate 
reduced ability to evade host chelation.  However, their access to highly restricted nutrients 
such as iron can be made possible under certain conditions such as diabetic ketoacidosis 
(DKA), deferoxamine therapy, multiple blood transfusions or dyserythropoiesis (Mendoza et 
al., 2015, Chayakulkeeree et al., 2006, Boelaert et al., 1989). This subsequently improves 





of impaired iron homeostasis in the development of mucormycosis both clinically and in 
animal models (Mendoza et al., 2015, Chayakulkeeree et al., 2006, Gebremariam et al., 2016, 
Boelaert et al., 1988, Boelaert et al., 1993).  
In addition, the role of iron in expression of glucose regulated protein (GRP) 78 and its fungal 
ligand the CotH3 has been characterised. Both initiate and promote invasion of endothelial 
cells by the R. oryzae. Glucose, iron and beta hydroxyl-butyrate, conditions synonymous 
during DKA promote over expression of these proteins which compromises survival of mice 
and treatment with an anti-CotH3 antibody rescues the mice making CotH a possible anti-
fungal target (Gebremariam et al., 2014, Gebremariam et al., 2016).  
 
1.4.4.3 Trauma and blast injuries  
Mucoralean fungi often target soft tissues such as sinuses, brain, lungs, gastrointestinal tract 
and the skin. In rare cases the maxilla may also be infected but not often due to a rich blood 
supply to these  regions which will most certainly prevent infection by most fungal agents with 
exception of the more virulent ones (Auluck, 2007).  
However, during trauma to soft tissues, opportunistic fungi including mucormycetes will thrive 
among immunocompetent and immunosuppressed individuals (Kaur et al., 2014, Kennedy et 
al., 2016, Kontoyiannis and Lewis, 2006, Chayakulkeeree et al., 2006, Mendoza et al., 2015, 
Saez et al., 2014, Wang et al., 2018, Gkegkes et al., 2018, Skiada and Petrikkos, 2013, Mayayo 
et al., 2013, Warkentien et al., 2015, Lelievre et al., 2014, Weddle et al., 2012).  
This is because traumatic injury promotes implantation of fungal propagules into deeper layers 
of the tissues possibly leading to accessibility of the endothelial cells by fungal spores. These 
host cells facilitate infection because they possess GRP78 receptor that binds CotH3, a highly 
expressed ligand on mucormycete spores that facilities spore binding with host cells as 
mentioned (Kaur et al., 2014, Kennedy et al., 2016, Kontoyiannis and Lewis, 2006, 





The commonest clinical form in these patients is invasive cutaneous mucormycosis often 
linked with co-morbidities such as Morel Lavallee lesions. Morel Lavallee lesion is a closed 
delving soft tissue injury resulting from an abrupt separation of skin and subcutaneous tissue 
(Singla et al., 2018, Jundt et al., 2018, Ingram et al., 2014, Kronen et al., 2017, Warkentien et 
al., 2015, Neblett Fanfair et al., 2012).  
Nonetheless, colonization by mucoralean fungi can still be facilitated by other confounding 
factors such as inoculum size or any of the other mentioned risk factors (Section 1.4.1). 
Meanwhile in other traumatic patient types such as those with burns, use of broad spectrum 
antibiotics and/or topical anti-bacterial increases the risk whereas nosocomial mucormycosis 
is also reported among patients with surgical wounds and catheterization (Chayakulkeeree et 
al., 2006, Zhao et al., 2012, Davuodi et al., 2015, de Chaumont et al., 2014, Kaur et al., 2014) 
 
1.4.4.4 Immunosuppressive and other risk factor for mucormycosis 
Several immunosuppressive conditions that trigger mucormycotic infections have already been 
mentioned and the list continues to grow, with mortality rates of between 60-100% now 
associated with immunosuppressive disorders (Chayakulkeeree et al., 2006) (Gurevich et al., 
2012, Mousset et al., 2010, Page et al., 2008, Hamdi et al., 2014, Petrikkos et al., 2014, Lewis 
and Kontoyiannis, 2013, Rodriguez-Gutierrez et al., 2015, Singh et al., 2007, Vinh et al., 2009, 
Deyo et al., 2017, Sriperumbuduri et al., 2017).  
Interestingly, HIV/AIDs is not a common risk for mucormycosis. Its link to the disease is so 
far associated with intravenous drug use (Chayakulkeeree et al., 2006). Other risk factors 
recently identified have included neonatal prematurity, systemic lupus erythematosus (SLE), 
nephrotic syndrome, malnourishment and prolonged use of broad-spectrum antimicrobials 
including antifungals such as voriconazole (Chayakulkeeree et al., 2006, Gomes et al., 2011, 






1.4.5 The mucormycete related virulence attributes  
Whilst host factors are somewhat known, pathogen associated factors for mucormycotic 
disease development are poorly understood. This knowledge gap has affected our 
understanding of aetiology, diagnosis, treatment and management, but most importantly the 
pathogenicity of mucoralean fungi. Thus, examining host-mucormycete interactions is key for 
underpinning the principles governing disease manifestations.  
 
From present data so far, we can tell that aetiology and risk factors are quite diverse but with 
common clinical presentations of the disease. This may suggest similar mechanisms in 
virulence attributes of the aetiological agents. Yet only a handful of virulence factors for 
mucormycetes have been identified to date including but are not limited to inoculum dose, 
spore size and dimorphism, hyphal biomass, and ability for attachment to matrix proteins as 
detailed below (Mendoza et al., 2015, Ibrahim et al., 2012, Gomes et al., 2011)   
 
1.4.5.1 Spore size, inoculum size, and hyphal biomass as virulence attributes for 
mucormycetes 
Mucoralean fungal spores are the main source of infection. The hypothesis that spore size may 
contribute towards virulence has been proposed (Iwen et al., 2005) . The size of these spores’ 
ranges between 3-11 m (Ribes et al., 2000, Richardson, 2009). Spore size is linked to their 
tropism into specific sites of infection, especially in the respiratory tract.  
It is believed that smaller spores of size <5m are deposited in the lower airway whilst larger 
ones of size >7m remain trapped in the upper respiratory tract (Richardson, 2009, 
Chayakulkeeree et al., 2006, Li et al., 2011, Gomes et al., 2011, Iwen et al., 2005). Infections 





mucormycosis, as opposed to Rhizopus pusillus of size 3-5m, causes lower tract disease and 
has been used to support this paradigm (Gomes et al., 2011, Antachopoulos et al., 2010).  
Additionally, size is also correlated with spore germination and virulence. For instance, reports 
show large spores metabolically germinate faster than small spores. This is further 
demonstrated during infection where large spores, but not small ones, are able to germinate 
inside macrophages (Gomes et al., 2011, Li et al., 2011). This can be compared to titan and 
goliath cells of Cryptococcus and Candida species, respectively which are believed to evade 
phagocytosis (Zaragoza et al., 2010, Okagaki et al., 2010, Mendoza et al., 2015, Dambuza et 
al., 2018).  
However, if we are to consider large spores as being more virulent, then we may fail to explain 
why the aetiology of mucormycosis is dominated by Rhizopus species which produces spores 
of small size less than 5m (Ribes et al., 2000, Petrikkos et al., 2014, Roden et al., 2005). 
Similarly, so the hypothesis on influence of size on tropism can also be thrown into question.  
On the other hand, infection by hyphal biomass can also occur. When this happens, 
Polymorphonuclear neutrophil (PMN) mediated killing is tasked to damage and eliminate the 
fungal mass. However, PMN killing can be overcome if the inoculum is heavy enough to impair 
PMN killing ability (Li et al., 2011, Mendoza et al., 2015, Chayakulkeeree et al., 2006, Honda 
et al., 1998, Antachopoulos et al., 2010, Simitsopoulou et al., 2010, Chamilos et al., 2008c). 
This pathogenicity feature is thought to be genus specific though. For instance, 
Cunninghamella bertholletiae, whose infections progress much faster than other aetiologies, 
are believed to largely benefit from impaired PMN effector functions (Chayakulkeeree et al., 
2006, Simitsopoulou et al., 2010). This may partially explain why neutropenic patients are 






1.4.5.2 Attachment to matrix proteins  
Attachment on a target cell is the first step of infection for most pathogens including most 
mucoralean fungi. Mucormycete spores have a high affinity for matrix proteins such as laminin 
and Type IV collagen in vitro (Ibrahim et al., 2005, Mendoza et al., 2015, Bouchara et al., 
1996). Mucormycetes also show affinity and specificity for endothelial cells in vitro, as 
demonstrated with R. oryzae, due to the presence on endothelial cells of the glucose-regulated 
protein GRP78, a specific receptor for the spore surface ligand CotH (Mendoza et al., 2015, Li 
et al., 2011, Ibrahim et al., 2005, Liu et al., 2015, Gebremariam et al., 2016, Gebremariam et 
al., 2014, Liu et al., 2010). Studies in a mouse model show that GRP78, a member of the heat 
shock protein (Hsp70) chaperone family, is overexpressed during hyperglycaemia and 
increased iron levels; and CotH expression by Rhizopus spores is also increased under similar 
conditions. Indeed, a mutant of R. oryzae for CotH, exhibits reduced ability to invade and 
damage endothelial cells over-expressing GRP 78; and fails to sustain an infection in DKA 
mouse model (Liu et al., 2015, Mendoza et al., 2015, Liu et al., 2010, Gebremariam et al., 
2014). Indeed, treatment with anti-CotH antibodies prevents R. oryzae from establishing an 
infection in a DKA mouse model, proving that the CotH ligand can be targeted as a virulence 
factor (Gebremariam et al., 2014, Gebremariam et al., 2016) 
 
1.4.5.3 Spore germination as a virulence attribute of mucormycetes  
Fungal spores are ubiquitous in the wider environment and their colonisation of environmental 
niches is initiated following germination. Similarly, so this physiological and an indispensable 
process is crucial for the establishment and manifestation of an infection. For instance, this is 
true with mucoralean fungi where germination of spores to hyphae manifests symptoms such 
as angio-invasion, tissue necrosis, thrombosis and dissemination (Sephton-Clark et al., 2018). 
In context, shifts in gene expression levels have been noted following initiation of fungal 





cytoskeleton have all appeared to be key for germination (Sephton-Clark et al., 2018, Soll and 
Sonneborn, 1971, Thevelein et al., 1982, Tsukahara, 1980). Indeed, the transition from 
dormancy to vegetative forms allows for the onset of disease. In vitro this can take as little as 
6 h, thus allowing the fungus to colonise favourable environments. Studies on R. delmar and 
Nosema bombycis reveal significant differences in transcriptional signatures in dormant and 
germinated spores (Liu et al., 2016, Sephton-Clark et al., 2018). However, the metabolomics 
of germinating spores is still poorly understood and exploration of these aspects in now 
invaluable. In this study, we shall explore the impact of spore germination on host fungal 
interactions.  
 
1.4.5.4 Bacterial symbiosis as a virulence attribute  
It is common for fungi to host bacterial symbionts in what can be termed as purely mutualistic, 
addictive and transmissible relationship. Mucormycetes, particularly of the Rhizopus genus, 
have been identified to harbour and maintain subtle interactions with endo-hyphal bacteria. 
(Ibrahim et al., 2008b, Dolatabadi et al., 2016, Araldi-Brondolo et al., 2017, Lackner et al., 
2009a, Lastovetsky et al., 2016, Frey-Klett et al., 2011, Gee et al., 2011, Moebius et al., 2014a, 
Compant et al., 2008, Bonfante and Desiro, 2017, Mondo et al., 2017).  
 
1.4.5.5 Bacterial symbiotic influence on Mucoralean fungi (non-pathogenic mechanisms) 
Bacterial endosymbionts are known to establish associations such as facultative, addictive and 
mutualistic relationships with several hosts. A diverse range of hosts have been revealed to 
establish such relations including but not limited to plants, insects and fungal hosts (Cooper et 
al., 2017, Mioduchowska et al., 2018, Papa et al., 2017, Sazama et al., 2019). These 
associations can influence the hosts capacity to adapt to various environments in addition to 
rendering them susceptible or resistant to pathogens and antimicrobials (Cooper et al., 2017, 





on various levels including influence on fungal reproduction, metabolism, virulence, thermo-
tolerance, antifungal resistance and their evolution among other effects (Spraker et al., 2016, 
Araldi-Brondolo et al., 2017, Mondo et al., 2017, Murray et al., 2017, Nazir et al., 2014, 
Salvioli et al., 2016, Hoffman et al., 2013, Shaffer et al., 2017, Lastovetsky et al., 2016, Frey-
Klett et al., 2011, Partida-Martinez et al., 2007c).  
For instance, Mondo et al (2017) has recently described that bacterial endosymbiont influences 
fungal sexuality by an endosymbiont gaining transcription control of the fungal RAS2 gene 
which encodes GTPases key for fungal reproduction in R. microsporus (Mondo et al., 2017). 
This is also implicated in the reproductive addiction that exists between this fungus and the 
proteobacteria Burkholderia (Mondo et al., 2017). Yet, what remains unclear is whether these 
impacts contribute towards clinical manifestation of mucormycosis. 
 
1.4.5.6 Bacterial symbiotic influence on mucoralean fungi (pathogenic mechanisms) 
Endo-hyphal bacteria contribute towards plant-fungal pathophysiology. Some Burkholderia 
species are endosymbionts of R. microsporus and are associated with toxinogenic 
manifestation of rice blight disease. For instance, the toxins rhizoxin, implicated in rice blight; 
and rhizonin, a hepatotoxic cyclopeptide are both produced by bacteria belonging to the genus 
Burkholderia. Rhizoxin is a potent anti-mitotic agent that acts by binding beta tubulin of 
eukaryotic cells, while the mode of action for rhizonin is not yet known but implicated in 
hepatotoxicity (Scherlach et al., 2006, Partida-Martinez and Hertweck, 2005, Takahashi et al., 
1987, Iwasaki et al., 1984, Fukushima et al., 1982, Partida-Martinez et al., 2007a). However, 
either toxins are yet to be implicated in the pathogenesis of human mucormycosis.  
Together with other clinical observations, the hypothesis that bacterial endosymbionts might 
play a role in the pathogenesis of mucormycosis has been proposed by Chamilos et al. (2007). 
He postulates that whilst mucoralean fungi are equally ubiquitous and virulent as Aspergillus, 





to the wide usage of antibiotics in the management predisposed patients. In their observations, 
they point out the predominance Rhizopus species as aetiological agents for mucormycosis. 
Given the close association between Rhizopus and bacterial endosymbionts, they highlight that 
pathogenicity of these mucoralean fungi might be modulated by bacterial presence (Chamilos 
et al., 2007).  
Indeed, there are other lines of evidence that also support this hypothesis. For instance, Sugar 
et al reports that ciprofloxacin, a quinolone with no intrinsic antifungal activity, can act 
synergistically with antifungals to improve the survival of mice during mucormycosis. This 
mode of treatment has been used against Candida spp but out-put has been attributed to 
inhibition of fungal topoisomerases (Sugar and Liu, 2000, Sugar et al., 1997, Chamilos et al., 
2007). Sugar et al further shows that elimination of the endosymbiont from the fungus by 
quinolones reduced fungal pathogenicity and increased antifungal efficacy. However, so far 
there is no evidence where administration of quinolones alone rescues mice from fungal 
infection. Taken together, Chamilos et al suggests that with use of antibiotics in management 
of immunosuppressed individuals, mucormycotic cases were kept in check until perhaps later 
when antibacterial resistance developed (Chamilos et al., 2007).  
In regard to, Ibrahim et al (2008) recently reported that endosymbionts, though widely found 
among mucoralean fungi do not contribute towards pathogenesis of mucormycosis. Showing 
no difference in the survival of DKA mice infected with parent or endosymbiont free strains of 
R. oryzae (Ibrahim et al., 2008b). Partida-Martinez et al (2008), also through screening of 
clinical isolates of mucormycetes for endosymbionts, reports absence of toxin producing 
bacteria employing metabolic, molecular and microscopic screening techniques (Partida-
Martinez et al., 2008).   
From this stand point, it is fair to say that the role of bacterial endosymbionts in pathogenesis 





only two studies suggesting otherwise. It is too soon to neglect bacterial endosymbionts without 
an exhaustive account. The existing evidence of possible modulation of fungal phenotypes by 
these symbionts is intriguing enough to demand through dissection of possible influence on 
fungal; and this thesis will further investigate this point. 
 
1.4.5.7 The fungal cell wall and its’ role in immunological responses 
The fungal cell wall is a recognised living cellular organelle that has the capacity to change 
and adopt to demands of the ever-changing environments apart from maintaining cellular 
integrity. Importantly it is the primary site of interaction with the host cells (Lee and Sheppard, 
2016).  Studies on the fungus C. albicans reveal that its cell wall is mainly composed of three 
major generic structures including mannans, ß-glucans and chitin as shown in (Figure 6)  (Gow 
et al., 2017). However, on the other hand the cell wall of filamentous fungal organisms is poorly 
studied. Recent studies of the filamentous fungi such as Aspergillus fumigatus show that over 
90% of its cell wall is made of polysaccharides (Latge et al., 2017). These include the (alpha 
and beta) 1,3 glucans, chitin, galactomannan and beta (1,3) (1,4) glucans, whose biosynthesis 
has been associated with three major enzymes i.e. the transmembrane synthases, the 
transglycosidases and glycosyl hydrolases (Latge et al., 2017, Bernard and Latge, 2001). 
Recently the role of melanin is being better appreciated as a filamentous fungi immune 
modulation tool especially with A. fumigatus (Chai et al., 2010, Stappers et al., 2018).  All of 
these structures (also called the pathogen associated molecular patterns (PAMPs) play major 
roles during infection because recognition of these structures by the host pattern recognition 
receptors (PRRs) can orient the host immune responses (Dubey et al., 2014, Bernard and Latge, 
2001, Gow et al., 2017). On the other hand, the study into the mucormycete cell wall is lagging 
behind. But so far, a few studies reveal the uniqueness that exists between the mucormycete 
and other well characterised fungal cell walls (Melida et al., 2015). Studies on Rhizopus oryzae 





to algal fucoidans (Melida et al., 2015). These are unexpected polymers usually associated with 
low glucans and increased chitin expressions levels (Melida et al., 2015). However, conserved 
production of mannans in Zygomycetes and Ascomycetes has been noted (Burnham-Marusich 
et al., 2018). To a lesser extent, the cell wall of the mucormycete spores remains poorly studied, 
but a study by Andrianaki et al, reveals the role of melanin in inhibiting macrophage functions 








Figure 6: The fungal cell wall is made of three main generic structures. 
The fungal cell wall is made of four major generic morphological structures including 























1.4.5.8 Stages of mucormycete infection of host cells  
Susceptibility to mucormycosis is strongly linked to the underlying conditions that predispose 
one this fungal disease. For instance, iron deposition is a marked factor for hypersensitivity to 
mucormycosis (Ibrahim et al., 2010, Shirazi et al., 2015). However, the lack of functional 
phagocytes also underlines how vital these cells are in the host defence against mucoralean 
fungi (Roilides et al., 2012, Inglesfield et al., 2018). For mucoralean fungi to be successful 
pathogens must adhere to, invade while evading host defence mechanisms. Thus, 
understanding how this happens in crucial to underpinning control of mucormycosis.  
Unfortunately, there is no enough information available on how mucoralean fungi invade host 
cells in the various sites including lungs, sinus, intestinal epithelial and soft tissue to elicit an 
infection. 
So far, the stages of infection have been suggested to involve; Firstly, interaction of infecting 
propagules with extracellular matrix components (Section 1.4.5.2). These are usually 
extracellular protein matrices that separate epithelial and endothelial cells from the stroma, 
providing support and acting as barriers for the invading organisms (Figure 7) (Timpl et al., 
1979). Secondly, breaching the endothelial barrier leads to the interface between the infecting 
particles with the host defence mechanisms particularly innate phagocytes and complement 
system. For instance, inhalation of mucoralean spores does not lead to development of disease 
because macrophages phagocytose spores and inhibit their germination (Figure 7) (Waldorf 
and Diamond, 1984). In susceptible individuals mucormycete can easily evade macrophage 
mediated killing such as generation of oxidative metabolites, cationic peptides and defensins 
(Ibrahim, 2011, Diamond et al., 1978, Waldorf and Diamond, 1985). Thirdly; interaction and 
evasion of the endothelium (angio-invasion). This has been suggested by some authors as the 
most crucial stage in the pathogenesis of mucormycosis also referred to as the hallmark for the 





into vessel thrombosis and tissue death further exacerbating the infection following cut off of 
leukocyte and antifungals to the foci of the infection. Additionally, this stage of infection is 
also underlined by the presence of host GRP78 and the fungal CotH ligand (Gebremariam et 
al., 2014). However, the interaction mechanisms between mucormycete propagules and host 







Figure 7: Mucoralean fungi invades host through evasion of host defence mechanisms. 
Mucormycosis is initiated through inhalation, ingestion or direct implantation into an abraded 
skin of fungal particles. The spores then bind host exposed matrix proteins, this can be aided 
by secreted fungal proteases. Once inside the tissue, the spores can evade macrophage mediated 
killing effector functions. This leads to invasion of the endothelium, in susceptible individuals 















1.4.6 Diagnosis of Mucormycosis 
Early diagnosis is important in clinical management of mucormycosis but can be challenging 
because early symptoms are usually non-specific and are often indistinguishable from other 
fungal infections (Kontoyiannis and Lewis, 2011). Unfortunately, there are hardly any 
serological biomarkers, and recently developed tools such as ß-D-glucan and Aspergillus 
galactomannan tests are yet to prove applicable to mucormycotic diagnosis (Farmakiotis et al., 
2018). Additionally, immunodiffusion techniques often used for the diagnosis of close 
relatives, the entomophthoramycetes, are yet to prove useful for mucormycosis and have shown 
vulnerability to cross-reactivity (Kaufman et al., 1990, Yangco et al., 1986, Mendoza et al., 
2015).  
Thus, mucormycotic diagnosis is achieved primarily by microscopy (direct or fluorescence), 
culture and histology (such as haematoxylin and eosin (H&E), Grocott –Gomori methenamine-
silver nitrate and period acid Schiff (PAS)) (Figure 8). Histology is a more definitive tool 
compared to direct microscopy and culture; in addition, both techniques are prone to 
environmental contamination. Indeed, sensitivity of culture results can be questionable, but 
repeated culturing and isolation from sterile sites does allow positive diagnosis (Kontoyiannis 
and Lewis, 2011, Kontoyiannis et al., 2000). Note that a positive direct examination does not 
always correlate with culture results.  
Recently, improved and more advanced diagnostic tools have also been invented to improve 
clinical diagnosis of mould infections. These have included aggressive computed tomography 
(CT) guided fine needle aspiration. This is superior to many of the conventional techniques 
such as staining, polymerase chain reaction, and antigen and enzyme biomarkers, but is not 
routinely applicable due to several challenges including limited access to CT scanners, lack of 
awareness of infection risk among diagnosis doctors, CT data interpretation, cost, rapid rate of 





It is important differentiation of mucormycetes from other moulds is promptly made for proper 
and specific management of mucormycosis. Usually, molecular approaches such as PCR are 
used for this purpose but are not widely applicable especially in resource limited settings 
(Schwarz et al., 2006, Kasai et al., 2008). It would also appear that a physician’s early suspicion 
of the disease can also be as important during diagnosis of mucormycosis (Kontoyiannis and 

























Figure 8: Tools for diagnosis of clinical mucormycosis 
 Clinical materials and some of the common tools used in the diagnosis of mucormycosis 
including (a) shows pathological tissue sample demonstrating sections of fungal infestation 
shown by arrows (b) demonstration of Grocott sliver staining of a pathological tissue sample 
(c) demonstration of haematoxylin and eosin staining of an infested pathological tissue sample 
and, (d) demonstration of calcofluor white staining of fungal elements in pathological samples. 
Images are adopted from clinical reports of mucormycosis (Taken and adapted from Lass-Florl 












1.4.7 Treatment of Mucormycosis 
Mucormycosis is a challenging infection to treat and proper management of the disease is 
dependent on four major factors including timely diagnosis, reversal of the underlying 
predisposing factors, surgical debridement, and aggressive administration of antifungal therapy 
(Chamilos et al., 2008b, Mendoza et al., 2015, Kontoyiannis and Lewis, 2011, Guevara et al., 
2004). A timely diagnosis significantly impacts prognosis, since early surgical removal of focal 
lesions can be triggered to prevent dissemination to vital organs (Mendoza et al., 2015). 
Reversal of predisposing factors helps to boost the host’s immunity (Mendoza et al., 2015, Abe 
et al., 1990, Ibrahim et al., 2007), and surgical debridement of infected tissues is widely used 
in mucormycotic management because the disease causes blood vessel thrombosis and necrosis 
that cut off blood supply to the infected sites. This also negatively impacts penetration by 
antifungals to the site  (Roden et al., 2005). Indeed, a combination of surgical debridement and 
antifungal treatment improves prognosis compared to use of antifungals alone, whilst a surgical 
remedy can be applied independently  (Langford et al., 1997, Tedder et al., 1994, Mendoza et 
al., 2015, Pelton et al., 2001, Ochi et al., 1988).  
 
1.4.7.1 Antifungal treatment remedy for Mucormycosis  
Mucoralean fungi are resistant to most antifungal agents but do show sensitivity to the polyenes 
which act by irreversibly binding ergosterol in the fungal cell membrane causing leakage of 
cell contents. These include drugs such as Amphotericin B deoxy cholate (AmB), however, 
treatment with this class requires administration of high doses to counter resistance. 
Mechanism of amphotericin B resistance can be via alterations in sterol content, re-orientation, 
masking or reduced ergosterol content and previous exposures to azoles (Spellberg et al., 





AmB is also associated with toxicity, but several modifications such as lipid modifications to 
Liposomal AmB (LAmBisome) or amphotericin B lipid complex (Abelcet) have been made 
that reduce toxicity though are also associated with reduced efficacy and penetration (Ibrahim 
et al., 2003, Noel, 1999, Reed et al., 2008, Gleissner et al., 2004, Mendoza et al., 2015, Groll 
et al., 2000, Ibrahim et al., 2008a, Lewis et al., 2010, Hamill, 2013, Gebremariam et al., 2017b).  
Occasionally, other antifungal classes such as azoles (e.g. itraconazole, fluconazole, 
voriconazole, triazole and posaconazole) have also been used to manage mucormycosis. These 
act by inhibiting the cytochrome P450-dependent 14-alpha-lanosterol demethylase of the 
fungal membrane leading to an accumulation of toxic cell membrane sterols and inhibit 
ergosterol production. This in turn causes impaired growth, replication and cell death. 
Mechanisms of resistance to azoles include, alteration or over-expression of lanosterol (14-
alpha) demethylase, and presence of energy dependent efflux systems (Sun et al., 2002, 
Espinel-Ingroff et al., 2001, Cuenca-Estrella et al., 2006, Mendoza et al., 2015, Dannaoui et 
al., 2002).   
In regard to azoles, Itraconazole has limited activity against Rhizopus species but has shown to 
have in vitro efficacy against Lichtheimia species (Sun et al., 2002, Mendoza et al., 2015). 
Fluconazole and the second generations broad spectrum azoles (e.g. triazole and voriconazole) 
have no in vitro activity against mucorales, whilst voriconazole, often used as a prophylactic 
treatment in at risk patients for invasive fungal diseases. Indeed, there have been reports for 
occurrence of mucormycosis in during treatment of aspergillosis and other mold infections 
with voriconazole  (Blin et al., 2004, Shindo et al., 2007, Pongas et al., 2009, Vigouroux et al., 
2005, Marty et al., 2004, Kobayashi et al., 2004, Oren, 2005, Sharifpour et al., 2018).  
In vitro investigations show similar findings, where simultaneous pre-treatment with all AmB, 
caspofungin acetate and voriconazole increases virulence of mucoralean fungi in both murine 





(Lamaris et al., 2009, Lewis et al., 2011). Labelling voriconazole as risk for acquiring 
mucormycosis in at risk individuals.  
Posaconazole demonstrates in vitro activity against mucormycetes but efficaciously inferior to 
AmB against Rhizopus oryzae and Mucor circinelloides in a murine model (Spreghini et al., 
2010, Dannaoui et al., 2003, Barchiesi et al., 2007, Luo et al., 2013, Enoch et al., 2011). 
Clinically, posaconazole can be an alternative in patients intolerant to or as a step down from 
polyenes (Mendoza et al., 2015, Enoch et al., 2011, Salas et al., 2012, Rodriguez et al., 2008). 
Isavuconazole and echinocandins (which target 1, 3-beta glucan synthase) are also activate 
against mucormycetes but with a narrow spectrum (Guinea et al., 2010, Guinea et al., 2008, 
Pfaller et al., 2013, Mendoza et al., 2015).  
Together, this demonstrates that antifungal mono-therapy is not enough for treatment of 
mucormycosis, and that combination therapy may improve prognosis when both intra- and 
interclass antifungals are used  (Lewis et al., 2010, Perkhofer et al., 2008, Simitsopoulou et al., 
2008, Gebremariam et al., 2017b, Gebremariam et al., 2017a, Luo et al., 2014). 
 
1.4.7.2 Other treatment remedies for mucormycosis 
Non-antifungal approaches can also be used in synergy to supplement treatment with 
antifungals. Such remedies include chelating agents such as iron chelators (e.g. deferoxamine 
and deferasirox). However as mentioned (Section 1.4.4.2) deferoxamine predisposes one to 
mucormycosis by acting as a xeno siderophore for iron whilst deferasirox is fungicidal against 
mucoralean fungi (Boelaert et al., 1993). A siderophore is a small, high affinity iron-chelating 
agent produced by fungi or bacteria to sequester iron across membranes; and a xeno 
siderophore would be a siderophore used by an organism other than the one that produces it 
(Boelaert et al., 1988, Arizono et al., 1989, Kaneko et al., 1991, Rex et al., 1988, Windus et al., 





burden in a murine model, though clinical trials of this combination were inconclusive 
(Donnelly and Lahav, 2012, Ibrahim et al., 2007, Spellberg et al., 2009, Spellberg et al., 2012).   
Lastly, other strategies have included use of barbaric oxygen in conjunction with standard 
therapy and FK506. The hyperbaric oxygen therapy is often used after surgical debridement 
particularly in cases of cutaneous disease and rhino-cerebral disease.  High oxygen 
concentrations may improve neutrophil killing of mucoralean fungi or inhibit fungal 
germination (Almannai et al., 2013, Ribeiro et al., 2013). FK506, is 23-membered macrocyclic 
polyketide. It possesses several biological activities such neuroprotective, neuro-regenerative 
anti-inflammatory and antifungal activities. It acts by targeting the heat shock protein 90 
(Hsp90) heavily involved in fungal survival and control calcineurin protein during stress 
responses and cell wall repair. Thus, FK506 operates by targeting Hsp90-calcineurin pathway 
(Ban et al., 2016, Lamoth et al., 2015)  
 
1.5 Immunity to Filamentous Fungal Infections  
Immunity is a balanced state of having primed or adequate defences to fight infection by 
unwanted biological invaders while having tolerance to self-antigens to avoid autoimmune 
disorders.  Antifungal immune responses can be dynamic depending on the individual 
organism characteristics such as morphology (conidia, spores or hyphae) and the site of 
infection. Primarily we are exposed to moulds such as mucoralean fungi through inhalation of 
infecting particles called spores. If not adequately cleared, disease progression often happens 
especially when a host’s recognition system or subsequent immune responses are broken down 
also known as immunosuppression (Blanco and Garcia, 2008, Romani, 2011). Antifungal 
immune responses are divided into innate or adaptive immunity (Deepe and Bullock, 1990, 






1.5.1 Innate Antifungal Immunity  
This is the first line of defence and largely not as specific as the adaptive. It is constitutive and 
includes physical barriers such as the skin, mucous membrane surfaces, normal microbial flora 
and several defensins including cell membranes, cellular receptors and humoral factors (Blanco 
and Garcia, 2008, Romani, 2011, Medzhitov and Janeway, 1997, Janeway, 2005). Beyond 
these is a host of other innate effector faculties such as hematopoietic phagocytes, including 
tissue resident macrophages, neutrophils, dendritic cells; and non-hematopoietic cells such as 
endothelial and epithelial cells (Janeway, 2005, Taylor-Smith, 2017, Leopold Wager et al., 
2016, Roitt and Delves, 2001, Brown, 2011).  The phagocyte including neutrophils, monocytes 
and macrophages are a key component of innate antifungal immunity because they facilitate 
intra and extracellular fungal containment and killing (Brown, 2011, Powers-Fletcher et al., 
2016). Respectively, monocytes and macrophages recognise, engulf and contain fungal 
particles attenuating fungal growth through antimicrobial secretions and nutrient deprivation, 
while neutrophils and monocytes will kill and damage conidia, spore germilings or fungal 
hyphae  by secretion of defensins and through oxidative mechanisms (Andrianaki et al., 2018b, 
Powers-Fletcher et al., 2016, Aimanianda and Latge, 2010, Luther et al., 2007, Schaffner et al., 
1982, Boyle et al., 2012). Indeed, underlying conditions such as leukaemia, aplastic anaemia, 
corticosteroid therapy, HIV/AIDs and auto immune diseases which can impair phagocyte 
counts and functions especially neutrophils can predispose one to infections by invasive fungal 
diseases including mucormycosis. For instance, corticosteroid therapy is known to impede 
oxidative burst and reduce lysosomal activity subsequently decreasing immune-cell 
mobilization (Duong et al., 1998, Ng et al., 1994, Powers-Fletcher et al., 2016).  
However, an interaction between these phagocytes and fungal particles is also facilitated by 
pattern recognition receptors (PRRs). These can be soluble or cell-associated and recognise 





instance, fungi possess cell wall antigens such as the capsule, glucans, glycoproteins, glucans, 
nucleic acids and melanin. These can trigger specific immune responses. PRRs are also 
expressed on other cells including dendritic and various nonprofessional immune cells such as 
endothelial cells, fibroblasts and epithelial cells (Janeway, 2005, Roitt and Delves, 2001, 
Garcia-Carnero et al., 2018, Blanco and Garcia, 2008, Salek-Ardakani et al., 2012, Powers-
Fletcher et al., 2016).  
Four families of PRRs have been identified so far and include C- type lectin receptors (CLR), 
Toll like receptors (TLR), nucleotide binding oligomerization domain (NOD)-like receptors 
(NLRs), and retinoic acid inducible gene (RIG)-I-like receptors (RLRs) Table 2.  Among all, 
CLRs and TLRs appear to be the empirical receptors associated with innate-antifungal 
immunity (Powers-Fletcher et al., 2016, Levitz, 2010).   
The CLRs are a group of both soluble and transmembrane receptors. Several including Dectin-
1, Dectin-2, dendritic cell (DC)-specific intracellular-adhesion molecule (ICAM) 3-grabbing 
non-integrin (DC-SIGN), macrophage inducible C-type lectin (Mincle) and soluble mannose-
binding lectin (MBL) receptors.  These interact with chitin, N-linked mannans and both alpha 
and beta glucans (Powers-Fletcher et al., 2016, Wang et al., 2011)  
Yet, TLRs, are a family of about 10 transmembrane receptors and appear to be one of the main 
recognition receptors for fungal pathogens through sensing beta glucan, mannans and nucleic 
acids. Specifically, TLR-2, -3, -4, -6, and -9 have been named in this regard (Braedel et al., 
2004, Powers-Fletcher et al., 2016).  It is important to note that, different fungal morphologies 
may impact on the type of immune responses via interaction with TLRs. For instance, whilst 
an interaction between Aspergillus conidia and macrophage via a TLR-4 dependent mechanism 
leads to production of pro-inflammatory cytokines (TNF-alpha) and interleukin (IL)-1ß, 





this, Aspergillus species are capable of evading the host’s innate immunity (Netea et al., 2003, 
Braedel et al., 2004, Powers-Fletcher et al., 2016). 
Table 2: Fungal PAMPs and cognate PRRs 
PAMPs on all fungi PRRs  
Mannans  Mannose receptor (CD206), 
DC-SIGN (CD209), 
Lingering (CD207), and 
dectin-2, mincle (CLEC4E) 
for alpha mannans, scavenger 
receptors CD5, CD36 and 
SCARF1. 
(Kim et al., 2011, 
Wang et al., 2011, 
Powers-Fletcher et al., 
2016, Means et al., 
2009) 
1,3 -glucans Dectin-1 (CLEC7A) and 
complement receptor 3 (CR3 
(CD11c/CD18)) 
(Kim et al., 2011, Stier 
et al., 2014) 
1,6 -glucans Dectin -1, and CR3 (Stier et al., 2014) 
Chitin  Mannose receptor (CD206), 
Dectin-1, TLR2 
(Bueter et al., 2013) 
Ligands specific to some fungi    
 glucans of Pseudallescheria 
boydii 
Dectin-2 (CLEC6A) (Levitz, 2010) 
BAD1 of Blastomyces 
dermatitidis  
CR3 (CD11c/CD18) (Levitz, 2010) 
HSP60 of Histoplasma 
capsulatum 
CD18 (Levitz, 2010) 
Phospholipomannan of Candida 
albicans  
TLR2 (Netea et al., 2006, 
Levitz, 2010) 
O-linked mannoses of C. 
albicans  
TLR4 (Netea et al., 2006, 
Levitz, 2010) 
Opsonic ligands    
C3b CR1 (CD35) (Levitz, 2010) 
iC3b CR3 (CD11b/CD18) and CR4 
(CD11c/CD18) 
(Levitz, 2010) 
IgG FcRI (CD64), FcRIIA 









1.5.2 Adaptive Anti-fungal Immunity  
Innate immunity plays a key role in activating the adaptive system. Several factors are involved 
including production of chemotactic factors such as complement peptides, chemokines, 
cytokines or leukotrienes produced by host cells but can also be pathogen specific. The linkage 
between the innate and adaptive immune responses against fungal infections is mediated 
mainly by dendritic cells. This is done through antigen presentation of fungal antigens, 
expression of lymphocyte costimulatory molecules, secretion of cytokines and migration to 
lymphoid tissues (Ramirez-Ortiz and Means, 2012, Roy and Klein, 2012, Powers-Fletcher et 
al., 2016). Resultant signals from these interactions may vary depending on the type of fungal 
antigen presented subsequently impacting the adaptive T cell and antibody production and 
response.  
For instance, a T-helper type 1 (Th1) or Th-17 activation leads to a pro-inflammatory 
antifungal cellular immune response through CD4+ differentiation. This causes production of 
anti-fungal specific cytokines including Th1 derived IFN-gamma and IFN-alpha; and / or a 
Th17 derived IL-17 and IL-22. While Th1/Th17 activation is pro-inflammatory, Th2 (e.g. IL-
4, IL-5 and IL-10) is anti-inflammatory thus, a strong Th1/Th17 response is protective against 
fungal infections.  
This also shows that T-cell immunity is crucial against fungal infection. Thus, conditions 
affecting T-cell functions such as anti-rejection therapy used during solid organ transplantation 
predisposes one to fungal infections (Espinosa and Rivera, 2012, Schlitzer et al., 2018, Rivera 
et al., 2006, Rivera et al., 2011, Wuthrich et al., 2016, Wuthrich et al., 2011).  
Finally, a few studies on invasive fungal diseases show that fungus specific antibodies may 
confer protection. Some in vitro and in vivo studies have demonstrated antibody mediated 





vaccine protection. Majority of the antibodies so far are restricted to recognition of cell surface 
molecules (Hernandez-Santos et al., 2013, Edwards, 2012, Powers-Fletcher et al., 2016). 
 
1.5.3 Phagocytosis, a key component of antifungal innate immunity  
Phagocytes recognise and engulf infectious particles via an actin polymerization dependent 
process called phagocytosis (Aderem and Underhill, 1999, Nicola et al., 2008, Stuart and 
Ezekowitz, 2005, Underhill and Goodridge, 2012). This process is also important during 
physiological body development and tissue remodelling (Aderem and Underhill, 1999). 
Phagocytosis is an intrinsically primed process among professional phagocytes such as 
macrophages, neutrophils and dendritic cells.  Other cells such as B-lymphocytes and epithelial 
cells may also possess limited phagocytic attributes and these are collectively called 
‘paraprofessional’ or ‘non-professional’ cells (Lovewell et al., 2014, Aderem and Underhill, 
1999, Hallett and Dewitt, 2007). 
The process is subtle and highly explicit, often triggered by the engagement between specific 
PRRs and conserved PAMP domains (Stuart and Ezekowitz, 2005). This trigger a flow of 
phagocytic based information including signal transductions, actin-based motility, membrane 
trafficking, and phagocytosis is complete when a target particle is engulfed in a cellular 
compartment called a phagosome (Figure 9) (Aderem and Underhill, 1999, Underhill and 
Goodridge, 2012, Underhill and Ozinsky, 2002, Stuart and Ezekowitz, 2005).  
Following engulfment, a series of downstream machinery, notably the formation of a 
phagolysosome, are activated where key defensive factors such as oxygen radicles, nitrogen 
oxide, antimicrobial proteins, defensins, binding proteins and hydrogen ion transporters are 
also recruited (Stuart and Ezekowitz, 2005, Diamond, 1993, Brakhage et al., 2010, Diamond 
et al., 1978). This subsequently culminates in the critical peak of phagocytosis called 
phagolysosome maturation leading to particle internalisation and degradation, antigen 





(Diamond, 1993, Nicola et al., 2008, Stuart and Ezekowitz, 2005, Underhill and Ozinsky, 2002, 
Underhill and Goodridge, 2012). 
However, given the importance of this process, some pathogens have developed mechanisms 
to evade phagocytosis (Aderem and Underhill, 1999). For instances, Listeria monocytogenes 
escapes phagosomes into the cytosol following uptake, while Mycobacterium tuberculosis can 
prevent the fusion between phagosomes and lysosomes. The antigenic capsules possessed by 
some bacterial and fungal pathogens also attenuates phagocytic processes (Aderem and 
Underhill, 1999). It is also important to note that certain therapeutic regimens such as 
corticosteroid therapy may interfere with phagocytic mechanisms. This has proved true for 



















Figure 9: Phagocytosis of foreign particles such as fungal spores is governed by strict host 
information flow. 
Under health conditions phagocytes will recognise mucormycete spores by conserved germ 
line PRRs that respond to spore PAMPs such as the cell wall glycoproteins. (a) This 
engagement then sets in motion a cascade of events including (b) an actin dependent 
phagocytic uptake of the spore leading to (c-d) containment, internalisation which is decorated 
with phagolysosome acidification and maturation € this subsequently leads to degradation of 
the fungal spore with activation of inflammatory responses and antigen presentation. The 



















1.5.4 Innate Immunity against Mucoralean Fungi 
Despite a detailed description of anti-fungal immunity here our understanding of innate 
responses against mucoralean fungi remains limited. However, if we are to compare with 
immune responses against other invasive fungal diseases such as Aspergillosis, perhaps similar 
conclusions can be drawn. So far, similar response patterns have been reported. For instance, 
the role of phagocytes such as neutrophils and macrophages in recognition, uptake and 
containment of mucoralean fungal spores has also been shown by several authors employing 
both in vitro and in vivo approaches (Figure 10) (Voelz et al., 2015, Inglesfield et al., 2018, 
Aimanianda and Latge, 2010, Brakhage et al., 2010, Li et al., 2011, Andrianaki et al., 2018b, 
Chamilos et al., 2008a).  
Importantly, both Aspergillus and mucoralean fungal species are able to evade phagocyte 
effector functions. Indeed, A. fumigatus resting conidia evades macrophage recognition due to 
masking by a spore protein coat, the rod let; while mucoralean fungi such as R. oryzae and M. 
circinelloides are able to avoid macrophage recognition and killing (Aimanianda et al., 2009, 
Aimanianda and Latge, 2010, Brakhage et al., 2010, Li et al., 2011, Andrianaki et al., 2018b). 
Whole genome expression data in a fly model also suggests that infection with mucormycete 
spores selectively regulates genes involved in pathogen recognition, stress responses, 
detoxification, steroid metabolism or tissue repair, including several other genes with no known 
functions (Chamilos et al., 2008a, Gomes et al., 2011). What is intriguing here is that 37% of 
the genes down regulated in the fly model are also involved in tissue repair.  Consistent with 
this, mucormycosis is clinically dominated by angio invasive and necrotic foci (Chamilos et 
al., 2008a).  
Thus, we ought to critically explore phagocyte-mucoralean fungal interaction mechanisms to 
better our understating of both molecular and cellular mechanisms involved during 






Figure 10: The innate immune system is crucial in containing mucormycete infecting 
propagules. 
Following inhalation of mucormycetes, innate cells such as macrophages recognise spores and 
phagocytose them. Following phagocytosis, macrophages release cytokines which amplify 
immune response by activating the complete system and recruitment of immune cells such as 

























1.6 Aims and Strategy 
Mucormycosis is the second most invasive filamentous fungal infection after Aspergillosis.  
The disease targets a cohort of individuals with certain underlying conditions (Section 1.4.1) 
and is associated with several challenges including poor diagnosis, costly but often 
unsuccessful treatment, and high level of antifungal resistance leading between 40-90% 
mortality rates (Section 1.4). This has raised awareness of the medical importance of the 
disease worldwide, and substantial efforts are being made to understand its pathogenesis in 
recent years. Indeed, we now have a better understanding of the factors that predispose one to 
the infection, but the virulence attributes of mucormycetes remain elusive. One of the major 
risk factors for mucormycosis is a defect in phagocytic effector function. Yet, studies on other 
filamentous fungi such as Aspergillus and mucormycetes highlight the importance of innate 
immunity, particularly phagocytes, in containing the infecting particles (Voelz et al., 2015, 
Inglesfield et al., 2018, Aimanianda and Latge, 2010, Brakhage et al., 2010, Li et al., 2011, 
Andrianaki et al., 2018b, Chamilos et al., 2008a). However, it is possible that while host 
immune response to filamentous fungi is conserved, different fungi including the mucoralean 
fungi may possess variable mechanisms for evading host immune responses.  All taken 
together, our understanding of host-mucormycete interactions is very limited, yet with recent 
technological advancements both molecular and cellular mechanisms involved can be 
navigated. The research presented in this thesis deepens our understanding by exploring the 
role played by phagocytes particularly macrophages against mucormycete infection. Future 
research will not only focus on molecular interactions but also other confounding factors such 
as signalling pathways mediated by both hosts and pathogens. 
 
The first study focuses on the host, where interactions between macrophages and 





macrophages are important in containing infecting particles especially in the early stages of 
infection. However, it has also been established that recognition and uptake of Aspergillus 
conidia by macrophages may depend on their metabolic state. This part of the thesis 
demonstrates interaction mechanisms between mucormycete spores and macrophages, 
describing some of the key protocols applicable for mucormycete study.  
 
The second study of the thesis is a follow up on observations made in the first study that pre-
germinated spores show reduced phagocytic uptake compared to resting spores. This is 
opposite to what has been found with Aspergillus. This section therefore reports that 
mucormycete metabolic spores secrete a supernatant factor that significantly affects phagocytic 
uptake by macrophages. The chapter characterises the impact of the supernatant factor on other 
phagocytic effector functions. The second part attempts to characterise and identify the 
supernatant using physical and chemistry approaches.  
  
The third and final study is a follow up of observations made in previous two studies. This 
fronts the hypothesis that the supernatant factor in question is secreted by a bacterial symbiont 
that resides inside the fungal cytosol. It is not uncommon for mucormycetes, especially R. 
microsporus, to harbour bacterial endosymbionts. Although endo-hypha bacteria have been 
implicated in plant pathology, their contribution to clinical mucormycosis is yet to be fully 
established. A few studies have already shown that bacterial symbionts may play no role in 
clinical manifestations of the disease, yet to the contrary others demonstrate that bacterial 
symbionts significantly modulate fungal phenotypes. Here, we identify the bacteria and explore 
the influence of bacterial symbiosis on fungal pathogenicity.
 














2.1 Chapter Overview 
Some of the methods presented in this chapter were performed in collaboration with other Lab 
groups. Specifically, metabolomics (Dunn Lab, School of Biosciences, UoB), Chemistry work 
(Trillo Lab and Mass spectrometry, School of Chemistry, UoB); and Mouse work (Ashraf 
Ibrahim’s Lab, University of California Los Angeles (UCLA, USA)). For all these, we 
prepared the samples and also participated in some experimental and data analyses, particularly 
HPLC and survival data analyses.  
2.2 Ethics  
All zebrafish care and experimental procedures were conducted according to Home Office 
legislation and the Animals (Scientific Procedures) Act 1986 (ASPA) under the Home Office 
project license 40/3681 and personal licenses l13220C2C to Kerstin Voelz and lCDB92D64 to 
Herbert Itabangi. 
Blood work: Blood was performed after completion of Hepatitis B vaccination. Whole blood 
was collected according to the Hall ethical approval for blood work. Buffy coat and whole 
blood derived cells were destroyed 7 days after initial blood isolation.  
 
2.3 Strains and growth conditions   
 2.3.1 Mucoralean strains and cultivation 
Mucormycete strains (Table 3) were routinely cultured on sabouraud dextrose agar (SDA) 
(EMD Millipore co-operation) or potato dextrose agar (PDA) to induce sporulation at room 
temperature. For metabolic activation assay, mucormycete spores were cultivated in conical 
flasks containing 100 - 250 mL of sabouraud broth or serum free Dulbecco’s modified eagle’s 
media (sfDMEM) supplemented with 1 % penicillin/streptomycin (stocks of 100 units / mL 
penicillin and 100 units / mL streptomycin); and   1 % L-glutamine (stock of 2 mM / mL) at 
37 o C with shaking (200 rpm) for 1, 2, 4, or 6 hr. For isolation of bacterial endosymbiont, fungi 
were fermented in 250 mL flasks containing VK media (1 % corn starch, 0.5 % glycerol, 1% 
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gluten meal, 1 % dried yeast, 1 % corn steep liquor, 1 % CaCO3) and pH adjusted to 6.5, as 
previously described by (Scherlach et al., 2006). HL5 (40 % peptone, 20 % yeast extract, 38 
% glucose, 1.4 % KH2PO4, 1.4% Na2HPO4) medium was also occasionally used. Mucormycete 
stocks were frozen down in 20 % glycerol and stored at – 80 ° C. Media and other chemical 
requirements were purchased from Sigma-Aldrich unless otherwise indicated.  
 
2.3.2 Other fungal strains and cultivation  
Both Candida albicans (SC5314) and Saccharomyces cerevisiae were also used in this project 
as phagocytic targets. The yeasts were grown either on yeast peptone dextrose (YPD) media 
plates or broth at 30 ° C with shaking at 200 rpm. Stocks were maintained in 20 % glycerol at 
-80° C. Both strains were obtained from the Hall Lab, University of Birmingham.  
 
2.3.3 Bacterial strains and cultivations  
Burkholderia cepacia (obtained from Queens University Belfast) and bacterial endosymbionts 
isolated from mucormycetes during the project as shown in Table 3 were cultured on nutrient 
agar plates (0.5 % peptone, 0.5 % NaCl, 1.5 % Agar and 0.3 % yeast extract) at 30° C. For 
molecular manipulations bacteria were grown in LB broth media at 30° C with shaking 80 rpm.  
For bacterial supernatants, the bacteria were grown in the respective media such as sf DMEM, 
VK or HL5 at 30 with shaking 80 rpm and processed.  Stocks of the bacteria were frozen down 
in 40% glycerol and stored at -80° C. 
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Table 3: Fungal and bacterial strains used in the project. 
No. Name  Strain id  Source  
1 Rhizopus microsporus  FP469-12.6652333 Clinical isolate from Queen 
Elizabeth Hospital Trauma centre 
by Dr Deborah Mortiboy 
2 Cured Rhizopus microsporus  (FP469-12.6652333) This project   
3 Ralstonia pickettii Bacterial endosymbiont Isolated from R. microsporus 
(FP469-12.6652333) 
4 Rhizopus microsporus CBS 631.82 Obtained from CBS collection 
centre  
5 Cured Rhizopus microsporus Cured CBS 631.82 
strain  
Created in the lab for this project   
 
6 Ralstonia pickettii   Bacterial endosymbiont  Isolated from R. microsporus CBS 
631.82. 
7 Rhizopus chenensis NA Clinical isolate from Marc Hospital  
8 Rhizopus delmar  RA 99-880  
9 Lichtheimia corymbifera  FP454-9.6002134 Clinical isolate  
10 Cunninghamella 
bertholletiae 
NB2 Obtained from Ashraf Ibrahim 
(UCLA) 
11 Mucor circinelloides f. 
lusitanicus 
FP624-CBS-277490 Obtained from CBS 
12 Mucor circinelloides f. 
lusitanicus 
FP623-NRRL-3631 Obtained from NRRL culture centre  
13 Cured Rhizopus chenensis NA-ESF This project  
14 Cured Rhizopus delmar  RA 99-880-ESF This project  
15 Cured Lichtheimia 
corymbifera  
FP454-9.6002134 This project  
16 Cured Cunninghamella 
bertholletiae 
NB2 This project  




This project  




This project  
19 Candida albicans SC5314 Obtained from Hall Lab  
20 Saccharomyces cerevisiae   AM13/0001 Obtained from Aberdeen (Donna 
MacCallum) 
21 Burkholderia cepacia Clinical isolate from 
cystic fibrosis  
Obtained from Queens University 
Belfast (Hall lab strain bank) 
22 Micrococcus luteus  Bacterial endosymbiont  Isolated from Mucor circinelloides 
f. lusitanicus FP624-CBS-277490 
23 Micrococcus luteus Bacterial endosymbiont  Mucor circinelloides f. lusitanicus 
FP623-NRRL-3631 





2.3 Harvesting Mucoralean Fungal Spores  
Mucormycetes sporangiospores generated from hyphae for 14-24 days were harvested by 
flooding the surface of the culture plate with 10 mL of PBS, washed 3x and counted with a 
haemocytometer.  Spores were used within 14-24 days of sporulation as previously described 
by Voelz et al., 2015. Spores prepared in this way are defined here as “resting spores”. 
For experiments that required metabolically active spores, the spores were incubated in 
Sabouraud broth media or sf DMEM media at 37o C with shaking at 200 rpm for respective 
time points, collected by centrifugation, and washed with 1x PBS. Spores prepared this way 
were defined here as pre-germinating, germinating, and swollen or metabolically active 
spores”.  
For experiments requiring UV or fixed killed spores, the spores were suspended in 20 mL 
1xPBS and irradiated twice for 15 min in a UV PCL-crosslinker at 1200 µJ/cm2, and cooled 
on ice between treatments as previously described by Voelz et al., 2015. Successful killing was 
confirmed by plating for CFUs. For fix killing, the spores were suspended in an appropriate 
volume of 4% paraformaldehyde (PFA) and incubated for 30 min at room temperature with or 
without shaking.  
Latex beads were also processed similarly to spores including, washing, with PBS, counting 
and re-suspension.  
 
2.4 Supernatant collection  
Fungal supernatants, sporangiospores were harvested as described above, counted and 
adjusted to 4x108 spores / mL in 250 mL of sfDMEM, VK or HL5 medium and incubated at 
37oC with shaking (200 rpm) for 4 h. Following incubation, the preparation was centrifuged at 
3990 rpm for 5 mins, supernatant collected and filter sterilized through a 0.45 µm (Millipore) 
syringe filter before assays commenced.  
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Bacterial supernatants, a loopful of bacterial colony was sub cultured in Lysogenic broth 
(LB) agar overnight at 30 oC and 150 rpm, colonies washed in 1x PBS, and adjusted to an 
optical density of 0.2 at 600 nm. To 250 mL of the respective medium including sfDMEM, VK 
or HL5, 200 µL of the bacteria suspension was added and incubated at 30 oC and 200 rpm 
(Scherlach et al., 2006).  
For pH measurement of the supernatants, the pH of the supernatants was measured using 
pH meter (Mettler Toledo). Three different replicates were collected measured. For accuracy, 
the meter was calibrated prior to taking the reading. Mettler Toledo displays pH corrected to 
the nearest 2 decimal points. 
For supernatant stability experiments, supernatants were collected and stored in the fridge 
at 4 C and its activity against phagocytosis evaluated when freshly collected and at other 
indicated time points for up to a period of 4 weeks.  
For inactivation experiments, the supernatants were boiled at 100 oC for 1 h, digested with 
50 µg / mL proteinase K at 37o C for 1 h or oxidized with 1 nmoles /mL of sodium periodate 
(NaIO4) at 37oC with mild shaking for 45 min. Phenylmethylsulfonyl fluoride (PMSF) was 
used to inhibit proteinase K following protein digestion.  
For size exclusion experiments, 15 mL of supernatant was filtered through an Amicon® tube 
(Sigma-Aldrich cat number UFC801024) equipped with a 3 kDa ultra-centrifugal filter. 
Samples were centrifuged for 30 min at 3000 g and both the ‘flow through’ (i.e. filtrate) and 
‘concentrated portions of the supernatant’ (i.e. retained by the filter) were kept for phenotypic 
assay.  
Media and chemicals were purchased from Sigma-Aldrich unless otherwise indicated and HL5 




2.5 Bacterial symbiosis experiments  
2.5.1 Generation of endosymbiont free strains  
For the generation of endosymbiont-free fungal strains, the fungi were cultivated in the 
presence of ciprofloxacin at a concentration of 60 µg / mL. Absence of the bacteria was 
confirmed through bacterial isolation, fluorescence microscopy by SYTO9 staining, and 
polymerase chain reaction (PCR) amplification of the 1.5 kb band for bacterial 16S rDNA as 
described in the later sections.  
For passage experiment, the fungus was continuously cultivated on ciprofloxacin and spores 
collected between age 14-21 days for a period of 5 months. Spores harvest and counts were 
performed as in (Section 2.3). However, it is important to note that only phenotypic and not 
genetical characteristics were monitored at this stage and details are provided in Chapter 5. 
 
2.5.2 Fermentation of R. microsporus for bacterial isolation  
To a 250-mL conical flask containing 100 mL of VK media, 200-500 spores were added 
aseptically and incubated at 30oC with shaking at 80 rpm for 2-7 days (Scherlach et al., 2006). 
Following cultivation, a small mycelial pellet was aseptically taken from a 2-day old liquid 
fungal culture and submerged into 500 µL of 2000 units / mL Lyticase enzyme (Sigma-Aldrich) 
in distilled water and incubated at 25o C for 2.5 h. Using mechanical stress (pipetting or 
vortexing) the mycelia were broken down and then centrifuged at 13200 rpm for 30 mins. 
Aseptically, 10-20 µL of the supernatant were plated on nutrient agar (NA) and incubated at 
30o C until a bacterial or fungal growth was observed. Bacterial colonies were then sub-cultured 
in LB broth and maintained at -80oC. 
 
2.5.3 Substrate experiment  
The influence of the bacteria on the fungus’s ability to produce the supernatant factor was also 
investigated. This was aimed at establishing whether the endosymbiont was a key signal for 
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the fungus to secrete the compound in question. Accordingly, fungal substrates were prepared 
in different growth conditions including SDA, HL5, DMEM and VK medium as described 
(Section 2.2). Spores or hyphal masses were harvested, washed, mashed using a bead beater 
with sterile soil beads (Qiagen) or heat killed by autoclaving, to yield live mashed or heat killed 
fungal substrate. The respective substrates (~0.1 g) were collected into sterile 50 mL falcon 
tubes and 20 mL of bacterial suspension at OD 0.2 and incubated at 30 with shaking (50-80 
rpm) for 24 h. After incubation, the tubes were centrifuged to collect the supernatant, and 
filtered before assays commenced.  
 
2.6 Susceptibility treatment of spores  
Mucormycete spores (with or without the endosymbiont) were tested for susceptibility towards 
a range of stress conditions. The settings mimicked different degrees of oxidative (0.25, 0.5, 1, 
and 5 mM hydrogen oxide (H2O2)), Nitrosative (1, 5, and 20 mM sodium nitrite (NaNO2) 
(Fisher scientific)), cell wall (0.005, 0.01, 0.05% sodium dodecyl sulphate (SDS) (Fisher 
scientific)), osmotic (0.05, 0.1, 0.3 M sodium chloride (NaCl)) and antifungal pressure (0.5, 1, 
2.5, 5 µg / mL Amphotericin B (AmB)) stress. The spores were grown, harvested, washed and 
counted as described before and adjusted to 105 cells /mL in sf DMEM containing the stress 
factor at the respective concentrations in a centrifuge tube. To each well of a 48 well plate, 1 
mL of the spores’ suspension was dispensed; and incubated at 37o C and 5% CO2 for 24 h. To 
evaluate the influence of the stress factor on the spores, serial dilutions were plated and colony 
forming units (CFUs) counted after 24 h or 48 h for endosymbiont-free spores. 
 
2.7 Tissue culture  
2.7.1 Media and growth conditions  
Both a macrophage-like cell line J774.1 and human primary monocyte-derived macrophages 
were used for experimental work. In addition, human isolated neutrophils and erythrocytes 
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were also employed during the project. The J774.1 cell line is a transplantable murine reticulum 
cell sarcoma exhibiting phagocytic effector properties of macrophages derived from a female 
BALB/c/NIH mouse (Ralph et al., 1975). The murine cell line was thawed and cultivated 
routinely in complete Dulbecco’s modified eagle’s media (cDMEM) supplemented with 10% 
foetal bovine serum (FBS), 1% penicillin/streptomycin (stocks of 100 units/mL penicillin and 
100 units/ mL streptomycin); and   1% L-glutamine (stock of 2 mM / mL) at 37o C, 5 % CO2 
(Smith et al., 2015, Ma et al., 2006, Voelz et al., 2009). J774 macrophages were used between 
passage 4 and 15. 
Human primary peripheral monocytes (PBMCs), neutrophils or erythrocytes were isolated 
from Buffy coats or whole blood obtained locally from healthy volunteers. The buffy coats 
were supplied by a local NHS blood transfusion unit at Queen Elizabeth Hospital. To isolate 
mononuclear cells from buffy coats, the buffy sample was diluted two-fold with PBS and 30 
mL centrifuged over a 15 mL Ficoll – Paque Plus cushion at 800 relative centrifugal force (rcf) 
for 20 min at 20o C.  The mononuclear layer was then collected, treated with ice cold lysis 
buffer (1L = 8.3g NH4Cl, 1g KHCO3, 0.04g Na2EDTA dehydrate) and then washed with ice 
cold PBS (+/- calcium and magnesium, pH 7.2) to remove platelets. Monocytes were then 
isolated through seeding and adherence in a plastic 24 multi-well plate at a concentration of 
4x106 cells / 400 mL in Rosewell Park Memorial Institute 1640 (RPMI 1640) adhesion medium 
(Life Technologies) supplemented with 2% AB human serum, 1% of 2 mM L-glutamine and 
1% 100 units/mL of penicillin/streptomycin at 37oC and 5 % CO2 for 1 h. The non-adherent 
monocytes and lymphocytes were removed with pre-warmed PBS and adhered cells 
differentiated into macrophages in RPMI 1640 supplemented with 10% AB human serum, 1% 
of 2 mM L-glutamine, 1% 100 units/mL of penicillin/streptomycin and 20 ng/mL macrophage 
colony stimulating factor (M-CSF) at 37o C and 5 % CO2 for 3 days.  After 3 days, non-viable 
and non-adhered cells were washed with pre-warmed PBS and incubated in 1 mL of 
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differentiation media minus M-CSF at 37o C and 5% CO2 for 3-4 days before assays 
commenced. This protocol is a revised version of that by Voelz et al (Voelz et al., 2009).  
 
For isolation of PBMCs and neutrophils from whole blood, 6 mL of undiluted blood was 
centrifuged over a double layer of Percoll made of different densities (6 mL of 1.098 under 6 
mL of 1.079) at 150 g for 8 min then 1200 g for 10 min. Top band was taken for monocytes 
and processed as described above whilst the lower second band was aspirated for neutrophil 
isolation and treated with red cell lysis buffer as described above, washed with room 
temperature PBS, re-suspended in adhesion RPMI 1640 media, checked for viability with 1% 
trypan blue and counted before assays commenced. Chemicals and media were purchased from 
Sigma-Aldrich unless otherwise indicated.  
 
2.7.2 Freezing down cells  
Cells were grown in sterile T75 tissue flasks until an approximate 80-90 % confluence was 
achieved. The cells were then mechanically detached off the tissue flask floor with a cell 
scrapper into 10 mL of cDMEM and transferred into a 15-mL centrifuge tube. The cells were 
centrifuged at 1000 rpm, 20o C for 7-10 min. The supernatant was discarded and the pellet re-
suspended in an appropriate volume of freezing media containing 50% FBS, 40% cDMEM and 
10% Dimethyl sulfoxide (DMSO). The suspension was aliquoted into 2 ml cry vials and tubes 
frozen down at -80 C overnight in Mr. FrostyTM (Nalgene Cryo1o C or CoolcellR LX 
controlled-rate alcohol free) freezing containers, before transferring to liquid nitrogen. The 
freezing down process was performed rapidly to avoid damage to the cells by DMSO.  
 
2.7.3 Defrosting cells from liquid nitrogen 
Aliquot tubes were briefly thawed in a water bath at 37o C and quickly transferred into a 15-
mL centrifuge tube with 10 mL of cDMEM to avoid damage by DMSO. The cells were then 
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centrifuged at 1000 rcf, 20o C for 7-10 min, supernatant discarded and pellet re-suspended in 
pre-warmed cDMEM and transferred to sterile T75 flasks for cultivation at 37o C and 5% CO2. 
 
2.7.4 Sub-culturing J774 phagocytes  
For routine maintenance and cultivation, cells were passage into fresh media after attaining an 
~80-90 % confluence. Accordingly, the old media was discarded and replaced with pre-
warmed cDMEM culture media, cells mechanically detached from the flask floor, diluted 
appropriately for instance in fractions of 1/2, 1/4, 1/8 or 1/10, and cultured in fresh media in tissue 
flasks.  
 
2.7.5 Phagocytosis assay 
Multiplicity of infection (MOI) determination: Appropriate infection doses for both J774 
macrophages and PBMCs to be used here were determined before phagocytosis assays 
commenced. This was performed by co-incubating macrophages with different concentrations 
of spore doses to make infection ratios of 1:1, 1:2, 1:3, 1:4 and 1:5. Seeding concentrations for 
macrophages were 105 for J774 and ~2x105 (for a 24 well plate) for PBMCs.  These 
preparations were then incubated for periods of 1, 1.5 and 2 h to determine the appropriate 
exposure time adequate for phagocytic uptake by the two cell types. Note; that MOI of 1: 5 for 
both cell lines and incubation periods of 1 h for J774.1 macrophage and 2 h for PBMCs were 
later established appropriate for application during project and were used as will be described 
in later section below.  
Phagocytosis assay applications: One day prior to the experiment, 1 mL of 105 cells/mL 
J774.1 murine macrophage-like cells were seeded in a 24 well plate in pre-warmed (37oC) 
complete Dulbecco’s modified eagles’ media (cDMEM) supplemented with 10% Foetal 
bovine serum (FBS), 1% penicillin/streptomycin and 1% L-glutamine. Monolayers were 
incubated at 37oC and 5% CO2 for 12 h. Following incubation, the overnight media was 
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aspirated and the cells were washed 2x with pre-warmed PBS, and then refreshed with 1 mL 
pre-warmed serum free DMEM (sfDMEM) and incubated as before for 1 h.  Then, the media 
was removed and the cells were washed 2x with PBS. Resting or germinated spores stained 
with FITC (Section 2.9) were added as 1 mL sfDMEM suspension of 5x105 spores/mL for a 
multiplicity of infection (MOI) of 1:5. 
Co-cultures were incubated as described above for 1 h to allow spore uptake.  Phagocytosis 
was terminated and cells subsequently fixed with 4 % PFA for 15 min, washed 3x with PBS 
and counter-stained with Con-A or calcofluor white (CFW) (Section 2.9). Note, cells were 
stained before fixing as fixing enhances CFW permeability. Cells were maintained in 500 mL 
PBS and imaged using a Nikon Ti microscope. 
For experiments requiring use of UV killed or metabolically activated spores, latex beads, C. 
albicans or S. cerevisiae, the particles were prepared as described in 2.1.2 and 2.1.4.  For live 
imaging, cells were maintained in sfDMEM+ 50 nm LysoTracker Red DND-99 (Invitrogen, 
molecular probes) under humidified conditions as described under microscopy section.  
For spore viability experiments, macrophages were lysed with 1 mL sterile water and 
aggressively washed to collect adherent cells. Then, 5 µL of the lysate was plated out on SDA 
and CFUs were counted. For supernatant effect experiments, the cells were treated with 75% 
supernatant or 3 pmoles/mL rhizoxin for 1 h and washed 3x before challenging with a 
phagocytic target.   
For PBMCs, the phagocytosis assay was performed using RPMI 1640 supplemented with 2% 
AB human serum, 1% of 2 mM L-glutamine and 1 % 100 units/mL of penicillin/streptomycin 
at 37oC and 5 % CO2 for 2 h as described above.  
Phagocytosis scoring, percentage phagocytosis was determined by counting the number of 
macrophages (that phagocytosed 1 or more spores and the those that didn’t) before computing 
the number of those that had phagocytosed spores divided by the total number of both 
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categories multiplied by 100. Accordingly; macrophages were counted and recorded from 
individual images taken until a final total of 1000 macrophages were realised each induvial 
technical repeat. For each of these data points, percentage phagocytosis was calculated, tested 
for normality using D'Agostino & Pearson omnibus normality test. Summary means of the data 
points were derived and statistically analysed using parametric nor non-parametric test 
depending on the normality findings. For each phagocytosis experimental set up, at 3 biological 
with subsets of 3 technical repeats were performed.  
 
2.8 Other assays  
2.8.1 Effect of R. microsporus spores or supernatant on erythrocytes 
Supernatants and spores were harvested as already described (sections 2.3 and 2.4) and 
erythrocytes obtained from health volunteers as already described (section 2.8). The red blood 
cells (RBCs) were washed and re-suspended in Dulbecco’s PBS (Sigma-Aldrich) at 1000 g, 
25o C for 7 min. To an Eppendorf tube containing 800 µL of fungal supernatants or control 
samples, 200 µL of the RBC suspension was added and incubated overnight at room 
temperature.  
Following incubation, the tubes were centrifuged to collect the supernatant and optical density 
of the supernatants measured at OD 550 nm. To determine the effect of the spores on the RBCs, 
the cells were co-incubated with RBCs in 24 well plate and live cell time lapse images acquired 
under phase contrasts as described in (section 2.8 and 2.9).  Control samples sfDMEM, PBS 
as negative and RBC lysis buffer as positive controls. Optical density from at least 3 biological 
with 3 subsets of technical repeats were measured. The technical repeats’ data points were then 
tested for normality, mean OD derived before analysis with parametric or non-parametric 




2.8.2 Cell viability assay using trypan blue staining  
We employed a trypan blue assay as one of the means to assess the effect of the supernatant 
factor on macrophage cell viability. Accordingly, macrophages were seeded in a 24 well plate 
at a concentration of 105, incubated overnight at 37o C and 5 % CO2.  Following incubation, 
cells were treated with the supernatant for 2 h, washed with pre-warmed PBS and 500 mL of 
1% trypan blue (1:1 v/v trypan blue and sf DMEM) was added, incubated at 37o C and 5% CO2 
for 10 min. Cell viability was assessed on the ability or inability to take up trypan blue stain, 
dead cells stained blue, whilst live cells remained unstained. The experimental set-up included 
3 biological repeats with 3 subsets of technical repeats. From these images were randomly 
taken and up to a total of 300 macrophages counted per each biological repeat. Thus, the 
percentage cell survival was computed from the number of unstained cells divided by the total 
number (stained and unstained) multiplied by 100.  
 
2.8.3 Cell viability assay using lactate dehydrogenase (LDH) 
LDH assay is another method of evaluating cell viability. The assay is based on the principle 
that injury or toxicity to a tissue causes cells to release lactate dehydrogenase, a fairly stable 
enzyme. The enzyme is an oxidoreductase that catalyses interconversion of pyruvate and 
lactate. Here we utilized an LDH kit purchased from Sigma-Aldrich (Kit no. MAK066-1KT) 
to determine the effect of supernatants, resting spores, swollen spores, and rhizoxin on the 
viability of macrophages. Procedures of the assay were based on the manufacturer’s 
instructions described in the kit insert. Test readings were done using a FLUO-star Omega plate 
reader at 450 nm and calculations done as directed by the insert. 
 
2.8.4 Neutrophil migration assay (Chemotaxis) 
To model Neutrophil chemotaxis, we employed the 2D chemotaxis assay using the ibidi- micro 
(µ) - slide chemotaxis kit (Ibidi cells in focus (kit no. 80322)). Detailed protocol instructions 
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were followed as provided for in the insert by the kit manufacturer. Accordingly; cells we 
loaded into the ibidi chamber and allowed to migrate towards supernatant, media (negative) or 
FMLP (positive) controls while being followed by time-lapse imaging under the phase contrast 
channel (section 2.9.3) at a time interval of 2 min for 2 h.  Cell movements were tracked 
manually in Image-J(Fiji)-Mtrack2. Cell tracks from pooled cells tracked in 3 separate 
experiments are shown. The tracks were analysed using statistical features of ibidi chemotaxis 
tool. Plotted data are obtained using the accumulated distance, velocity, euclidian distance, 
Forward Migration Index (FMI), and directionality. Differences between the test and controls 
is statistically determined using raileys test. However, some data was eliminated from this 
analysis because of a difference in tracking slice numbers. For two of the biological repeats 
where 61 slices were used as opposed to 31 used in the initial experiment.    
2.9 Microscopy  
2.9.1 Fluorescence staining of Mucoralean Spores  
For experiments requiring stained spores, the spores were counted, adjusted to 2x107 in PBS 
and stained with 100 g/mL fluorescein isothiocynate isomer 1 (FITC) (Sigma-Aldrich) in 
0.1M sodium bicarbonate buffer (pH 7.45) (Sigma-Aldrich), 25-50 g/mL Rh-TRITC-
Concanavalin A (Thermo-fisher scientific) or 250 g/mL calcofluor white (Sigma-Aldrich) in 
PBS for 30 min with shaking at room temperature. 
 
2.9.2 Cytotoxic assay 
J774A.1 cells were seeded onto round 13 mm coverslips in 24 well plates and cultured as 
described (Section 2.7). Prior to staining, cells were treated with supernatants or 3 pmoles / mL 
rhizoxin and synchronised on ice for 10 min.  
Media was then replaced with pre-warmed sfDMEM and cells incubated for 30 min. Samples 
were then fixed with 4% PFA for 10 min, permeablised with 0.1% Triton X for 5 min and 
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washed 3x with PBS. To stain for beta tubulin, coverslips were firstly immersed in 1% bovine 
serum albumin (BSA) for 1 h and further incubated overnight in PBS containing 5 µg/mL anti-
beta tubulin ab18207 (Abcam) primary antibody and 0.1% BSA. Samples were then washed 
and incubated with 2 µg/mL Alexa Fluor 488 goat anti-rabbit secondary ab 150081(Abcam) 
for 1 h.  
For F-actin staining, samples were incubated with 3 Nano moles phalloidin conjugated to Alexa 
Fluor 488 (Thermofisher Scientific) for 15 min.  After cytoskeleton staining, cells were 
counter-stained with 2 µg/mL Hoechst (4’6 Diamichino-2-phenylindol for 15 min) where 
appropriate and mounted onto glass slides with ProLong ant fade mountant (Thermofisher 
Scientific).  
 
2.9.3 Image acquisition  
Live-cell time lapse images were acquired under phase contrast at 14X magnification on a 
Nikon Ti microscope (20x magnification combined with a 0.7x de-magnifier) equipped with a 
QICAM Fast 1394 CCD camera (Q-Imaging). Fixed-cell fluorescence imaging was, unless 
stated otherwise, performed at 63x magnification on a Zeiss Axio Observer Z1 equipped with 
structured illumination (Apotome) using a Flash 4 sCMOS camera (Hamamatsu).  
 
2.9.4 Image processing 
Mean staining intensity score, cell size and shape 
Spores (refer to section 2.9.1), Images were processed in image-J to measure mean staining 
intensity or cell size for each induvial spore per image. Up to 300 spores were analysed from 
3 biological repeats.  
Macrophages (actin, tubulin or phagosome maturation) (refer to section 2.9.2), Images 
were processed with either Image-J or Metamorph software to determine mean staining 
intensity or cell shape. Up to 300 cells were analysed from at least three biological repeats.  
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These data points were tested for normality using D'Agostino & Pearson omnibus normality 
test employing parametric or non-parametric statistical tests.  
 
2.9.5 Transmission Electro-microscopy (TEM) 
This work was done in collaboration with University of Aberdeen’s Microscopy Core Facility. 
Images were acquired by Xin Zhou and Dr Elizabeth R Ballou using a JEM-1400 Plus Electron 
Microscope. The experiments were performed on resting or swollen spores processed as 
described in (Section 2.3). 
 
2.10 Molecular techniques  
2.10.1 Fungal and bacterial DNA isolation  
DNA isolation from fungal or bacterial strains for polymerase chain reaction was performed 
with a DNeasy® powerlyzer® soil Kit (Qiagen kit no.120888-50) for fungal strains or a 
Dneasy® powerlyzer® microbial kit (Qiagen) for bacterial strains. DNA was obtained from 
107 spores or a sizeable collected bacterial pellet by homogenised with beads in a screw-cupped 
tubes using a bead beater (Bertin technologies) at speed 6500 for 1 min following the 
manufacturer’s instructions. 
 
2.10.2 Polymerase chain reaction (PCR) 
To detect the presence of the bacterial endosymbiont, we employed universal primers as 
applied elsewhere by (Ibrahim et al., 2008b, Partida-Martinez et al., 2007a) that amplify the 
1.5 kb band for 16S rDNA from genomic DNA isolated from mucormycetes. The primers used 
were Forward: 5’CCGAATTCGTCGACAACAGAGTTTGATCCTGGCTCAG3’, Reverse; 
5’CCCGGGATCCAAGCTTACGGCTACCTTGTTACGACTT 3’.  PCR conditions using the 
Phusion kit (Bio Labs) were 35 cycles, at 95o for 2 min, 60oC for 30s, and 72oC for 1 min 
(Table 4 and 5), for both reactions, and products were analysed by means of UV trans-
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illumination through gel electrophoresis. PCR kits purchased from Bio labs and primers from 
Eurofins. 
Table 4: PCR reaction components using Phusion high fidelity DNA polymerase 
Components  50L 
5X Phusion HF buffer   10 L 
10 mM dNTPs  1.0 L 
10 M Forward primer   0.5 L 
10 M Reverse primer   0.5 L 
Template DNA 2.0 L 
Phusion DNA polymerase  0.5 L 
DMSO  1.5 L 
Nuclease free water  34 L 
Total volume  50 L 
 
 
Table 5: PCR conditions 
Step Temperature, o C Time  Number of cycles  
Initial denaturation  95 2 min 1 
Denaturation  95 30 s 25-33 




72 1 min/kb 25-33 
Final extension  72 10 min 1 
Hold   10o C  
 
2.10.3 Agarose gel electrophoresis  
This technique is common for separating nucleic acids according to molecular weight. This is 
achieved by staining the acids with an intercalating and fluorescent dye such as SYBR safe 
DNA gel stain (Invitrogen). To this end, 1% agarose gels were prepared in 1 X TBE buffer (10 
mM TRIS, 150 NaCl at pH 7.6) and 0.5 g/mL ethidium bromide (Bio Labs) added. DNA 
product samples were then mixed with the loading dye (Thermo-scientific) and loaded onto the 
gel. The samples were separated with current set to 70 volts for 45 mins in 1 X TBE as the 
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buffer. A 10-kb ladder (gene ruler from Thermo-scientific) was also run alongside the samples 
as a control for the obtained sample band size estimates. Fragments were detected by UV trans-
illumination using ChemiDocTM MP imaging system (Bio-Rad). Gel electrophoresis was 
performed on PCR products from at least 3 biological repeats.  
 
 2.11 Chemistry experiments 
2.11.1 Chloroform extraction of the supernatants 
Medium including sfDMEM, VK, HL5 and fungal supernatants were prepared as described in 
(Sections 2.2, 2.4). These were then exhaustively extracted 3x with chloroform in a 2:1 v/v 
supernatant/control to chloroform ratio in a separation funnel, and the combined organic phases 
were dried over anhydrous sodium sulphate, filtered and fully evaporated under reduced 
pressure. The dried product was re-constituted in 500 µL of dimethyl sulfoxide (DMSO) or 
sfDMEM for high performance liquid chromatography (HPLC) analysis or phagocytic 
assaying as described in (Section 2.7.5), respectively. Chloroform extraction was performed 
on supernatants from at least three biological repeats harvested on different days.  
 
2.11.2 HPLC analysis  
Extract products and control samples including commercial cytochalasin D and cytochalasin E 
(0.2 mg/mL in DMEM) (standards) were separated through a Kinetex® C18-EVO column 
(Phenomenex®: 5 μm, 100 Å, 250 x 4.60 mm) maintained at 35oC, and chromatograms were 
recorded by UV-Vis detection at 210 nm. HPLC analysis was performed using mixtures of 
solvent ‘A’ (water + 0.1% v/v trifluoro-acetic acid) and solvent ‘B’ (acetonitrile + 0.1% v/v 
trifluoro-acetic acid) as mobile phase with the following method: 3% B isocratic for 10 min, 
3-50% B gradient for 30 min, 50% B isocratic for 5 min, 50-3% B gradient for 5 min, and 3% 
isocratic for 10 min, at a constant flow rate of 1 mL/min. 
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For HPLC fractionation and peak isolation experiments, 10 min HPLC fractions and 
individual HPLC peaks were collected in the parent elution buffer, concentrated under vacuum 
at 45oC for 20 min to eliminate acetonitrile/trifluoro-acetic acid and freeze dried overnight for 
phagocytic assay. The freeze-dried products were reconstituted into 200 L of DMSO, then 
diluted with DMEM to a final volume of 20 mL, and filter sterilised through a 0.45 m filter 
for phagocytic assay, as described in (Section 2.7.5).  
HPLC chromatograms were analysed and drawn using X chromatogram soft tool.  
 
2.11.3 Mass Spectrometry 
Reproducible supernatant HPLC peaks were isolated in an HPLC elution buffer and submitted 
for high-resolution mass spectrometry (HRMS) analysis. This was performed in the Chemistry 
School, University of Birmingham by Chi Tsang. Samples were also sent to Dyanne Brewer 
from the University of Guelph, Canada for Liquid chromatography mass spectrometry (LC-
MS MS) and nuclear magnetic resonance (NMR) on the basis of further analysis by more 
sensitive techniques.  
 
2.12 Metabolomics study of the supernatant  
These experiments were performed and analysed by Dunn Warwick, Bioscience, University of 
Birmingham on supernatant and control samples collected and processed as described in 
(sections 2.3 and 2.4) above.  
 
 2.13 In vivo work  
2.13.1 Zebrafish experiments  
2.13.1.1 Cultivation and maintenance  
We employed the wild type AB zebrafish as well as the transgenic zebrafish Tg (mpx: GFP) 
i114 expressing green fluorescent protein (GFP) in neutrophils (Renshaw et al., 2006). The  
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Tg(mpeg1:Gal4-FF)gl25crossed with Tg(UAS-E1b:NfsB.mCherry)c264 [herein referred to as 
Tg(mpeg1:G/U:NfsB-mCherry)] with macrophage-specific expression of red fluorescent 
protein mCherry (Ellett et al., 2011). Fish lines. The fish were cultivated and maintained in a 
recirculating system at the University of Birmingham Zebrafish Facility. They were kept under 
a 14 h-10 h light-dark cycle with water temperature maintained at 28°C. The eggs were 
obtained by natural mating, collected and incubated at ~40 per plate in 25-50 mL of E3 medium 
plus 0.00003% methylene blue and 26.6 μg/mL 1-phenyl-2-thiourea (PTU) (Sigma Aldrich). 
PTU at that concentration prevents melanisation of the fish, thus permitting microscopic 
investigation without impacting larval viability and development post fertilization (d.p.f). The 
medium was changed every 2 days (Inglesfield et al., 2018, Ellett et al., 2011, Renshaw et al., 
2006, Voelz et al., 2015). All media and reagents used were purchased from Sigma-Aldrich 
unless otherwise indicated, and all husbandry and care procedures performed by the University 
Biomedical Service Unit (BMSU) staff. 
 
2.13.1.2 Spore preparations for injections  
Spores were collected in 10 mL of PBS, washed 3x, and countered using a haemocytometer 
(Section 2.3). For localization following injection, spores were stained with fluorescent 
brighter 28 in 0.1 M of NaHCO3 or PBS (Sigma Aldrich) for 30 min. Stained spores were 
washed 3 times in PBS, counted and adjusted to 108 spores/mL in 10% (w/v) 
polyvinylpyrrolidone-40 (PVP) (Sigma Aldrich) in PBS with 0.05% phenol red (Sigma 
Aldrich) in ddH2O. PVP was used as a carrier medium with increased density to prevent 
clogging of micro-injection needles.  
 
2.13.1.3 Hindbrain injection  
The fish were injected in accordance to a protocol by Brothers et al., 2011 and zebra fish 
development was assessed in accordance to Kimmel et al., 1995 (Brothers et al., 2011, Kimmel 
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et al., 1995, Voelz et al., 2015). The fish were injected at prim-25 stage following manual 
dechorionation and anaesthesia with 160 µg/mL of Tricaine (Sigma Aldrich) in ddH2O. The 
fish were then micro-injected with 2 nL of 10% (PVP) in PBS or a high dose (108 spores/mL) 
of R. microsporus spore suspension in PVP through the otic vesicle (Figure 11) into the hind 
brain to achieve an inoculum dose of approximately 50-100 spores / larva.  Following injection, 
the larvae were anesthetized with 160 µg/mL Tricaine in E3 media in a 96 well plate and 
screened by fluorescence microscopy, using the Zeiss Axiobserver Zi microscope equipped 
with Apotome system for the presence of spores (Section 2.9.3). Only larvae with approximate 
correct inoculum were selected and transferred to individual wells of 48 or 24 well plates 
containing E3 media (plus 0.00003% methylene blue). The fish were monitored over a period 
of 96 hours post infection (96 h.p.i) for survival or 72 h.p.i and at 96 or 72 h.p.i, the fish were 





Figure 11: Injection sites of zebrafish larvae. 
Anatomical representations of the different injection sites used to study fungal or bacterial 
infections of zebrafish larvae. Different sites are used to achieve specific objectives when using 
this model. Hindbrain injections like in our case were used to study directed leukocyte response 
to fungal whilst caudal vein and duct of cuvier can be used to study systemic infection and the 
dashed lines indicate where aorta gonad mesonephric (AGM) and caudal hematopoietic tissue 
(CHT) where emergency granulopoiesis takes place. The image was adopted from Duggan and 
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2.13.1.4 Evaluation of spore viability 
Following injection, the larvae were euthanized with 1600 µg/mL Tricaine for 2-5 min. The 
fish were then homogenized individually in an Eppendorf containing 100 µL of E3 media 
supplemented with penicillin-streptomycin (5000 U/mL-5 mg/mL) (Sigma Aldrich) and 
gentamicin (10 mg/mL) (Sigma Aldrich) using pellet pestles. The homogenate was then plated 
out on SDA plates containing 100 U/mL-100 µg/mL penicillin-streptomycin and 30 µg/mL 
gentamicin. The antibiotics prevent growth of fish normal flora. The plates were then incubated 
at room temperature for between 24 and 48 h and colony forming units (CFUs) counted. At 
least 3 biological repeats were performed with 5 fish per condition (total of 15 fish) per 
condition. CFUs for each fish were recorded as individual data points and tested for normality.  
 
2.13.1.5 Assessment of phagocyte recruitment  
To quantify phagocyte recruitment, transgenic zebrafish larvae Tg (mpx: GFP) i114 expressing 
green fluorescent protein in neutrophils or Tg (mpeg1: G/U: NfsB-mCherry) with macrophage-
specific expression of red fluorescent protein mCherry were injected with high dose viable 
spores stained with calcofluor white and observed after 6 h.p.i up to 72 h.p.i (Renshaw et al., 
2006, Ellett et al., 2011). Positive phagocyte recruitment was defined by accumulation of >10 
neutrophils or macrophages to the site of infection. At least 3 biological repeats were performed 
with 5 fish per condition to give a total of 15 fish per group.  Recruitment was analysed in 
Image-J using the macros plugin script written with the help of Dr Joao Correia. The principle 
behind this analysis is that the software creates 3D image of the infection site and enumerates 
the number of cells basing on the fluorescence signal. Number of recruited phagocytes per fish 
were recorded as individual’s data points and tested for normality using D’Agostino & Pearson 





2.13.2 Galleria mellonella experiment 
R. microsporus spores with or without the bacterial endosymbiont were harvested, washed, 
metabolically activated and quantified using a haemocytometer as described before (2.2.4), and 
spores’ concentration adjusted to 1x108 /10 L for high dose or 1x104/10 L for low dose. The 
Galleria mellonella larvae were then injected with the respective doses, incubated at 25o C, 
and both melanisation and survival scores recorded every 24 h over a period of 140 h. At least 
3 biological repeats were performed with 5 larvae per condition to give a total of 15 larva per 
experimental condition. 
 
2.13.3 Mice experiment 
This experiment was performed by Ashraf Ibrahim’s lab at the University of California 
Los Angeles (UCLA) on strains sent from University of Birmingham.  
 
Immunocompetent CD-1 male mice were infected with 106/25 L resting or pre-germinated 
spores of R. microsporus with or without the bacterial endosymbiont as shown in Table 6. The 
spores were pre-germinated in sfDMEM for 4 has described before (section 2.2.4). Infection 
was carried out intratracheally, with 5 mice per infection category.  Lungs were harvested at 
two different time points: 4 h post infection and at day 2. At each time point, 5 mice per group 
were sacrificed, and right after infection two mice were sacrificed for inoculum verification. 
Following harvest, the organs were homogenized in 2 mL of PBS and 200 L of both direct 







Table 6: Inoculum plan of mice 
Fungal strain  Time and number of mice used  










Parent strain of (R. microsporus) N=5 N=5 N=5 N=5 20 
Endosymbiont free (R. microsporus) N=5 N=5 N=5 N=5 20 
 
2.14 Bioinformatics  
Genome sequencing of the respective bacterial strains was done by Microbes NG, at University 
of Birmingham. Following sequencing, a series of bioinformatics tools were used to analyse 
the genomes which included; Anti-smash for secondary metabolites and basic local search 
alignment (BLAST) tools from databases such as the National Centre for Biotechnology 
Information (NCBI), Ensembl, FungiDB and EuPathDB. Most of this work was done with help 
from Poppy Sephton-Clark. 
 
2.15 Statistical analysis  
At least 3 independent experimental biological repeats were performed for each assay on 
different days. For some experiments as respectively indicated subsets of 3 technical repeats 
were included.  
For phagocytic assays, the data shown herein are for mean percentage phagocytosis computed 
from at least 3 biological repeats with subsets of 3 technical repeats. Up to about 1000 cells 
were scored from each technical repeat (Section 2.7.5).  
For spore, actin, -tubulin, and phagosome maturation staining, the data shown represent 
the mean staining intensity with the respective dyes as detailed in the individual sections.  On 
average scoring was performed on 300 cells from 3 biological repeats.  
For chemotaxis, the data shown represents tracks from 100 cells of a single biological repeat 
as detailed in (Section 2.8.4).  
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The raw data was processed in Microsoft excel before data summaries were transferred to 
Graph Pad prism for further analysis.  The data were tested for normality using and normally 
distributed data was analysed by one-way anova. Multi-comparisons were also performed to 




























3.1 Background  
Mucormycosis is an opportunistic fungal infection targeting a range of at-risk individuals. The 
infection can be self-limiting and latent in health individuals. The significance of phagocytes 
in controlling filamentous fungal infections is becoming better appreciated, yet our 
understanding of the underlying molecular and cellular mechanisms is still very limited.  
This is proven clinically when patients presenting with defective phagocytic effector functions 
including neutropenia show increased susceptibility to mucormycotic infections (Roden et al., 
2005, Ribes et al., 2000).  
Studies on Aspergillus show that both macrophages and neutrophils are essential components 
of innate antifungal immunity (Brakhage et al., 2010, Aimanianda and Latge, 2010, Dagenais 
et al., 2010, Luther et al., 2007, Herbst et al., 2015). Similarly, recent ex and in vivo studies 
also show the importance of innate immunity against mucormycete infections (Inglesfield et 
al., 2018, Kraibooj et al., 2014, Li et al., 2011, Voelz et al., 2015).  
For instance, studies by Voelz et al. (2015), Inglesfield et al. (2018); and Chamilos et al (2008) 
have utilized zebrafish or fly models, respectively, to study specific innate immune responses 
during mucormycotic pathophysiology.  
Overall these works report that phagocytes are recruited early to the site of infection and are 
important in protecting against disease onset. In zebrafish, the role of pro-inflammatory 
response in recruitment is highlighted with subsequent prevention of spore germination 
following recruitment, but lack of spore killing and reactive oxygen burst which may result to 
latency are also shown in zebrafish (Inglesfield et al., 2018, Voelz et al., 2015). In the fly, 
although readily recruited phagocytic cell display reduces phagocytic uptake of zygomycetes 
spores and sequencing reveals down-regulation of genes involved in pathogen recognition, 
immune defence, stress response and detoxification (Chamilos et al., 2008a).  
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Gebremariam et al (2014) and Ibrahim et al. (2005) also highlight the role of endothelial cells 
in mucormycete antifungal immunity and pathogenesis, specifically showing that endothelial 
cells are required for onset of angio-invasion. They demonstrate that R. oryzae spores adhere 
to, are phagocytosed by and damage endothelial cells offsetting a cascade of angioinvasive 
events, whilst Andrianaki et al. (2018), Li et al (2011) and Kraibooj et al. (2014) use in vitro 
systems to highlight the role and importance of innate immunity against mucormycetes These 
three works contribute an improved understanding of macrophage–fungal interactions. All 
showing that macrophage recognise and phagocytose mucormycete spores in vitro 
(Gebremariam et al., 2014, Ibrahim et al., 2005, Inglesfield et al., 2018, Voelz et al., 2015, 
Chamilos et al., 2008a, Andrianaki et al., 2018b, Li et al., 2011, Kraibooj et al., 2014).  
From this stance, the role of innate immunity against mucormycete infections seems vital but 
our understanding of the principles driving these mechanisms is still poor.  Several evidences 
highlight that fungal infecting particles are capable of evading phagocyte effector functions. 
This is particularly happens with Aspergillus species where dormant conidia elude recognition 
by macrophages, yet evasion is lost when spores are metabolically activated(Aimanianda and 
Latge, 2010). This is attributed to the presence of the hydrophobin protein coat which masks 
the spores (Aimanianda and Latge, 2010, Brakhage et al., 2010, Gow et al., 2017). Whether 
mucoralean fungi possess similar mechanisms remains a question that perhaps will be 
addressed in this work.   
However, as regards mucoralean fungi, so far Li et al (2011) showed that, although readily 
phagocytosed by macrophages, M. circinelloides spores are not killed and can germinate inside 
macrophages. This is in addition to Chamilos et al (2008)’s  demonstration of a pattern of 
down-regulation in the expression of phagocytic-related genes following zygomycotic 
infections; and recently, Inglesfield et al (2018)’s  showing of the development of a latent 
mucormycete infection in a zebrafish model as mentioned before, where spores are maintained 
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and controlled in granulomas, possibly reactivating during immunosuppressive conditions (Li 
et al., 2011, Inglesfield et al., 2018, Chamilos et al., 2008a).  
This background indicates how invaluable innate immunity can be against mucormycete 
infections, importantly highlights the possibility of immune evasion by the infecting particles. 
This is rather medically challenging given that mucormycete spores are ubiquitous, with an 
increasing range of at-risk individuals. Thus, it is apparent we navigate the molecular 
interactions involved in what appears to be a transition from saprophytic to opportunistic 
pathogens. In this chapter therefore, we first describe some in vitro experimental approaches 
developed and applied during this project to investigate spore macrophage interactions. We 
shall later phenotypically demonstrate spore-macrophages interactions.  
 
3.2 Developing a Phagocytosis assay for Mucoralean Fungi  
We still do not fully understand how mucormycete spores interact with phagocytes such as 
macrophages. Therefore, there are limited operating protocols to demonstrate in vitro spore-
macrophage infection biology. In this project, we mainly focused on a clinical isolate of R. 
83icrospores (Rm FP469-12) as the model organism, employing both murine and human 
derived PBMCs. Other mucormycete species were also employed for comparison.   
In an infection assay, a phagocyte should recognise and subsequently engulf phagocytic targets 
such as fungal spores. However, to efficiently demonstrate and quantify phagocytic uptake, an 
appropriate infection dosage also known as multiplicity of infection (MOI) must be formulated. 
The MOI is the number of macrophages to the number of spores. For instance, if you have 105 
macrophages and 5x105 spores then the MOI would be 1:5. However, this does not reflect 
actual uptake. The higher the MOI, the more likely uptake events will occur. Too high MOI 
can lead to stuffing of macrophages, and too low MOI may lead to low or no uptake events, 
both of which subsequently affect data analysis. 
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Quantification of phagocytic uptake also depends on the ability to differentiate engulfed from 
an engulfed or associated targets. This is achieved through differential staining. The target is 
labelled prior to and post phagocytosis.  This can be done with commonly used empirical 
fluorophores such as Fluorescein isothiocynate (FITC), tetramethylrhodamine (TRITC) and 
calcofluor white/fluorescent brightener (FB) (Card et al., 2013, Stewart and Deacon, 1995, 
Kraibooj et al., 2014). Common examples include but are not limited to Concanavalin A (Con-
A), wheat germ agglutinin (WGA) and calcofluor white (CFW).  
The principle  of application depends on the fact that dyes bind specific fungal ligands such as 
amines, sulfhydryl and phenolate ions of tyrosine (FITC); non-reducing alpha D- mannosyl 
and alpha D-glucosyl groups of glycoproteins or glycolipids (Con-A); cellulose and chitin 
(CFW) and N-acetyl-D- glucosamine and sialic acid N- acetyl-D-glucosamine found naturally 
in the chitin of insects, cell membranes of yeast and bacteria, and in cartilages and cornea of 
mammals (WGA)  (Podhradsky et al., 1979, Sumner et al., 1938, Marfurt, 1988, Hoch et al., 
2005, Stewart and Deacon, 1995).  
Below, we demonstrate appropriate MOI and staining conditions that can be used to study in 
vitro macrophage-spore interactions  
 
3.2.1 Multiplicity of infection (MOI) 
To determine the appropriate MOI, both J774 and PBMC-derived macrophages were co-
incubated with a range of spore concentrations. Macrophages of each type were seeded at 
concentrations of 105 and 2x105, respectively, and co-incubated with appropriate spore 
concentrations to give infection ratios of 1:1, 1:2, 1:3, 1:4 or 1:5.  These were then incubated 
for 1 h, 1.5 h or 2 h to establish an optimal contact time required to engulf a spore (Section 
2.7). 
Here, we defined uptake rate as the number of macrophages containing at least one fungal 
spore. It is important to note that increasing the MOI significantly increased phagocytic uptake 
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by J774 macrophages, but no significant effect on uptake was seen with increasing incubation 
time. In this regard, the average uptake of 20 % at MOI 1:1 and significantly increased to 40 
% at MOI 1:2 (p < 0.01), 45 % at MOI 1:3 (p < 0.01), 60% at MOI 1:4 (p < 0.001) and 85% at 
MOI 1:5 (p < 0.0001) was seen across all the incubation periods (p = 0.8194) (Figure 12a). 
With the highest uptake being obtained at MOI 1:5.  
On the other hand, both increasing the MOI and incubation time seemed to affect phagocytic 
uptake by PBMCs with an increasing uptake from 10 % at 1 h to 15 % at 1.5 h (p > 0.05) and 
20 % at 2 h (p < 0.05) for MOI 1:1; compared with 15% at 1 h to 20% at 1.5 h (p > 0.05) and 
22% at 2 h (p < 0.05) for MOI 1:4; and finally, 40% at 1 h to 44% at 1.5 h (p < 0.05) and 65% 
an 2 h (p < 0.001) at an MOI of 1:5 (Figure 12b). The highest uptake was obtained at 2 h for 






Figure 12: Multiplicity of Infection. 
Resting spores of R. microsporus (FP 469-12) were harvested, washed, stained and counted. 
These were then co-incubated with (a) murine (J774) or (b) human (PBMCs) phagocytes at 
indicated infection ratios and time points at 37oC before phagocytic uptake was assessed. For 
all assays, the number of phagocytes containing at least one spore were counted at the indicated 
time points (n=9000, One way ANOVA with Tukey’s correction for multiple comparisons). In 
each graph, three biological repeats were examined and error bars represent s.e.m. (*=p<0.05, 











Based on the results here, we chose MOI of 1:5 for both cell lines and incubation periods of 1h 
or 2h for J774 and PBMCs, respectively. On average J774 macrophages engulfed 45 % more 
spores than PBMCs within the first hour, 40 % after 1.5 h and 25 % more after 2 h of incubation.  
This clearly, demonstrated that J774 macrophages phagocytosed spores better than PBMCs 
could. 
The difference in uptake here can be attributed to the difference in the level of activity by the 
cell lines. Where J774 macrophages which usually express interferon gamma even at baseline 
are more active than PBMCs which may require prior stimulation. Although, in vitro activation 
with specific bacterial lipopolysaccharides (LPS), IFN-gamma or Phorbol 12-myristate 13-
acetate (PMA) (Crosby et al., 2010)  is a possibility, we choose not to stimulate PBMCs to 
eliminate experimental comparison bias.  
It should also be noted that PBMCs used in this study were obtained from buffy coats, and 
more studies are needed to establish this as a viable source for these cells. Given the 
experimental demand, majority of the infection assays performed with J774 macrophages with 
PBMCs only used to validate or compare findings with J774 murine macrophages 
 
3.2.2 Mucoralean spores staining and its effect on phagocytic uptake 
Differential staining is key for identifying phagocytosed from non-phagocytosed or associated 
particles during infection assays.  However, it was imperative that the ability of spores to take 
up specific dyes, and the subsequent impact of labelling with specific dyes on phagocytic 
uptake is evaluated. Therefore, here spore labelling with dyes such as Con-A, FITC, CFW and 
WGA was evaluated to determine optimal staining conditions as described in (Section 2.9). 
As shown in Table 7, several optimal conditions including appropriate concentrations, buffers 
and exposure time were optimised for the other mentioned dyes. Generally, spores were ably 
stained by FITC at an optimal concentration of 100 µg mL-1, Con-A at 25-50 µg mL-1, CFW 
at 250 µg mL-1 and WGA at 50 µg mL-1 for an average incubation time of 30 min.  
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It was interesting to see that although spores generally picked up the stains, some dyes such as 
Con-A and CFW demonstrated heterogeneity in their ability to label mucormycete spores 
(Figure 13). Visual evaluation and quantitative scoring for stained intensity spores showed that 
over 95% of spores are ably stained with a range of concentrations for Con-A or CFW and 
100% with FITC. Additionally, incubation time may influence staining by Con-A or CFW, 
especially at lower concentrations, but FITC was not affected (Figure 13a).  
 
Table 7: Required conditions for mucormycete spore labelling with the indicated dyes.  






FITC 100 0.1 M 
Na2CO3(7.4) 
30 490/525 
Con A-TRITC 25-50 PBS (7.4) 30 557/576 















Figure 13: Mucormycete spores stain but demonstrate staining heterogeneity. 
Resting spores of R. microsporus were harvested, washed, stained with the indicated 
fluorophores and images taken using fluorescence microscopy.  (a) Stain uptake was quantified 
by visually counting the number of stained spore cells. The data are presented as standard error 
of means from 300 spore cells per indicated stained from at least three individual biological 
repeats. (b) Representative micrographs showing stain uptake for Concanavalin-A (Con-A), 




To counter this effect, we hypothesised that pre-germination of the spores might improve dye 
uptake and indeed, it is interesting to note that pre-germination significantly improved stain 
uptake with CFW (p < 0.0001), but not Con-A or FITC (p > 0.05) (Figure 14a). However, 
even with improvement, the heterogeneous pattern was not eliminated (Figure 14b). Thus, we 
concluded that heterogeneous staining may be a characteristic for mucormycete spores, but 
more studies are still needed to fully understand the origin of this staining pattern.  
 
However, despite the staining variations demonstrated, the dyes could still be used to quantify 
phagocytic uptake. Here, we employed FITC (green) as the primary stain, and either CFW 
(blue) or Con-A (red) were interchangeably used as post phagocytosis dyes (Figure 15). CFW 
appeared to demonstrate the highest level of heterogeneity among the three dyes and for this 
reason it was mainly used as an alternative option, especially where microscopic differentiation 
















Figure 14: Spore pre-germination improves staining ability with CFW but doesn't eliminate 
heterogeneity. 
Resting and pre-germinated spores of R. microsporus were washed and stained with the 
indicated fluorophores. Images were taken using fluorescence microscopy and stain uptake was 
quantified by scoring the average staining intensity. (a) At least three biological repeats were 
examined and error bars represent standard deviation (s.d) from 300 spore cells per condition. 
Data was assessed for normality using D’Agostino and Pearson omnibus normality test and 
significance assessed via un paired T test for normally distributed or 2Way ANOVA for non-
normally distributed data. Statistically significant differences are indicated by asterisks where 
(****=p< 0.00001 and ns= p>0.05). (b) Representative micrographs demonstrate changes in 








Figure 15: Primary and post staining during phagocytosis assay. 
Resting spores of R. microsporus were harvested, washed, stained with FITC (green) and 
counted. These were then co-incubated with J774 and PBMC phagocytes for 1 h, fixed with 
4% PFA, and counterstained with Con-A (red). Cells were imaged and analysed for single and 
double stained cells representing engulfed (green) and un engulfed (green and red) spores. 
















3.2.3 Spore staining has no effect, but pre-germination inhibits phagocytic 
uptake by macrophages 
In addition, the effect of both staining and germination on phagocytic uptake of spores was 
determined. Accordingly, the spores were pre-germinated for 0 or 1 h, stained with FITC, Con-
A or CFW, and phagocytic uptake by J774 macrophages was evaluated as described before. It 
is important to note that the addition of the dye did not affect phagocytosis of stained spores of 
R. microsporus where a percentage phagocytic rate of about 75% (p > 0.05) by J774 
macrophages was realised compared to the un stained control (Figure 16a). However, it was 
rather intriguing to find that pre-germinated spores showed reduced phagocytic uptake of 55 
% (p = 0.015) by J774 and 40 % (p=0.00293) by PBMCs (Figure 16b). This reduction in 















Figure 16: Addition of cell wall dyes does not affect phagocytic rate of R. microsporus. 
 (a) Harvested resting spores of R. microsporus were stained with the indicated dyes, washed 
and counted. These were then co-incubated with J774 phagocytes for 1 h and phagocytic uptake 
assed. (b) Spores were then pre-germinated, stained with FITC and co-incubated with J774 and 
PBMC phagocytes for 1 h and 2 h respectively and uptake assessed. For all assays, the number 
of phagocytes containing at least one spore were counted after 1 hour or 2 h (n=9000, One way 
ANOVA with Tukey’s correction for multiple comparisons). In each graph, three biological 








3.3 Spore-macrophage interactions in detail 
3.3.1 Pre-germination effects are not only exhibited by R. microsporus but 
also other mucoralean fungi 
The impact of pre-germination of Aspergillus conidia on macrophage recognition is fairly 
characterised (Aimanianda and Latge, 2010, Brakhage et al., 2010). These reports show that 
germination enhances macrophage recognition and uptake of conidia. However, these 
observations are opposite to what we observe here with R. microsporus. 
Indeed, whilst resting spores of R. microsporus spores are readily phagocytosed by both J774 
(75 %) or PBMCs (65 %) (Figure 16b), pre-germination significantly reduced their uptake. 
This characteristic was not only exhibited by R. microsporus but also other mucoralean fungal 
species. For instance, using  pre-germination time points of 0, 2 and 4 h, we observed a general 
decrease in percentage phagocytic uptake of swollen spores of four other mucoralean species 
from an average uptake of 75 % at 0 h;  to 30 % at 2 h or 15 % at 4 h for R. microsporus (p < 
0.00001); to  20 % at 2 h or 30 % at 4 h for M. circinelloides (CBS 227490) (p < 0.00001); to 
an average of 30 % at 2 h and 4 h for M. circinelloides (NRRL 3631) (p < 0.00001); to 43 % 
at 2 h or  35 % at 4 h for C. bertholletiae (p < 0.0001); and finally from  55 % to 35 % at 2 h 
or  30 % at 4 h for L. corymbifera  (p < 0.001) (Figure 17).  
This data demonstrates that metabolic spores are capable of evading macrophage effector 
functions, particularly phagocytosis. However, whether the mechanism of this evasion is 
similar to what has been characterised with other filamentous fungi such A. fumigatus remains 





Figure 17: Pre-germinated spores of mucoralean fungi show reduced phagocytic uptake by 
J774 macrophages. 
Harvested and pre-stained resting and pre-germinated spores of R. microsporus (FP469-12) 
and other mucoralean fungi as indicated were co-incubated with J774 phagocytes for 1 h and 
phagocytic uptake assessed. For phagocytosis assay, the number of phagocytes containing at 
least one spore were counted after 1 h (n=9000, One way ANOVA with Tukey’s correction for 
multiple comparisons). In each graph, three biological replicates were examined and error bars 
represent s.e.m. (* = p<0.01, ** p<0.001 and ***=p<0.0001). 
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3.3.2 Resting spores of R. microsporus are readily phagocytosed but are not 
killed and do not germinate inside macrophages 
Li et al (2014) has previously showed that M. circinelloides spores are phagocytosed but are 
not killed and can germinate inside macrophages. Here, the ability of Rhizopus spores to evade 
macrophage killing was also determined. To answer this question, both resting and pre-
germinated spores were co-incubated with macrophages and fungal survival evaluated.  
Accordingly, macrophages were co incubated with spores for 0, 6 and 24 h. Un-engulfed spores 
were washed away, then macrophages were lysed and the lysate sub-cultured for colony 
forming units (CFUs) on SDA plates as described (Section 2.3 and 2.7).  
It is interesting to note that both resting and pre-germinated spores remained viable, with no 
statistically significant differences in fungal survival at 0 h and 6 h or 24 h (p > 0.05) (Figure 
18).  
Live cell imaging (Section 2.9) also showed similar findings; resting spores are well contained 
for the first 6 h of incubation. However, after 24 h, they begin to germinate inside macrophages 
(Figure 18). A similar trend is seen with swollen spores, although germination begins much 
earlier, at 6 h of incubation (Figure 18) and overall uptake rates are lower as already shown in 
Figure 17 above. In addition, at 6 h, macrophages exhibit morphological differences including 
rounding (Figure 18).  
The difference in macrophage containment of both spore types is intriguing and can be linked 
to several factors. Firstly, spore metabolism: Metabolically active spores are more likely to 
respond to and interfere with macrophage functions faster than resting can. Secondly, that 
macrophage viability deteriorates with increasing co-incubation time.  This is more pronounced 
in the case of resting than swollen spores. The switch from a well spread out phenotype at 0 h 
to a rounded and deflated morphology of macrophages at both 6 and 24 h can be indicative of 




Figure 18: Macrophages inhibit germination but don't kill mucoralean spores. 
 Resting and swollen spores of R. microsporus were co-incubated with J774 macrophages for 
the indicated time points. The macrophages were then lysed and plated for CFUs for fungal 
survival. Data are plotted as s.e.m for fungal survival from 3 biological repeats and statistical 
differences are determined using One way ANOVA with Tukey’s correction for multiple 
comparisons (n=3 biological replicates) where (ns=p>0.05). Representative micrographs are 











3.3.3 Spores show minimal altered response to stress  
The results above show that R. microsporus spores are resistant to macrophage killing. But 
since mucormycete fungi are environmentally ubiquitous, it is befitting to hypothesise that 
resistance towards macrophage killing is mediated in response to the various stresses in the 
wider environment. Indeed, fungal spores can withstand extreme conditions of desiccation, 
heat, ultraviolet light and high pressure (Setlow, 2014, Sephton-Clark et al., 2018). Thus, spore 
susceptibility to a range of environmental stresses was also considered and evaluated.  
Accordingly, Rhizopus spores were incubated under different concentrations of oxidative, cell 
wall, antifungal, osmotic and nitrosative stress conditions as described (Section 2.6). 
Growth of swollen spores was the most affected and mainly altered in their response to 
oxidative, osmotic, and antifungal stresses (p<0.05) when compared to cell wall (SDS) and 
nitrosative (NaNO2) stress. However, for all treatments responses seemed concentration 
dependent since high concentrations such as (0.05%) SDS and (5 mM) H2O2, 0.3 M NaCl and 
5 g / mL AmB of either stress factors altered growth of both resting and swollen spores 
(p>0.05) (Figure 19). Generally, resting spores were more resistant to the stresses tested here 





Figure 19: Resting and swollen spores show varying growth alterations under different stress 
conditions. 
Harvested resting and swollen spores of R. microsporus were suspended in sfDMEM with 
varying concentrations of different indicated stress conditions and incubated for 24 h at 37oC. 
Fungal survival was then evaluated by plating out for colony forming units on SDA at 37oC at 
room temperature. Three biological repeats were examined and error bars represent s.e.m. 
Statistical significance was assessed via One way ANOVA with Tukey’s correction for 







The swollen spore-stress responses here can be linked to metabolism, where key metabolic 
processes can be targets by some of such stress conditions that would not otherwise be 
expressed in a dormant state. However, on this account you would also expect swollen spores 
to be susceptible to macrophage killing, contrary to our observations in (sections 3.2.3 and 
3.3.2). Thus, the findings here may partly highlight why mucoralean spores are resistant to 
macrophage killing but do not specifically address why swollen spores are able to evade 
phagocytic uptake.  
 
So, to answer this question, we derived three hypotheses. That reduction in phagocytic uptake 
is First, a mechanical effect; Second, a cell wall dynamic effect; or Third, a result of spore 
secretory mechanisms.   
3.4 Reduced phagocytosis of pre-germinated spores is not a 
mechanistic effect  
It is important to note that spore size and morphological dimorphism have been linked to 
virulence, particularly in the heterothallic fungus M.  circinelloides (Li et al., 2011). We 
therefore hypothesized that pre–germinating spores might lead to an increase in size, which in 
turn impacts engulfment by macrophages. To answer this question, specifically, we initially 
pre-germinated spores from 5 different mucormycete species in SDA at 37o C for 0, 2, 4 and 6 
h and measured spore size before evaluating phagocytic uptake (Sections 2.3 and 2.7).  
 
Notably, spore size significantly increased with pre-germination (Table 8 and Figure 20). For 
instance, from 4.58 µm at 0 h to 7.30 µm at 6 h (p = 0.003) for R. microsporus; 9.18 µm at 0 h 
to 13. 63 at 6 h (p = 0.001) for M. circinelloides (CBS-277490); 5.11 µm at 0 h to 7.55 at 6 h 
(p = 0.01) for M. circinelloides (NRRL-3631); 5.09 µm at 0 h to 9.46 µm at 6 h for (p < 0.0001) 
L. corymbifera; and finally, 8.02 µm at 0 h to 11.81 µm at 6 h (p < 0.01) for C. bertholletiae 
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(Table 8). Although, generally increased, R. microsporus spores remained smaller than other 
mucoralean fungi.  
Table 8: Pre-germination leads to increase in spore size 
 Resting spores 
0 h 
Swollen 
spores 2 h  
Swollen 
spores 4 h  
Swollen 
spores 6 h  
p value  
R. microsporus  4.58 6.32 6.46 7.30 0.003 
M. circinelloides 
(CBS-277490) 
9.17 12.61 14.96 13.62 0.001 
M. circinelloides 
(NRRL-3631) 
5.12 6.58 7.06 7.55 0.01 
L. corymbifera 5.09 6.48 8.93 9.46 <0.0001 



















Figure 20: Pre-germination leads to increase in spore size. 
Resting spores of mucoralean fungi including R. microsporus as indicated were harvested, 
washed, counted and pre-germinated in SDA at 37oC. At the indicated time points, images were 
taken and spore size scored. Representative micrographs from one of at least three individual 















We then compared uptake of the 4 h swollen spores of size 6.23 m from R. microsporus with 
uptake of latex beads of 11.9 m (Figure 21). Yet, still phagocytosis of the 4 h swollen spores 
was significantly (p < 0.001) lower than that of the latex beads (Figure 21). 
 
These findings clearly showed that although spore size significantly increased during pre-
germination, macrophages are able to phagocytose particles of comparable or larger size, 






















Figure 21: Phagocytosis of spores not affected by size. 
Spores of R. microsporus were pre-germinated in SDA at 37oC for 4 h and stained with FITC. 
These were then co-incubated with J774 phagocytes for 1 h and phagocytic uptake assessed. 
Controls with latex beads and dormant spore were both included as shown. The number of 
phagocytes containing at least one spore were counted at the indicated time points (n=9000, 
One way ANOVA with Tukey’s correction for multiple comparisons) Three biological repeats 




3.5 Reduced phagocytosis of pre-germinated spores is not due to 
cell wall dynamism 
The fungal cell wall plays an integral role between the cell and the surrounding environments. 
Under certain conditions, fungi can remodel their cell wall to meet demands of specific 
environmental niches (Lenardon et al., 2010, Dagenais et al., 2010, Melida et al., 2015, 
Wagener et al., 2014, Sherrington et al., 2017). Immunologically, cell wall remodelling can 
significantly modulate immune responses. Notably, conidial germination modulates immune 
recognition of Aspergillus fumigatus (Aimanianda and Latge, 2010, Dagenais et al., 2010). 
Observations with A. fumigatus are strongly linked to cell wall masking. Thus, we hypothesized 
that mucormycete spore pre-germination also enabled cell wall-based masking from 
recognition by macrophages.  
To answer this question, we employed four approaches. Firstly, a bioinformatics search. With 
A. fumigatus, the influence of pre-germination on immune modulation has been linked to the 
presence of a hydrophobin protein layer (the rod let). Here, a BLAST search for its homologs 
among the mucormycetes was performed.  However, no homologs among most of the 
mucoralean fungi were identified, except L. corymbifera where a hit with about 36% homology 











Figure 22: BLAST search reveals no homologs of hydrophobin protein layer in mucormycetes. 
Basic local Alignment Search Tool (BLAST) for homologs of hydrophobin protein common 
to Aspergillus species. Using the nucleotide sequence of RodA gene a search was performed 
among the mucoralean fungi including Rhizopus, Mucor, Lichtheimia and Cunninghamella 
genera using the tools from National Centre for Biotechnology Information (NCBI) data base. 











Secondly, a staining approach where several fluorophores such as Con A-(mannans), CFW- 
(total chitin), WGA- (exposed chitin) and FITC-(glycoproteins) were used to monitor and 
measure change in availability of specific cell components during the course of pre-
germination.  Accordingly, spores were pre-germinated, stained and stain-uptake quantified as 
described before. 
 
 Interestingly the staining signal for total chitin by CFW significantly increased with swelling 
after 2 h and 4 h incubation (p < 0.0001); and exposed chitin by WGA staining drops after 2 h 
and 4 h but the difference is not statistically significant (p > 0.05). Mannan availability by Con-
A staining also increased after both 2 h and 4 h incubation but the difference was not 
statistically significant (p > 0.05). While glycoproteins’ availability by FITC barely changes 
after 2 h or 4 h incubation of germination (Figure 23).  
 
The increase in chitin availability here would be intriguing, but although chitin is a known 
immunomodulator, its effects are usually opposite to my observations here. Instead chitin is an 
activator of innate responses including innate cells such as eosinophils and macrophages with 












Figure 23: Cell wall staining of resting and swollen spores, CFW (total chitin), WGA (exposed 
chitin), Con-A(mannans) and FITC (total protein). 
Resting R. microsporus FP 469-12 spores were pre-germinated at the indicated time points then 
with the indicated fluorophores, visualized by fluorescence microscopy and stain uptake for 
individual spores quantified. (n=300, One-Way ANOVA with Tukey’s correction for multiple 
comparisons). Three biological repeats were examined and error bars represent s.e.m (ns = 




Thirdly, we tested the requirement for active cell wall remodelling by testing phagocytosis 
rates when spores were killed through UV or PFA-fixation treatments; For UV killing, spores 
were treated with 1200 joules/cm2 or 4% PFA for 30 min and phagocytic uptake assessed as 
described before. This was aimed at inactivating metabolism with preservation of the cell wall 
integrity. Interestingly, whilst phagocytosis of live pre-germinated spores is significantly (p < 
0.0001) reduced compared to resting spores, phagocytosis of the equivalent UV and PFA fixed 
spores was no different from fixed resting spores (p > 0.05) (Figure 24).  
 
Notably though, there was a significant difference in uptake of resting spores fixed by either 
method compared to resting live spores (p = 0.046). Though not probed further, a reduction in 
phagocytosis of killed spores noted here is intriguing. Overall, these findings suggest that spore 
cell wall dynamism may not be involved in preventing uptake of pre-germinated spores but do 
















Figure 24: Phagocytosis of spores is restored when UV or PFA fixed killed. 
R. microsporus spores were harvested, pre-germinated for the indicated time points, UV treated 
or PFA Fixed killed, washed and stained. These were then co-incubated with J774 phagocytes 
for 1 h and phagocytic uptake assessed. Live spores were also included as indicated. The 
number of phagocytes containing at least one spore were counted at the indicated time points 
(n=9000, One way ANOVA with Tukey’s correction for multiple comparisons) Three 





Lastly, we tested the requirement for active cell wall remodelling by assessing phagosome 
maturation; this was also aimed at establishing the effect of cell wall dynamics on phagocytosis 
after germination. Accordingly, live or killed, resting or swollen spores were co-incubated with 
macrophages in sfDMEM containing 50 nM LysoTracker (DND-99), live cell imaging was 
performed, and phagosome maturation determined as described (Sections 2.3 and 2.9).  
Phagosome maturation was quantified by measuring the average LysoTracker staining 
intensity of phagosomes per macrophage using Image J software (Section 2.9).  
 
As shown in Figure 25, we saw that both resting and swollen live spores inhibited phagosome 
maturation, with no statistical differences (p>0.05) noted between the two. However, 
significant phagosome staining intensity (p < 0.0001) was obtained with killed swollen spores. 
Meaning that if phagosome maturation inhibition by live spores was due to cell wall masking 
upon germination, then perhaps similar findings should have been revealed with killed spores. 
Generally, demonstrating that the differences seen here can eliminate the role of cell wall 
dynamism in inhibition of both phagocytosis of swollen spores and phagosome maturation. 











Figure 25: Live metabolic spores inhibit phagosome maturation. 
 (a) Live or killed resting and swollen spores of R. microsporus were co-incubated with J774 
macrophages for 2 h and phagosome maturation determined with LysoTracker staining. The 
staining intensity per phagosome was quantified with Image J. The data are analysed using 
Student’s two-tailed T-test with Welsh’s correction for unequal variance (n=150 per replicate 
with three biological replicates). The data are shown as means with s.e.m (ns = (p = 0.835) and 











3.6 Reduced phagocytosis of pre-germinated spores is due to spore 
metabolism  
It is not uncommon for filamentous fungi to evade innate immunity through metabolic 
mechanisms. For instance, the most common example of such is via the production of 
mycotoxins e.g. aflatoxins or secondary metabolites such as cytochalasins (Qiao et al., 2011, 
Keller et al., 2005, Cox, 2007).  
However, our understanding of such pathways is still limited. In regard to mucormycetes, 
identification of two key toxins, namely rhizoxin and rhizonin, has recently been made. These 
have so far been associated mainly with R. microsporus. Although implicated in plant 
pathology, there is no evidence of association with clinical mucormycosis.  Most importantly, 
both toxins are produced by bacterial endosymbionts rather than the fungus (Gee et al., 2011, 
Lackner et al., 2009b, Ibrahim et al., 2008b, Partida-Martinez et al., 2008).  
Thus, we hypothesized that pre-germinated spores produced a factor that antagonizes 
phagocytosis by macrophages, and that this might be a secreted factor. We hypothesized this 
factor might accumulate in supernatants of germinated spores. Therefore, accordingly spores 
were pre-germinated in sfDMEM for 4 h, supernatant collected, and its impact on macrophage 
functions evaluated (Sections 2.2 and 2.3).  
The initial treatment was with 75% of the supernatant for 1 h, after which macrophages were 
washed with PBS and challenged with resting spores for 1 h.  Treatment with Rhizopus 
supernatant significantly inhibited phagocytic uptake by both J774 macrophages, and PMBCs. 
Uptake by J774s decreased from 80% by untreated cells to about 38 % following supernatant 
treatment (p < 0.00001). For PBMCs, uptake decreased from 60% by untreated cells to about 
37% following supernatant treatment (p<0.0001) (Figure 26). Additionally, supernatants 
collected from other species also exhibited similar but varying levels of inhibitory activity. For 
instance, their supernatants inhibited phagocytosis from about 78 % to 45 % by both M. 
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circinelloides species (p<0.001), 60% by L. corymbifera (p=0.0375) and 40% by C. 
bertholletiae (p < 0.0001) (Figure 27).  Taken together, we can draw conclusions that the effect 
exhibited by swollen spores on phagocytosis is due to spore metabolism rather than cell wall 
























Figure 26: R. microsporus swollen spore supernatant can inhibit macrophage functions. 
R. microsporus spores were pre-germinated in sfDMEM for 4 h and supernatant collected. This 
was then used to treat J774 and PBMC phagocytes for 1 h, which were then co-incubated with 
dormant spores of R. microsporus and phagocytic uptake assessed. For both assays, the number 
of phagocytes containing at least one spore were counted after 1 hour (n=9000, One way 
ANOVA with Tukey’s correction for multiple comparisons). In each condition, three 





Figure 27: Supernatants from other mucoralean fungi inhibit phagocytic uptake by J774 
macrophages. 
Supernatants were collected from pre-germinated spores of other mucoralean fungi in 
sfDMEM. These were used to treat J774 macrophages for 1 h, then co-incubated with dormant 
spores of R. microsporus and phagocytic uptake assessed.  For all conditions, the number of 
phagocytes containing at least one spore were counted after 1 hour (n=9000, One way ANOVA 
with Tukey’s correction for multiple comparisons). Three biological replicates were examined 
and error bars represent s.e.m. (**=p<0.001, *** p<0.0001 and **** = p<0.0001).  
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3.7 Discussion  
The pathobiology of mucormycosis has gained attention in the past decades specifically 
because of the nature of the disease. The disease is severely aggressive and targets individuals 
with key underlying conditions, especially those with defects in phagocyte effector functions. 
These conditions are the main drivers of what appears to be a transition from environmental 
saprophytes to now being one of the main emerging opportunistic filamentous fungal agents 
after Aspergilli species.  
However, if we are to appropriately navigate the clinical aspects of mucormycosis, we ought 
to understand key defining molecular and cellular mechanisms governing interactions between 
the host immunity and infecting particles. We currently lack a clear understanding of how 
infection and eventually colonisation is initiated by mucormycetes spores. 
The role of innate immunity and in particular phagocyte effector functions in combating 
filamentous fungal infection particles including mucoralean fungi has now been highlighted by 
several authors, but specific mechanisms to particular pathogens remain unclear (Horn et al., 
2012, Brakhage et al., 2010, Inglesfield et al., 2018, Jahn et al., 2000, Kraibooj et al., 2014, Li 
et al., 2011, Voelz et al., 2015).  Here, we employ a series of in vitro approaches to explore 
spore-macrophage interactions and show that infection due mucormycetes can be initiated 
through evasion of phagocyte effector functions.  
Phagocytes such as macrophages represent the most prominent and professional component of 
innate immunity.  Often resident in tissues, macrophage cells are constitutively primed to 
recognize, contain and eliminate infectious particles, in addition to activating other components  





Here we report that both murine and human derived macrophages can be used in vitro to study 
mucormycete infection biology, and employing fluorescence dyes such Con-A, CFW, and 
FITC can be complementary to their application, similar with what has been established by 
others (Kraibooj et al., 2014, Li et al., 2011, Brakhage et al., 2010, Park and Voigt, 2014, 
Andrianaki et al., 2018b).  
One difference between these mucormycetes and other fungi is that mucormycete spores may 
demonstrate staining heterogeneity. This can be linked to a number of factors, including 
difference in expression levels of certain cell wall components, as well as other factors such as 
melanin, spore size or metabolism. Indeed, large and metabolically active spores show 
improved staining ability (Figure 14). It is not clear if melanin found in fungal spores impacts 
stain uptake, but has been reported to block mitochondrial staining in melanocytes, phagosome 
maturation and recently reported to be recognised by MelNec pattern recognition receptors 
(Ando et al., 2016, Stappers et al., 2018, Andrianaki et al., 2018b).  On this account, staining 
protocols described here should be further evaluated and validated during application, since 
other specific parameters such as dye concentration can be affected under certain experimental 
conditions.   
By applying the tools and conditions described here, we were able to explore several aspects 
of mechanisms involved during interactions between mucormycete spores and macrophages; 
particularly with a clinical strain of Rhizopus. Rhizopus is the most clinically relevant genus, 
although others included species from the Mucor, Lichtheimia and Cunninghamella genera to 
cater for the changing trends in aetiology.   
We demonstrated here that dormant spores of R. microsporus are readily phagocytosed by 
macrophages. Yet, they do not germinate and are not killed inside the phagolysosome. These 
findings are similar to those by Kraibooj et al (2014), Park and Voight, 2014 and Li et al (2011) 
but differ from observations made with Aspergilli species, which show that dormant conidia 
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are poorly recognised by macrophages (Kraibooj et al., 2014, Park and Voigt, 2014, 
Aimanianda and Latge, 2010, Brakhage et al., 2010). These findings could provide an 
explanation for why we are protected from mucormycetes under normal health conditions but 
prone to the infection when phagocyte functions are compromised or with possible latent 
infection.   
Profoundly though, we establish that whilst dormant spores are phagocytosed, pre-germinated 
spores of not only R. microsporus but also other mucoralean fungi showed reduced 
phagocytosis by macrophages. This is also similar to what Andrianaki et al (2018) has recently 
reported with species of R. oryzae and R. delemar. Interestingly, it is the reverse of what has 
been determined with A. fumigatus (Andrianaki et al., 2018b, Aimanianda and Latge, 2010, 
Brakhage et al., 2010).  
While modulations by Aspergillus are linked with expression of a hydrophobin protein coat, 
mucormycetes, with the exception of L. corymbifera lack homologs of this protein. The 
homolog found in L. corymbifera shows homology of about 36 % to the Aspergillus 
hydrophobin.  Indicating perhaps that this may not be a functional rod let in L. corymbifera and 
thus, could explain why resting spores of this strain are also phagocytosed as opposed to 
Aspergillus conidia. However, our observations most certainly point to spore’s metabolism 
rather than cell wall masking as a major modulator of phagocytosis. Further details pertaining 
this observation are to follow in the subsequent chapters.  
 
The data presented here describes several tools for assessing phagocytosis of the mucormycetes 
using both murine and human macrophage cell lines. The multiplicity of infection 
demonstrated here for both cell lines is applicable and can be adapted elsewhere. However, the 
staining tools used here for scoring phagocytosis can be hard to reproduce with other 
mucoralean fungal spores and thus, advisable that the protocols employed here are re-evaluated 
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on every occasion of application. Additionally, other techniques such as flow cytometry or 
immunostaining can be employed. On the other hand, the buffy coats can be used as a source 
for PBMCs but more studies are still required to establish it as reliable source of this cell line. 
Finally, we are unable to optimise a phagocytic assay with neutrophils, because are a tough 


































4.1 Chapter Overview 
Part of the data presented in this chapter, was performed in collaboration with the chemistry 
department. Particularly, Lipidomics experiments were performed by Warwick Dunn, from 
metabolomics unit, school of Biosciences. Chloroform extractions were performed by myself 
with the help of Ignacio Insua in the Trillo Lab, school of Chemistry.  HPLC work was done 
by myself with help from Ignacio Insua, Oliva Creese and Allen Bowden in the HPLC facility, 
school of chemistry   and Mass Spectrometry analysis was performed by myself with technical 
help from Chi Tsang in the Mass spectrometry facility School of Chemistry, University of 
Birmingham.  
 
4.2 Background  
Data from chapter 3 suggests that mucormycete spores may secrete factors that negatively 
impact on macrophage effector functions. Indeed, it is not unheard of for filamentous fungi to 
evade host immunity via metabolic processes. For instance, Aspergillus, Penicillium and 
Fusarium species are all known producers of a diverse range of mycotoxins (Miller and 
McMullin, 2014, Felicio et al., 2011, Rousseaux et al., 2014).  
These are bioactive compounds of low molecular weight. They include fungal secondary 
metabolites, and about 10,000 different kinds have been identified including but not limited to 
aflatoxins, ochra-toxin, T-2, HT-2, kojic acid, patulin, tremor genic toxins, zearalenone, ergot 
alkaloids, cytochalasins, trichothecenes, fumonism and deoxynirolenol toxins (Miller and 
McMullin, 2014, Pitt and Miller, 2017, Botha et al., 2014, Botha et al., 2018, Varga et al., 
2003).  
However, whilst some of these compounds are often implicated in plant pathology and 
agricultural produce contamination, association with human pathobiology may not be 
uncommon, though poorly characterized  (Miller and McMullin, 2014, Duba et al., 2018, Liew 
and Mohd-Redzwan, 2018, Varga et al., 2003, Botha et al., 2018).  
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For instance, compounds such as the cytochalasins, aflatoxins, kojic acid and tremor genic 
mycotoxins are linked with angio-genic, carcinogenic or neuro-mycotoxin genic effects in both 
humans and ruminants (Sohrabi and Taghizadeh, 2018, Botha et al., 2014, Botha et al., 2018, 
Qiao et al., 2011).  
On the other hand, our observations here with mucoralean fungi clearly indicate the possibility 
of a metabolically-based escape from phagocytic uptake and killing by spores. This directly 
implicates the role of metabolism in immune evasion.  
Interestingly, mucormycetes such as Rhizopus are also associated with metabolic compounds 
like rhizoxin, a potent antimitotic toxin, and rhizonin, a potent hepatotoxic compound, but both 
are yet to be linked with virulence (Scherlach et al., 2006, Partida-Martinez et al., 2007c, 
Partida-Martinez and Hertweck, 2007, Partida-Martinez and Hertweck, 2005, Partida-Martinez 
et al., 2007a, Partida-Martinez et al., 2008, Ibrahim et al., 2008b).  
What is clear so far is that both of these toxins are not directly produced by the fungus but 
rather by bacterial endosymbionts such as Burkholderia rhizoxinica (rhizoxin) or Burkholderia 
endofungorum (rhizonin). These maintain a mutualistic symbiotic relationship with the fungus  
(Partida-Martinez et al., 2007a, Partida-Martinez et al., 2007b). Additionally, whilst rhizonin 
is mainly an agricultural produce contaminant, rhizoxin is involved in the pathogenesis of 
blight disease in rice seedlings via inhibition of mitotic processes by targeting beta tubulin 
(Partida-Martinez and Hertweck, 2005, Partida-Martinez et al., 2007a, Lackner et al., 2009b, 
Moebius et al., 2014a).  
From this stand point, it is fair to say that our understanding of mucormycete metabolism and 
thus its impact on host-fungal interaction is limited. Yet, it appears that spores are capable of 
evading phagocytic effector functions via metabolic processes.  Although, rhizo-toxins are not 
implicated in the pathogenesis of mucormycosis, our demonstration of supernatant factors 
produced by metabolically active spores is intriguing enough to probe further characterization 
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and identification.  In this chapter therefore, we attempt to describe the effect of factors secreted 
by fungal spores on phagocyte function by characterizing the supernatants, evaluating their 
impact on macrophage function, and finally attempting identification of the compounds.   
 
4.3 The supernatant factor is relatively bio-stable at 4°C 
If the supernatants were to be experimentally manipulated, characterised and identified, basic 
properties such as bio-stability of the factors at routine lab storage temperature of 4°C had to 
be established. Accordingly, supernatants were collected and the activity of different 
supernatant concentrations including 50, 75 and 100% in sfDMEM evaluated over a storage 
period of 4 weeks (Section 2.4).   
As shown in Figure 28, all concentrations demonstrate significant activity at time of collection 
but then significantly declined with storage. For instance, average phagocytic uptake following 
exposure to supernatant increased from 52% when fresh to 63% after 1 week; 75% after 2 and 
3 weeks; and to 80% after 4 weeks (p < 0.05) for all concentrations, indicating a loss of activity 
of the supernatant. These data show that at although relatively stable for the first 2 weeks of 
storage, the active factor begins to degrade with storage beyond 2 weeks, and thus freshly 
collected supernatants were used for all experiments. Where not possible the supernatant was 












Figure 28: Supernatant factor is relatively bio degrades with storage. 
Supernatants were collected, diluted to the indicated concentrations and tested for activity 
against phagocytosis of resting spores of R. microsporus by J774 macrophages after the 
indicated time points. For all experimental conditions, the number of phagocytes containing at 
least one spore were counted after 1 hour (n=9000, One way ANOVA with Tukey’s correction 
for multiple comparisons). Three biological replicates were examined and error bars represent 




4.4 pH of the supernatant does increase but has no effect on 
macrophage function 
Resting spores are in a state of low metabolic activity, a feat necessary for overwintering 
dormancy. However, under optimal conditions including moisture, oxygen, nutrients and 
ambient temperature, dormancy is broken to allow germination and growth. During infection 
and colonization by spores, substrates like pathological exudates can also promote germination 
and growth.  
Inducing spore germination can also influence micro-environment pH by increasing 
extracellular bio-products. Undeniably, when associated with the host this may significantly 
affect physiological processes that are prone to pH change. For instance, low pH causes over 
expression of stablin-1 receptor involved in phosphatidylserine-dependent removal of 
apoptotic cells; and also causes reduced iron binding by ferrin carrier proteins increasing iron 
bio-availability (Park et al., 2012, Shirazi et al., 2015, Ibrahim et al., 2008c). Most importantly 
the optimal pH for phagocytosis is 6 - 7.5; and below pH 5 or above 8 phagocytosis  is abolished 
and bactericidal activity by phagocytes is reduced (Gargan et al., 1993).   
Here, the effect of supernatant pH on macrophage function was also considered. Accordingly, 
4 h supernatants were collected from 5 mucormycete species of interest and pH measured as 
described in section 2.3. 
Notably, there were no significant differences in the average measured values of sfDMEM 
control (pH 7.54) and individual supernatants from R. microsporus (pH 7.86), M. circinelloides 
(CBS-227940) (pH 8.46), M. circinelloides (NRRL 3631) (pH 8.41), L. corymbifera (pH 8.31), 




Table 9: Average measured pH values of medium control and supernatants.  
The data are presented as standard error of means from at least three individual biological 
repeats, a t –test vs the control was performed and statistical differences are indicated; where 
(p < 0.05).  
 
Supernatant source Average pH +/- SEM  p value 
Sf DMEM 7.54 ± 0.31  
R. microsporus  7.86 ± 0.17 0.5653 
M. circinelloides (CBS-227940)  8.46 ± 0.22 0.1843 
M. circinelloides (NRRL-3631)  8.41 ± 0.35 0.07234 
L. corymbifera  8.31 ± 0.19 0.0971 
C. bertholletiae (NB2) 8.47 ± 0.50 0.01862 
 
Using the above findings as reference, a pH gradient of 8.00, 8.50 and 9.00 similar to the 
supernatants was created using sfDMEM to investigate the effect of this pH range on 
phagocytosis described in sections 2.4 and 2.7. As shown in Figure 29, untreated and adjusted-
pH treated cells demonstrated percentage phagocytosis of 74% for a normal sfDMEM control, 
79% for pH 8.00 adjusted sfDMEM, 75% for pH 8.50 adjusted sfDMEM and 60% for pH 9.00 
adjusted sfDMEM. The differences observed in percentage uptake were not statistically 
significant (p = 0.9231). These data indicate that the inhibitory effects demonstrated previously 
are not due to increased pH of the supernatants, as there was no correlation between pH and 







Figure 29: Supernatant pH does not affect macrophage functions. 
The pH of sfDMEM was adjusted to the indicated ranges to match measured values for the 
collected supernatants. The adjusted medium was then used to treat J774 phagocytes, which 
were co-incubated with R. microsporus dormant spores for 1 h and uptake rate was assessed.  
For each adjusted pH conditions, the number of phagocytes containing at least one spore were 
counted after 1 hour (n=9000, One way ANOVA with Tukey’s correction for multiple 




4.5 The supernatant factor also inhibits phagocytosis of particles 
other than resting spores 
We have demonstrated in Chapter 3 that the supernatant inhibits phagocytosis of resting spores. 
Thus, activity against uptake of other particles such as latex beads and other fungal particles 
such as Candida albicans and Saccharomyces cerevisiae was also determined. Accordingly, 
macrophages were treated, challenged with the specified particles, and phagocytosis 
determined as in sections 2.4 and 2.7.  
 
As shown in Figure 30a, treatment with Rhizopus supernatant significantly inhibited uptake of 
latex beads from an uptake of 70% to 37% ± 2 (p < 0.001) and S. cerevisiae from 80% to about 
35% ± 4 (p < 0.001). Similarly, so, supernatants from other mucoralean fungi also showed 
varying levels of activity against uptake of C. albicans and S. cerevisiae. Particularly, 
supernatants of M. circinelloides (NRRL 3631) and Cunninghamella had a large significant 
impact against phagocytosis when compared with the untreated control (Figure 30b).  
 
These findings continue to show that this is a cross-species characteristic, but most importantly, 
that inhibitory activity is universal against other particles, consistent with a metabolic, rather 










Figure 30: Mucormycete supernatant inhibits phagocytic uptake of other particles. 
Supernatants from (a) R. microsporus and (b) other mucoralean fungi, as indicated, were 
collected and their activity against phagocytosis of particles other than dormant R. microsporus 
spores determined. The supernatants were used to treat J774 macrophages, which were then 
co-incubated with R. microsporus dormant spores or other phagocytic targets as indicated for 
1 h and uptake rate was assessed. For both experiments, the number of phagocytes containing 
at least one spore were counted after 1 hour (n=9000, One way ANOVA with Tukey’s 
correction for multiple comparisons). Three biological replicates were examined and error bars 








4.6 The supernatant factor also inhibits phagosome maturation  
We already highlighted the importance of phagocytosis and phagosome maturation. Most 
importantly, we have also demonstrated the effect of spore metabolism on phagosome 
maturation. Thus, the effect of the supernatant factor on phagosome maturation was also 
considered here.  
 
Accordingly, macrophages were treated with supernatant from pre-germinated R. microsporus 
spores, co-incubated with killed spores of the same species, and their ability to develop matured 
phagosomes determined through LysoTracker staining.  
 
As demonstrated in (Figure 31a), supernatant treatment significantly reduces LysoTracker 
staining intensity (p < 0.0001). The differences are also depicted in representative images 
(Figure 31b). These findings comparable to those obtained when macrophages were co-
incubated with live pre-germinated spores (Section 3.5), indicating that supernatant treatment 












Figure 31: R. microsporus culture supernatant inhibits phagosome maturation. 
Supernatants were collected and used to treat J774 phagocytes for 1 h, which were then co-
incubated with fixed killed swollen spores for 2 h. (a) Phagosome staining following uptake 
was determined with LysoTracker and intensity quantified by Image J. (b) Effect of the 
treatment on phagosome maturation was also monitored by time lapse microscopy for the 
indicated time points. For the graph, 450 cells with phagocytosed spores from three biological 












4.7 Cytotoxic effects by the supernatant factor on macrophages  
4.7.1 Secreted factor is not as toxic at collected supernatant concentrations  
The cytotoxic effects of some mycotoxins such as cytochalasin and rhizo-toxins are well 
known and thus we examined if the secreted factors exhibited similar properties (Qiao et al., 
2011, Partida-Martinez and Hertweck, 2005, Partida-Martinez et al., 2007a).   
Accordingly, macrophages were treated with the supernatant, and the effect on viability and 
cell injury was determined through trypan blue staining and LDH assay, respectively, as 
described (Section 2.8).  
Trypan blue, stains dead cells blue leaving live ones unstained. An LDH assay calorimetrically 
measures the amount of LDH enzyme released due to cell injury. As shown in Figure 32a, 
treatment with either 75 or 100 % supernatant did not affect macrophage viability, there was 
no difference in the number of cells that took up the blue dye between treated and untreated 
controls meaning that the overall viability was 100% (p = 0.1198). 
 Similarly, the LDH assay showed supernatant treated cells to release significantly lower 
enzyme levels compared to the water treated positive control (p < 0.0001). When co-incubated 
with pre-germinated spores, the amount of LDH enzyme slightly increased compared to the 
supernatant treatment, but the increase was not statistically significant compared to the 
supernatant (p>0.05) (Figure 32b). The data showed that although the supernatant affects 




Figure 32: Supernatant factor has no effect cell viability. 
Quantification of macrophage viability by (a) Trypan blue staining following treatment with 
swollen spore supernatant. (b) Quantification of cell viability by LDH release following 
treatment of J774A.1 macrophages with swollen spore supernatant. Cell lysis buffer (positive) 
and DMEM only (negative) treated cells serve as controls. For all graphs, 100 cells with 
phagocytosed spores from three biological repeats were examined; error bars represent s.d.  













4.7.2 The supernatant factor affects cytoskeleton and morphology J774 
phagocytes  
The eukaryotic cytoskeleton is dominated with structures such as actin and tubulin. 
Macrophages require these for motility, phagocytosis, antigen presentation, and other 
morphological dynamics (Jonsson et al., 2012, Ting-Beall et al., 1995).  
However, if pathogens are to successfully evade phagocyte effector functions, inhibiting 
polymerization of actin or tubulin can be a crucial step. In this regard, several pathogens are 
already known to secrete compounds that specifically inhibit polymerization of cytoskeletal 
components, including actin and tubulin (Hartwig and Yin, 1988).  
Amongst these are two cytochalasins, chaetoglobosin and rhizoxin, that target F-actin and ß-
tubulin respectively (Lackner et al., 2009b, Partida-Martinez and Hertweck, 2005, Qiao et al., 
2011). Cytochalasin B can also cause defects in  nitrogen oxide (NO) production (Kim et al., 
2014). Undeniably, some pathogens have evolved mechanisms to evade macrophage functions 
including disruption of the cytoskeleton. Therefore, with evidence of metabolic spores evading 
phagocytosis here, the effect of spore metabolism on phagocytosis was also determined.  
Accordingly, macrophages were treated, stained for F-actin or ß-tubulin, and staining analysed 
(Sections 2.4 and 2.9) Cells were examined for the presence of actin filaments and 
microtubules, indicative of an intact cytoskeleton (Prota et al., 2014, Takahashi et al., 1987, 
Sullivan et al., 1990, Shoji et al., 2012, Cooper, 1987). As demonstrated in (Figure 33), there 
was a significant decline in actin staining of treated cells compared to untreated (p<0.0001).  
additionally, there was significant differences between actin staining with supernatant and 
Cytochalasin D (an inhibitor of actin polymerisation) (p<0.001), used as a positive control. 
This is perhaps suggestive of similar target and mode of action between supernatant factor and 






Figure 33: R. microsporus culture supernatant can inhibit macrophage cytoskeletal (actin) 
function. 
J774 macrophages were treated with the collected R. microsporus culture supernatant or 
cytochalasin D as positive control for 1 h, stained for F-actin for 15 min with rhodamine-
conjugated phalloidin, and staining intensity quantified with image J.  Analysed using 
Student’s two-tailed T-test with Welsh’s correction for unequal variance (n=150 per replicate, 
with three biological replicates). For the graph, data shown are mean with s.e.m. (**p<0.001, 






Similarly, with beta tubulin immuno-staining, there were significantly marked differences 
between average staining intensity of untreated cells and those treated with supernatant culture 
(p <0.0001). In addition, similar findings as with the supernatant were obtained with Rhizoxin 
D, a known beta tubulin in inhibitor (p <0.01). Here, Rhizoxin was used as a positive control 
for microtubule destabilisation (Figure 34). The differences are also depicted in the 
representative images.  
However, in both cytoskeletal experiments above, there was a significant change in 
morphology of the cells treated with supernatant and thus further investigated. This defect was 
further examined through evaluating cell shape such as scoring their circularity where; (0 is a 
perfect line and 1 a perfect circle).  
As demonstrated in (Figure 35), significant changes in average cell shape occurred from 0.19 
when untreated to 0.25 when treated (p<0.00001). Taken together, defects in cytoskeletal 
staining and changes in cell shape here all point to significant cytotoxic effects driven by spore 












Figure 34: R. microsporus culture supernatant can inhibit macrophage cytoskeletal (beta 
tubulin) function. 
J774 macrophages were treated with the collected R. microsporus supernatants or rhizoxin D 
as positive control for 1 h, immuno-stained for 1h with anti-beta tubulin antibody and 
counterstained with secondary antibody (goat anti-rabbit) and stain intensity quantified with 
image J. Analysed using Student’s two-tailed T-test with Welsh’s correction for unequal 
variance (n=150 per replicate, with three biological replicates). For the graph, data shown are 







Figure 35: R. microsporus culture supernatant affects macrophage cell morphology. 
J774 phagocytes were treated with collected supernatants for 1 h and cell shape (roundness) 
scored using image J. 1 represents a perfect circle while 0 a perfect line. Analysed using one-
way ANOVA (Mann Whitney test) for non-parametric data (n=150 per replicate, with three 
biological replicates). For the graph, error bars shown are for s.d (**** p < 0.00001). 









4.8 Effect of the supernatant factor on other human cells  
Hallmark symptoms of mucormycosis include severe angio-invasion, thrombosis and tissue 
death as already mentioned (Ghuman and Voelz, 2017, Ibrahim and Kontoyiannis, 2013, 
Ibrahim et al., 2012, Kontoyiannis and Lewis, 2006, Roden et al., 2005, Riley et al., 2016).  
Some of these manifestations demonstrate a pattern of affinity and association between the 
fungus and particular host components that perhaps facilitate pathogenesis of the disease. For 
instance, mucormycotic dissemination progresses via a strong association between infecting 
spores and endothelial cells and this is facilitated by the fungal surface CotH ligand that 
strongly binds the host GRP78 receptor (Gebremariam et al., 2014, Liu et al., 2015, Ibrahim, 
2014, Gebremariam et al., 2016). This interaction allows adhesion of fungal spores to the host 
endothelial cells facilitating invasion by the fungus. 
Also, recently, Ghuman et al (2018) showed that M. circinelloides spores induce platelet 
aggregation in whole human blood and platelet rich plasma (PRP) through interactions with 
surface receptors including the low affinity immunoglobulin G (IgG) receptor (FcγRIIA) and 
the most abundant surface glycoprotein (platelet integrin αIIbβ3). Both of these are also heavily 
involved during platelet –bacterial interactions (Ghuman et al., 2018, Watson et al., 2016, 
Moriarty et al., 2016, Arman and Krauel, 2015, Hamzeh-Cognasse et al., 2015). Together, these 
interactions are thought to mediate platelet aggregation 
Most importantly though, Ghuman et al also highlights the influence of spore developmental 
stages on platelet responses. They show that 3 h germinating spores significantly induced 
platelet aggregation more than dormant spores and germinated hypha (Ghuman et al., 2018). 
This difference in affinity for platelets suggests that metabolically active spores are capable of 




Therefore, given the important role that spore interaction with different cell types has on 
disease progression, the effects of spore metabolism on other human cells such as erythrocytes 
and neutrophils were also considered here. 
 
4.8.1 Spore metabolism affects morphology but does not lyse erythrocytes  
Emerging data suggest that spore metabolism can manipulate or create an imbalance in the 
host’s hemodynamic during infection, and similar interactions with erythrocytes may not be an 
exception. Platelets, fibrin and erythrocytes are all part of the clotting system (Janeway, 2005, 
Roitt and Delves, 2001). Intriguingly, there have been some preliminary reports from a 
different mucormycete research group that R. oryzae spore metabolic processes may promote 
erythrocyte lysis (Ibrahim et al., Personal communication).  Thus, the effect of supernatant 
factors on erythrocytes, particularly lysis, was also investigated here.  
 
Accordingly, erythrocytes were treated with the supernatant, co-incubated with both dormant 
or metabolically active spores; and haem release due to lysis determined microscopically and 
calorimetrically as described before (Sections 2.2, 2.3, 2.7 and 2.9).  
Notably, all treatments caused significantly low levels of haemolysis (p < 0.0001) when 
compared with the positive control, indicating no lysis caused by the various indicated 
treatments (Figure 36). Interestingly, microscopically, treatment with both supernatant and co-
incubation with metabolic spores caused a significant change in erythrocyte cell morphology 
from a smooth surface to a crenate phenotype (Figure 36).   
This phenotype can be linked to hypertonic tension for the supernatant treatment but osmolality 
was not measured to rule this out. What is clear is that the supernatant did not lyse red cells 
and if we were to ignore osmotic pressure here, these findings show that spore effects may go 
beyond inhibiting only phagocyte functions to encompass other key physiological parameters 




Figure 36: R. microsporus culture supernatant doesn't lyse but affects erythrocyte cell 
morphology. 
Whole blood erythrocytes were washed in PBS and treated with collected supernatants, 
indicated controls, or co-incubated with spores as indicated. Co-cultures were assessed for cell 
lysis (Hg binding) calorimetrically or effect on cell morphology determined as represented by 
micrographs. For the graph, the data was analysed by ordinary One-way ANOVA (Brown 
Forsythe test) for non-parametric data. The data is from three biological repeats and errors bars 







4.8.2 Spore metabolism influences neutrophil migration 
Neutrophils compose about 40-60% of peripheral blood cell count and are an integral part of 
the innate immune system (Summers et al., 2010, Miralda et al., 2017). Just like macrophages, 
neutrophils are primed prior to activation and their immunological response is dependent on 
the availability and exposure to a particular stimuli such as inflammatory cytokines, anaphyla-
toxins,  chemokines or PAMPs (Miralda et al., 2017). However, when the interplay between 
all these is not well controlled, a diverse range of life-threating conditions including serious 
inflammatory responses may arise (Kannengiesser et al., 2008, van de Vijver et al., 2012, 
Miralda et al., 2017).  
In regards to antifungal immunity, neutrophils also possess phagocytic attributes and are 
invaluable in controlling the damage of the hyphal form of filamentous fungi by the formation 
of neutrophils extracellular traps (NETs) (Brakhage et al., 2010). This subsequently limits 
dissemination and extent of damage by hyphae. Indeed, neutropenic patients are prone to not 
only bacteria but also filamentous fungi as already mentioned (Ibrahim et al., 2012, Kousha et 
al., 2011, Kontoyiannis and Lewis, 2006, Ibrahim and Voelz, 2017).  
Currently, our understanding of neutrophil-mucormycete spore interactions is very limited. 
Given the evidence so far regarding the impact of spore metabolism on other human cell 
functions, spore metabolic influence on neutrophil function, particularly recruitment, was also 
considered and investigated here. The impact of supernatant factors on neutrophil migration 
was determined using an in vitro micro-slide migration assay, with appropriate gradient setups 
as described (Section 2.4 and 2.8). In this assay, cells loaded into a central well are analysed 
for attraction towards two gradients 
As shown in (Figure 37 and Table 10), the ability of neutrophils to migrate between two 
chemotactic gradients was investigated using both sfRPMI and sfDMEM medium as negative 
and N-formyl-Methionyl-leucyl Phenylalanine (fmlp) as positive controls. In control 
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experiments, there was no significant difference in migration towards two sfRPMI only 
chambers, with mean accumulated distance of 70.1 µm, mean Euclidian distance of 8.3 µm 
and mean velocity of 1.17 µm/min (p = 0.154648) (Figure 37a and 37b); nor was there a 
difference in migration towards sfRPMI or sfDMEM gradients, with mean accumulated 
distance of 116.4 µm, mean Euclidian distance of 18.5 µm and mean velocity of 1.94 µm/min 
(p = 0.172552) (Figure 37a and 37b), although cells covered more distance towards sfDMEM 
than towards the sfRPMI gradient. Significant differences were noted with the positive control 
fmlp. Cells in the fmlp gradient demonstrated a mean accumulated distance of 445.4 µm, mean 
euclidian distance of 195.3 µm and mean velocity of 7.42 µm / min (p < 0.05) (Figure 37a 
and 37b);  
 
When a spore supernatant gradient was examined, significant neutrophil migration was 
observed, with a mean accumulated distance of 415.8 µm, mean euclidian distance of 53.0 µm 
and mean velocity of 6.93 µm / min (p < 0.05) (Figure 37a). These data clearly show that the 
supernatant gradient significantly influences neutrophil migration, although not to same level 
as fmlp.  
Interestingly, a combination of both supernatant and fmlp (Figure 37a) revealed reduced mean 
accumulated distance of 144.6 µm, mean euclidian distance of 34.05 µm and mean velocity of 
2.41 µm / min (p < 0.05) almost similar with sfDMEM control gradient. Although statistically 
significant migration was observed, this may still indicate an inhibitory effect of supernatant 
on migration in the presence of fmlp. More studies are need to fully explore specific 
mechanisms of this interaction. Generally, we can to some extent conclude here that spore 
metabolism may influence neutrophil migration but remains to be fully explored by future 
studies.   
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Similar readings are seen with forward migration index (FMI), showing significant migration 
in the Y (FMI parallel) direction between supernatant and negative controls (p<0.001); between 
the supernatant and FMLP (positive control) (p<0.00001) and; a combination of supernatant + 
FMLP and FMLP (positive control) (p<0.00001) (Figure 37b). In the X (FMI perpendicular) 
direction, there is a difference in migration between supernatant and the negative controls 
(p>0.05). However, significant differences existed between supernatant and FMLP (positive 
control) (p<0.0001). Yet a significant migration in the X direction by the supernatant + FMLP 





















Figure 37: R. microsporus shows minimal effect on neutrophil migration. 
Cell trajectory, using an Ibidi micro slide kit, (a) the ability of neutrophils to migrate towards 
supernatant and other indicated control gradients was determined.  The gradients included; 
sfRPMI control, sfDMEM as a negative control, N-formyl-methionyl-leucyl-phenylalanine 
(FMLP) chemotactic peptide as a positive control, the supernatant and FMLP + supernatant 
test gradients. (b) Forward migration index (FMI) of cells (n=100) was scored and analysed 
using one way ANOVA (Mann Whitney test) for non-parametric data. The data presented here 















Table 10: R. microsporus shows minimal effect on neutrophil migration. 










Negative control (sf 
RPMI) 
70.1012 8.30383 1.16835 0.154648 
Positive control (fmlp) 445.47 195.317 7.4245 1.2730e-34 
Sf DMEM control 116.474 18.5146 1.94123 0.172552 
Supernatant  415.834 53.019 6.93057 6.39179e-06 
Supernatant + fmlp 144.662 34.0547 2.41104 8.1226e-12 
 
4.9 Chemistry of the supernatant factor  
My data thus far suggest that mucormycete spores metabolically secrete factors that facilitate 
evasion of innate antifungal immunity. Phenotypic characterization of the supernatant so far 
points to a range of bioactive attributes as highlighted previously. Interestingly, some of the 
attributes described, particularly cytotoxic effects, escape from phagocytosis and macrophage 
killing, reveal a pattern in mode of action similar to that demonstrated by some known 
metabolic compounds such as cytochalasins and rhizo-toxins. However, these observed effects 
could still be the result of a range of virulence factors including peptides, sugars, lipids or 
aromatic compounds that are yet to be identified and characterized (Londono-Hernandez et al., 
2017, Abe et al., 2007). 
In this regard, a phenotypic comparison drawn between supernatant factors and some of the 
characterized compounds can mean one of three things here. Firstly, that the supernatant 
factors are the same in structure and function to some of those already characterized. Secondly, 
that supernatant factors are different in structure but similar in function. Thirdly, that 
supernatant factors are totally different in structure and perhaps function. Thus, to answer these 
questions we used known compounds as references and employed several approaches such as 
physical denaturation, chromatography, mass spectrometry and lipid profiling in an attempt to 




4.9.1 Supernatant factor is a compound of small molecular size  
The raw and crude collected supernatants from germinating spores can be a pool of secreted 
and shed bio-products of different molecular sizes and chemical conformation. Here we asked 
whether the causative compound is a small molecule (< 3kDa) or larger. To answer this 
question, supernatants were collected, respectively filtered through columns of size 100 kDa 
and 3 kDa by ultra-centrifugation and activity of both column fractions i.e.  the flow-through 
and remaining solute, were determined as described before in (section 2.3 and 2.6). In both 
experiments an unfiltered supernatant control was also included.  
As shown in (Figure 38a), for the 100 kDa column, both the unfiltered (mean uptake rate 54%) 
and flow-through (mean uptake rate 56%) supernatants demonstrated similar levels of activity 
against phagocytic uptake (p > 0.05) and were significantly different from the untreated control 
(mean uptake rate 75%) (p < 0.001). The activity of the remaining solute (mean uptake rate 63 
%) was not statistically significantly different to the untreated control (p = 0.3912). This meant 
that most of the active compounds were able to pass through the column, suggesting the 
compounds in question are smaller than 100 kDa.  
Upon further analysis, significant differences in activity levels were noted with the 3 kDa 
column fractions, where flow-through showed significantly higher activity against phagocytic 
uptake to about 40 % (p < 0.0001) than both the unfiltered supernatant (mean uptake rate 56%) 
and remaining solute (mean uptake rate 55%) (p = 0.0452) when compared to untreated control 
of (mean uptake rate 76%) (Figure 38b). This data suggests that the most active compound is 
less than 3 kDa in size, but active factors large than 3 kDa may also be secreted alongside, 




Figure 38: Effect of seclusion of molecular size on activity of the supernatant factor. 
Collected supernatants were filtered through columns for (a) 100 kDa and (b) 3 kDa 
fractionation to collect both the column (Top remains) and filtered (Flow through) portions. 
The total unfiltered supernatant and column portions were then used to treat J774 phagocytes, 
which were co-incubated with R. microsporus dormant spores for 1 h and uptake rate assessed. 
For both assays, the number of phagocytes containing at least one spore were counted after 1 
hour (n=9000, One way ANOVA with Tukey’s correction for multiple comparisons). Three 
biological replicates were examined and error bars represent s.e.m. (*=p < 0.01, ** =P<0.001, 










4.9.2 Supernatant activity withstands protein digestion, sugar oxidation or 
heat denaturation  
We have already highlighted the possible candidates for the compounds in question including 
proteins such as hydrolytic enzymes and other peptides, sugars and lipids. To rule out if the 
active compound is any of these, the supernatant was digested, oxidized or profiled for lipids.  
Thus, the supernatant was physically denatured through boiling at 100 oC for 1 h and treated 
with proteinase K (50 g/ml) or sodium periodate (1mM/mL) for 60 min. Additionally, the 
supernatant was also analysed for lipids through a lipidomics spectrometry to establish a 
hydrophilic interaction liquid chromatography (HILIC) profile as highlighted in (Sections 2.4, 
2.7 and 2.12).  
The principle governing some of these approaches include; proteinase K being a serine protease 
with a broad range of cleavage specificity for peptide bonds while sodium periodate is an 
inorganic salt that oxidizes saccharide rings into aldehyde groups and was used here to denature 
compounds with such chemical conformation including carbohydrate sugars.   
It was interesting to see that all treated supernatants still exhibited significant activity against 
phagocytosis. Percentage uptake significantly decreased from 80% by untreated cells to about 
35% by cells treated with the unmodified supernatant, 40% by cells treated with boiled 
supernatant, 36% by cells treated with enzyme-digested supernatant and 42% by cells treated 
with oxidized supernatant (p < 0.0001) (Figure 39). Additionally, the differences in uptake 
noted between treatments with various supernatant types compared to unmodified supernatant 






Figure 39: Protein digestion, oxidation and physical denaturation has no effect on the 
supernatant activity. 
Collected supernatants were treated for protein denaturation with proteinase K digestion and 
boiling; and sugar oxidation with sodium periodate. Both the untreated and treated supernatants 
were then applied to J774 phagocytes, which were co-incubated with R. microsporus dormant 
spores for 1 h and uptake rate assessed. For all assays, the number of phagocytes containing at 
least one spore were counted after 1 hour (n=9000, One way ANOVA with Tukey’s correction 
for multiple comparisons). Three biological replicates were examined and error bars represent 
s.e.m. (***p=<0.0001 and ns=p>0.05). 
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HILIC analysis revealed lipid candidate compounds including L-citramalyl-CoA a compound 
annotated in the KEGG database to be involved in a multitude of metabolic pathways; 
Phosphatidylinositol-3,4,5 trisphosphate (PIP3), heavily involved in activation of downstream 
signalling components such as protein kinase that activate anabolic signalling pathways 
required for cell growth (Auger et al., 1989). In addition, a few other compounds that were 
HILIC positive are unidentified, making this finding inconclusive (Table 11). Taken together 
the findings here showed that the factor in question is unlikely to be a protein, carbohydrate 




















Table 11: HILIC profile of medium control and supernatant.  
HILIC positive are the compounds that tested positive for lipids and verse vasa for the HILIC 
negative. 
XCMS_ID m/z Matched 
molecular 
formula 
Possible analytes Lipid/HILIC 
profiles 
M161T257 160.842065   Unidentified HILIC negative 
M377T466 377.085803 C12H22O11 Trehalose, Turanose, Neotrehalose, 
mannobiose, Kojibiose and 
inulobiose 
HILIC negative 
M538T29 537.53525   Unidentified  HILIC positive 
M269T410 269.08776 C10H14N4O5 Hydroxymelatonin, isoleucyl-
thronine, Temurin, nananol and 
spermic acid  
HILIC negative 
M379T466 379.08267   Lactose, maltose, epimelibiose, 
Galabiose and Galactinol  
HILIC negative 
M300T473 299.91923 C3H8NO6P Phosphoserine  HILIC negative 
M455T466 455.10214 C16H26O7 Flavin mononucleotide, 
Epicatechin 3-0-(3-0-
methygallate), 5-Hydroxyfenchone 
glucoside and Gericudranins B 
HILIC negative 
M405T466 405.10826 C15 H20 O10 Edulane, N-Demethyleletriptan, 




M898T307 898.14463 C26H42N7O20P3S L-Citramalyl-CoA Lipids positive 
M214T473 214.03339 C5H9NO4 L-4-Hydroxyglutamine 
Semialdehyde; L-Glutamic acid, N-
Acetyll serine; O-Acetyl serine 
HILIC negative 
M378T466 378.08923   Lactose, maltose, epimelibiose, 
Galabiose and Galactinol 
HILIC negative 
M236T35 236.14908   Unidentified  Lipids positive 
M157T60 157.01419 C4H8N2O 3-hydroxy-cis, cis-Muconic acid, 





M187T412 187.07226 C10H14O2 Agmatine, Valaraldehyde 
propyleneglycol acetal, 
Suspensolide methyl heptanoate, 
Perillic acid, Cyromazine, L-glycyl-
L-hydroxyproline 
HILIC negative 
M248T81 248.00204 C5 H11 NO3 S Methionine sulfoxide; “1,2,3,4-
tetralydroisoquinoline” 
HILIC negative 
M214T53 213.89215   Unidentified  HILIC negative 
M703T323 
 
702.9380043 C12H24O22P4 Phosphatidylinositol-3,4,5 
trisphosphate 




4.10 Chloroform extraction of the supernatant 
Stemming from the above findings, we hypothesized that the factor in question is not a protein 
or carbohydrate but possibly a lipid or secondary metabolite. In other systems, compounds such 
as cytochalasins and rhizo-toxins (Figure 40) have been identified as having similar activity 
to supernatant factor here.  
To determine whether the anti-phagocytic compound might be a secondary metabolite, the 
supernatant was subjected to secondary metabolite extraction methods. Specifically, a 
chloroform extraction was performed because the majority of secondary metabolites are 
alkaloids, which are readily soluble in organic solvents such as chloroform (Lucio et al., 2015, 
Tsuruo et al., 1986). Additionally, chloroform is denser than water with a low boiling 
temperature making it easier to extract and dry the aqueous supernatant under reduced pressure. 
Accordingly, the supernatant was exhaustively extracted in a volume ratio of 2:1 v/v 
(supernatant: chloroform), extract obtained under reduced pressure at 45º C (Figure 40a), 
reconstituted into dimethyl sulfoxide (DMSO) and subsequently into sfDMEM (final DMSO 














Figure 40: Chloroform extraction setup and reference compounds for the supernatant factors 
in question. 
The collected supernatant was (a) exhaustively extracted with chloroform, dried under reduced 
pressure at 45 o C and extract reconstituted into DMSO (for HPLC) + SfDMEM (for the 
infection assay). Extractions were made from at least individual biological repeats. (b) 
















It was interesting to see significant differences in activity of both the unextracted and 
chloroform extracted supernatants.  While the unextracted supernatant significantly decreased 
percentage uptake from 75% to 35% on average (p < 0.0001), the chloroform extract showed 
moderate activity, decreasing uptake from 70% to 50% on average. The difference in uptake 
in the extract was not statistically significant compared to unextracted (p > 0.05) (Figure 41). 
Because reconstitution of the extract products was initially made in DMSO then sfDMEM, we 
also sought to determine the effect of DMSO on phagocytic uptake. However, DMSO did not 
show any significant effect against uptake, with respective average uptake rates of 73% for 



















Figure 41: Chloroform extracted supernatant shows reduced anti-phagocytic effect on J774 
macrophages. 
The collected supernatant was exhaustively extracted with chloroform and reconstituted in 
DMSO and sfDMEM.  Both the unextracted and extracted supernatants were then used to treat 
J774 phagocytes, which were co-incubated with R. microsporus dormant spores for 1 h and 
uptake rate assessed. For both assays, the number of phagocytes containing at least one spore 
were counted after 1 hour (n=9000, One way ANOVA with Tukey’s correction for multiple 
comparisons). Three biological replicates were examined and error bars represent s.e.m. 
(**p<0.001, ***p=<0.0001 and ns=p>0.05). 
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However, the decline in activity of the extracted supernatant suggested that the extraction 
process might affect concentration, molecular conformation and interaction ability of the active 
compounds. We were unable to rule out the possibility that the extraction method destroys the 
compound of interest. However, the reduction in activity observed upon treatment with the 
extract supports the hypothesis that some active compound remains intact. To further 
investigate the identity of this compound. We sought to use more sensitive and specific 
techniques such as high-performance liquid chromatography (HPLC), mass spectrometry (MS) 
or nuclear magnetic resonance (NMR). 
 
4.10.1 HPLC analysis reveals significant differences between extract 
products of supernatant and control 
HPLC analysis is a common technique in analytical chemistry often employed to identify, 
quantify or separate a sample of mixed compounds under pressure/ (Carr et al., 2011, Vella et 
al., 2015, Horvath et al., 1967, Aturki et al., 2014). The technique is based on pumping a 
pressurized sample mixture through a column usually lined with granular adsorbent material 
such as silica or polymers in the presence of a buffer that supports binding. Separation of the 
sample mixture is dependent on how individual sample components interact with the column 
during elution with an increasing gradient of a second buffer (Vella et al., 2015, Sparkman, 
2007).  
The paradigm behind application of HPLC analysis here was based on the principle that 
polarity of the medium influenced individual molecular interactions (Figure 42). We draw 
three hypotheses for this; First, that in the hydrophilic phase molecules are far apart in charge 
and interacted freely with the column. Second, that following extraction the molecules tightly 
interact and that freedom is lost. Third, HPLC elution causes protonation of the molecules, 
changing molecular conformations, and subsequently frees molecules for interaction but other 
confounding factors such as synergy and antagonistic activity may not be ignored. Thus, HPLC 
 
 160 
profiling here would quantitatively determine the relative abundance of the individual 
compounds in a mixed sample. With suspicion that the factor in question is an alkaloid, a 
reverse phase (RP) polarity-based chromatography was performed using the carbon chain 























Figure 42: A paradigm for possible molecular interactions of a particular solute. 
A paradigm demonstrating molecular interactions in both hydrophilic and hydrophobic phases 










HPLC profiling identified the peaks in the fungal supernatant that were absent in the media 
only control (Figure 43). When compared with the reference compounds rhizoxin D and 
cytochalasins (B and D), there were peaks with similar retention times in the supernatant profile 
(Figure 43). For instance, all major peaks in the reference compound controls come out late in 
the HPLC run i.e. between 34 - 42 min (Figure 43). This is comparable with 4 of the 
supernatant peaks (Figure 43). This can point to a similarity in molecular conformation such 
as polarity, and in this particular case would indicate that these compounds are mainly 
hydrophobic because they appear late in the HPLC profile.  
To specifically identify the active compounds, the activity of individual HPLC analytes was 
investigated. Two approaches were employed here. Firstly, fractionation: 10-minute interval 
HPLC fractions were dried, and activity against phagocytic uptake determined (Section 2.11). 
In total, 6 fractions were collected (0-10 min (1), 10-20 min (2), 20-30 min (3), 30-40 min (4), 
40-50 min (5) and 50-60 min (6)) (Figure 44).  Interestingly, with the exception of fraction 1, 
all other fractions demonstrated significant activity against phagocytic uptake.  
Uptake rate decreased from an average percentage uptake of 80 % of the control to 70 % by 
fraction 1 (p > 0.05); 60 % by fraction 2 (p = 0.04987); 55 % by fraction 3 (p < 0.01); 40 % by 
fraction 4 (p < 0.0001); 64 % by fraction 5 (p < 0.05); and 45 % by fraction 6 (p < 0.001) 
(Figure 44). Fraction 4 and 6 gave the largest reduction in uptake. We observed a broad 
distribution of activity in the supernatant fractions, with fraction 4 having the strongest effect. 
Therefore, in subsequent work we focus on fraction 4. When interpreting this data, we noted 
that some of the demonstrated activity may be due to a background impact by HPLC elution 
solvents such as acetonitrile (AcN), formic (FA) or trifluoro-acetic acid (TFA). However, to 
mitigate the possible impact of these contaminants on macrophage behaviour, the samples were 
thoroughly evaporated prior to re-suspension. When a media only control was passed through 
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the same workflow, no significant impact on phagocyte uptake rates were observed (Figure 
44).  
 
Figure 43: HPLC profiles of individual extracts and reference controls. 
High performance liquid chromatography (HPLC) profile of extracted supernatant and 
sfDMEM control samples; and purified reference compounds including rhizoxin D, 
cytochalasin B and D. For the extracted samples, data are presented from at least three 




Figure 44: HPLC fractions of the R. microsporus culture supernatant exhibit anti-phagocytic 
activity. 
HPLC products of both supernatant and control were fractionated as indicated, freeze dried and 
reconstituted in sfDMEM.  The fractions were then used to treat J774 phagocytes, which were 
co-incubated with R. microsporus dormant spores for 1 h and uptake rate assessed. For all 
fraction assays, the number of phagocytes containing at least one spore were counted after 1 
hour (n=9000, One way ANOVA with Tukey’s correction for multiple comparisons). Three 
biological replicates were examined and error bars represent s.e.m. (**p<0.001, 
****p=<0.00001 and ns=p>0.05).  
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Thus, the second approach was based on isolating individual HPLC peaks and determining 
their activity. This way, a total of 8 (1-8) peaks (Figure 45a) were collected from the pooled 
supernatant, dried and activity determined as described before (section 2.10). Interestingly, 
peaks 3, 5 and 8 demonstrated activity against phagocytosis from 80 % by the control to an 
average uptake of 60 % by peak 3 (p <0.05); 40 % by peak 5 (p < 0.0001); and 50 % by peak 
8 (p < 0.001) (Figure 45b), with peaks 5 and 8 giving the highest level of activity. Both peaks 
5 and 8 belonged to fraction 4 that had earlier shown the highest level of activity among the 
fractions, while peak 3 belonged to fraction 3 as shown in (Figure 44). Together, these data 
suggest that the active compound elutes in the 30-40-minute range and can be separated into at 
least two elution profiles (peaks 5 and 8).  
 
With these data sets, we can conclude that the supernatant factor contains more than one active 
factor as depicted with peaks 3, 5 and 8, but most importantly, further characterization of these 













Figure 45: Individual supernatant HPLC peaks demonstrate similar anti-phagocytic activity. 
Individual HPLC peaks (a) annotated were isolated, freeze dried and reconstituted in sfDMEM. 
(b) The peaks were then used to treat J774 phagocytes, which were co-incubated with R. 
microsporus dormant spores for 1 h and uptake rate assessed. For each peak, the number of 
phagocytes containing at least one spore were counted after 1 hour (n=9000, One way ANOVA 
with Tukey’s correction for multiple comparisons). Three biological replicates were examined 








4.10.2 Mass spectrometry profiles of active HPLC peaks reveals masses 
consistent with rhizo-toxins 
Mass spectrometry is an analytical technique often employed to characterize chemical species 
by mass to charge ratio (Sparkman, 2007).  This way, a sample is ionized with electrons that 
cause the sample to break into smaller charged fragments. These can then be separated 
according to their charge to mass ratio when subjected to an electromagnetic field (Sparkman, 
2007). Therefore, mass spectra are used to describe the chemical structure of molecules through 
elucidation of their isotropic signatures  (Sparkman, 2007).  
Using this method, some studies have already characterized rhizo-toxins and give mass ranges 
of between 300 and 812 m/z for rhizoxin and rhizonin derivatives (Scherlach et al., 2006, 
Partida-Martinez et al., 2007a, Partida-Martinez and Hertweck, 2007). Here, a similar approach 
was used to characterise the active peaks. Accordingly, peaks were isolated and high-resolution 
mass spectrometry characterization performed as described (Section 2.11).  
As shown in Figures 46-48, peak 3 yielded masses of 144, 162, 163 and 194 m/z (Figure 46); 
peak 5: masses of 251, 319, 421, 698 and 700 m/z (Figure 47); and peak 8 yielded 130, 162, 
203, 290 and 330 m/z (Figure 48). Whilst most of the peaks here are uncharacterised, special 
attention was given to masses 330 m/z (from peak8) (Figure 48), 698 m/z and 700 m/z (both 
from peak 5) (Figure 47).  These masses are consistent with rhizonin and rhizoxin (Figure 49) 
(Scherlach et al., 2006, Partida-Martinez et al., 2007a). The questions at this stage would be 
whether these are also derivatives of rhizo-toxins or not. Nonetheless, if we are to assume that 
they are, we ought to recall that the rhizo-toxins are not secreted by the fungus but bacterial 
symbionts (Lackner et al., 2009b, Partida-Martinez et al., 2007a, Partida-Martinez et al., 2007b, 
Partida-Martinez and Hertweck, 2005) Yet bacterial symbionts are yet to be implicated in 





Figure 46: Mass spectrometry profile of HPLC peak 3. 
Individual HPLC peak 3 was profile by high resolution mass spectrometry (HRMS). The 
highlighted region contains the peak of interest and subtraction of the background information 














Figure 47: Mass spectrometry profile of HPLC peak 5. 
Individual HPLC peak 5 was profile by high resolution mass spectrometry (HRMS). The 
highlighted region contains the peak of interest and subtraction of the background information 

















Figure 48: Mass spectrometry profiling of peak 8. 
Individual HPLC peak 8 was profile by high resolution mass spectrometry (HRMS). The 
highlighted region contains the peak of interest and subtraction of the background information 
















Figure 49: Mass spectrometry profile of Rhizoxin D. 
High Resolution Mass Spectrometry profile of the rhizoxin D standard. The highlighted region 
contains the peak of interest and subtraction of the background information reveals the masses 















4.11 Discussion  
Fungal metabolism is fundamental for successful evasion of host immunity. It is not uncommon 
for filamentous fungi to produce compounds such as mycotoxins and other metabolites in a 
diverse range of matrices. Depending on their biochemistry, these compounds can demonstrate 
a diverse range of effects on both plant and animal health. In fact, some of them are already 
implicated in food poisoning, water contamination and human disease pathogenesis (Oliveira 
et al., 2018).  
 
Here, we report that mucormycete spore metabolism also induces expression of key secretory 
factors, with significant effects on host pathogen interactions particularly negatively impacting 
macrophage effector functions, although our understanding of the mechanisms involved is still 
very limited.  In this regard, R. microsporus has recently been reported to be associated with 
both a macrocyclic polyketide phytotoxin metabolite, rhizoxin and a hepatotoxic cyclopeptide 
rhizonin (Partida-Martinez et al., 2007a, Partida-Martinez and Hertweck, 2005).  
 
However, both are yet to be implicated in fungal pathogenicity and are produced by bacterial 
symbionts rather than the fungus (Lackner et al., 2011a, Araldi-Brondolo et al., 2017, Frey-
Klett et al., 2011, Gee et al., 2011, Husnik and McCutcheon, 2018, Ibrahim et al., 2008b, 
Lackner et al., 2011b, Partida-Martinez et al., 2007a). 
 
Interestingly, rhizoxin is associated with plant pathology and rhizonin hepatotoxic and 
agriculture produce contamination (Partida-Martinez et al., 2007a, Partida-Martinez and 
Hertweck, 2005). This raises the possibility that perhaps association with human pathogenesis 




The data presented here show that phenotypic (particularly cytotoxic) effects of spore 
metabolism on both murine and human cells are similar to those by rhizoxin and cytochalasin 
in vitro. Instigating the question of whether the supernatant factors in question here are similar 
in structure or function to either toxin types as already characterised by other studies (Qiao et 
al., 2011, Newman and Watt, 1988). 
 
Yet, implicating the rhizo-toxins means implicating bacterial endosymbionts in host 
pathogenesis. However, this would not be the first-time; Chamilos et al (2007) had earlier 
alluded to possibly why the prevalence of mucormycosis has increased in recent years, 
suggesting that changes from use of antibiotics when managing opportunistic fungal infections 
then to now when they are particularly not being used as often (Chamilos et al., 2007). 
Suggesting that anti-bacterial usage then, perhaps even unknowingly was protective against 
targeted bacterial endosymbionts which in turn distabilised fungal pathogenicity. And as a 
result, mucormycosis was less prevalent as it is today.  
 
Indeed, the role of bacterial endosymbionts in pathogenesis of mucormycosis is poorly 
characterized and somewhat ignored. So far, studies by Ibrahim et al (2008) and Partida-
Martinez et al (2008) suggest that these bacteria may play no role in pathogenesis of 
mucormycosis (Ibrahim et al., 2008b, Partida-Martinez et al., 2008). However, both of these 
studies were not exhaustive enough and mainly focused on the late stages of the infection. Yet 
the significant damage may be caused early during colonization and infection, and our 
demonstration of the impact of metabolic process here could point to that. 
 
From this stand point, we can conclude that spore metabolism plays a crucial role in evading 
innate anti-fungal immunity. We also suggest here that the evasion mechanism begins quite 
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early during infection. This is depicted through a demonstration of reduced phagocytic uptake, 
lack of macrophage killing and inhibition of phagosome maturation illustrated here. 
 
On characterization of these metabolites, we note that the compound is not proteinus or a 
carbohydrate in nature but most likely a hydrophobic secondary metabolite or lipid. A 
chloroform extraction process of the supernatant gives a somewhat solid account to this. 
Further analysis reveals the active compounds’ profiles to be consistent with the rhizo-toxins 
and cytochalasins at HPLC level; and with rhizoxin derivatives at mass spectrometry anlytical 
level. However, if we are to consider the similarities with rhizoxin we ought to contemplate 
the role of bacterial symbionts in the production of the active compound, excluding 
cytochalasin which is produced by Aspergillus species (Partida-Martinez and Hertweck, 2005, 
Scherlach et al., 2006, Partida-Martinez and Hertweck, 2007, Partida-Martinez et al., 2007b, 
Partida-Martinez et al., 2007a). Given the data here, it is seeming that the question of bacterial 
symbionts contributing towards pathogenicity of mucoralean fungi is becoming inevitable.  
 
The data presented in this chapter demonstrates that pre-germinated mucormycete spores 
secrete a factor capable of inhibiting macrophage effector functions.  We employed several 
assay tools and techniques including culture, fluorescence microscopy, phagocytosis, 
metabolomics and chemical extraction of the supernatant to describe the nature of the factor. 
However, most of the tools including HPLC, MS, metabolomics and fluorescence microscopy 
were qualitative rather than quantitative. Additionally, the effect of the supernatant factor was 
mainly assessed against macrophages and little attention was paid to other host parameters. 
The role of other cells such as neutrophils, red blood cells, other innate immune components 
such as   complement can be a focus for future directions. More specialised and specific tools 
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such as NMR, MS/MS-LCS can also be considered for future directions to characterise this 





























CHAPTER FIVE:  The Role of Bacterial Symbiosis in 





5.1 Chapter Overview 
Some of the data presented in this chapter, was performed in collaboration with University of 
Aberdeen and University of California Los Angeles (USA). Specifically, Transmission 
Electron microscopy (TEM) work was performed with the help of Dr Elizabeth Ballou and Xin 
Zhou at the Aberdeen TEM facility. The mouse work was done in Prof Ashraf Ibrahim’s Lab 
at UCLA by Teklegiorgis Gebremariam, Yiyou Gu and Lin Lin. Fish work was performed at 
the University Birmingham BSMU facility by myself with the help of Dr Kerstin Voelz, Dr 
Elizabeth Ballou, Mark Probert and Dr Joao Correia. Finally, bioinformatics work herewith 
was performed by myself but with technical support from Poppy Sephton Clark and Dr 
Elizabeth Ballou.  
 
5.2 Background  
Over time environmental and biological features of fungi have mainly been characterized 
through the study of associated abiotic factors such as pH or temperature. These, to some 
extent, have been extrapolated to explain fungal growth, gene expression and host-fungal 
pathogen interactions (Araldi-Brondolo et al., 2017, Husnik and McCutcheon, 2018). 
However, ecological modes of fungi are not only mediated by the environments where they 
thrive and their intrinsic features but also interactions with other microbial communities 
(Araldi-Brondolo et al., 2017).  
In this regard, studies employing recent advancements such as whole genome sequencing 
highlight significant links between microbiome and microbiome networks which contribute 
towards disease pathogenesis. This is changing the way fungal phenotypes and hence 
associated diseases are perceived and studied (Witherden et al., 2017). For instance, study of 
the gut microbiome and mycobiome interactions seem to reveal an interplay between the two 
microbial communities and is now implicated in disease development such as  chron’s disease 
(CD) (Hoarau et al., 2016, Li et al., 2014, Sam et al., 2017, Hernandez-Santos and Klein, 2017, 
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Huseyin et al., 2017, Paterson et al., 2017, Botschuijver et al., 2017, Nash et al., 2017, 
Ackerman and Underhill, 2017, Leung et al., 2016, Husnik and McCutcheon, 2018). 
 
Indeed, a definitive exploration of poly-microbial interactions including bacterial-fungal 
interfaces shows that bacteria can network with fungi at various levels, mediating shifts in 
substrate consumption, enzyme production, thermotolerance, sexuality, antifungal resistance, 
metabolism and virulence (Araldi-Brondolo et al., 2017, Salvioli et al., 2016, Shaffer et al., 
2017, Moebius et al., 2014a, Mondo et al., 2017, Spraker et al., 2018, Hoffman et al., 2013, 
Lastovetsky et al., 2016, Nazir et al., 2014, Dixon and Hall, 2015, Harriott and Noverr, 2011, 
Hoffman and Arnold, 2010). 
One way that fungi would interact with bacteria is by a complex mutualistic and heritable 
symbiotic relationship between fungal hosts and endo-hyphal bacterium. Recently, endo-
hyphal bacteria have also been identified among mucoralean fungi, as already mentioned 
(Section 1.4.5.4). Although these are not yet linked with pathogenesis of human mucormycosis, 
their influence on sexuality, horizontal gene transfer, metabolism, antifungal resistance and 
plant pathology is highlighted (Moebius et al., 2014a, Mondo et al., 2017, Spraker et al., 2018, 
Spraker et al., 2016, Scherlach et al., 2006, Partida-Martinez et al., 2007c, Partida-Martinez 
and Hertweck, 2005, Partida-Martinez et al., 2007a, Mobius and Hertweck, 2009, Lackner et 
al., 2009b, Husnik and McCutcheon, 2018). 
With this background, it is likely that some of these phenotypic shifts will also influence host-
pathogen interactions. Studies by Lackner et al (2011), Mondo et al (2017), Murray et al (2017) 
and Spraker et al (2016) all attest to this possibility. For instance, Lackner et al (2011) show 
that endo-fungal bacteria including B. rhizoxinica are able to control fungal hosts such as R. 
microsporus through a hypersensitive response protein (hrp) type III secretion system, 
influencing sexuality and reproduction via toxinogenic derived alliances between bacteria and 
the fungus.  
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In context, taking B. rhizoxinica and B. endofungorum involvement in plant pathology and 
hepatotoxicity respectively, we realize that the impact of endosymbiont-driven modulations on 
manifestation of mucormycosis is not completely understood. Some studies, for instance 
Ibrahim et al (2008), showed no difference in the infection of endothelial cells by both parent 
and endosymbiont-free strains of R. oryzae in a DKA mouse model; while Partida-Martinez et 
al (2008) was unable to isolate endosymbiont bacterium from some clinical isolates of 
mucoralean fungi (Ibrahim et al., 2008b, Partida-Martinez et al., 2008).   
However, one can make the argument that both of these studies were not exhaustive enough: 
Ibrahim et al employed an immunosuppressed mouse model whilst Partida-Martinez et al does 
not provide crucial information regarding anti-bacterial treatment history. Additionally, both 
studies focus on the latter events of pathogenesis, when possibly significant damage would 
have been done during early stages of infection, colonization or latency.  
All taken together, it is important to recall that our findings here so far show a correlation 
between spore metabolism and immune evasion. Most importantly the data highlights that a 
bacterial endosymbiont could be the source of the active metabolites involved. However, if we 
are to implicate bacterial endosymbionts here, we ought to exhaustively establish what they are 
via specific characterisation and identification of the bacterium, associated metabolites and 
their modes of action. Thus, in this chapter we attempt to characterize the role of bacterial 
endosymbionts in mucormycete fungal pathogenicity, focusing mainly on the events that 
transpire during the early stages of infection. 
 
 5.3 Evidence of bacterial symbiosis among mucoralean fungi  
In chapter 4, we showed the supernatant factors in question are similar to the rhizo-toxins which 
are secreted by bacterial endosymbionts. To rule out bacterial endosymbionts as producers 
here, screening for presence of the bacteria was investigated.  
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Previously studies by Ibrahim et al (2008), Nazir et al (20014), Moebius et al (2014), and 
Partida-Martinez and Hertweck (2005) have all demonstrated the presence of endosymbionts 
by using ciprofloxacin to cure the fungus of the bacteria and successfully confirming 
elimination of the bacteria by either localized screening with fluorescence microscopy, PCR 
for 16S rDNA or isolation of bacteria in pure culture (Moebius et al., 2014a, Mondo et al., 
2017, Nazir et al., 2014, Partida-Martinez et al., 2007c, Partida-Martinez and Hertweck, 2005). 
Similarly, here bacterial elimination was performed on SDA plates containing ciprofloxacin. 
Spores were harvested, fermented in VK media for 2 to 4 days; and mycelia processed for 
microscopy, DNA isolated for PCR or bacteria isolated as described before (Sections 2.2, 2.4, 
2.5 and 2.10).  
 
5.3.1 Fluorescence microscopic screening reveals presence of endo-hyphal 
bacterial 
For a fluorescence microscopic approach, LIVE/DEAD Backlight staining kit, was used which 
is popular for demonstrating endo-hyphal bacteria (Partida-Martinez and Hertweck, 2005, 
Partida-Martinez et al., 2007c). The kit is made of two portions; A (a green fluorescing SYTO 
9) and B (a red fluorescing propidium iodine (PI)). Both of these dyes are able to get through 
the fungal cell wall and specifically bind bacterial DNA (Partida-Martinez et al., 2007a, 
Partida-Martinez et al., 2007c). SYTO 9 will enter all cells while PI stains is limited to dead or 
damaged cells. 
Notably, SYTO 9 staining revealed clusters of green stained bacterium along fungal filaments 
as demonstrated in Figure 50a for both the control and clinical strains of R. microsporus. 
Interestingly, treatment with ciprofloxacin abolished the staining signal (Figure 50b), 
indicating elimination or absence of the bacteria. More importantly parent strains of other 
mucoralean fungi also demonstrated a staining signal for the bacterium as with R. microsporus 
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previously (Figures 51-53). These findings showed that indeed different mucoralean fungi may 
also harbour endo-hyphal bacterial.   
 
 
Figure 50: Endosymbiont bacteria can be located inside fungal hyphal mass with fluorescence 
microscopy. 
Spores of (a) parent strains of a positive control (CBS-63182) and clinical isolate (FP469-12) 
of R. microsporus were fermented in VK, mycelia pellet submerged in NaCl, stained with 
SYTO9 and bacterial staining determined by fluorescence microscopy (b) The parent strains 
were then treated with ciprofloxacin (60 g/mL) for a period of 8 weeks to eliminate the 
bacterial endosymbiont, spores collected and processed for staining with SYTO 9. Micrographs 




Figure 51: Endobactrerium located among other Rhizopus species 
Collected spores of parent strains of other mucoralean fungi (R. chinensis and R. delemar RA-
99-80) were fermented in VK, mycelia pellet submerged in NaCl and stained with SYTO9 and 
bacterial staining demonstrated by fluorescence microscopy. Representative micrographs from 














Figure 52: Endobacterium located among other mucoralean fungi specifically Mucor species. 
Spores of parent strains of two other M. circinelloides isolates (NRRL-3631 and CBS-277490) 
were fermented in VK, mycelia pellet submerged in NaCl and stained with SYTO9 and 
bacterial staining demonstrated by fluorescence microscopy. Representative micrographs from 














Figure 53: Endobacterium located among other mucoralean fungi specifically 
Cunninghamella and Lichtheimia 
Spores of parent strains of other mucoralean fungi, L. corymbifera (FP454-9.6) and C. 
bertholletiae (NB2), were fermented in VK, mycelia pellet submerged in NaCl and stained 
with SYTO9 and bacterial staining demonstrated by fluorescence microscopy. Representative 












5.3.2 PCR screening reveals a band specific for bacterial 16S rDNA 
The 16S rDNA sequence is a well conserved DNA region in bacterial species that can be used 
for identification of bacteria and is absent in fungal nuclear genomes. The equivalent in fungi 
is 18S rDNA.  Therefore, using universal PCR primers, a band was amplified among DNA 
isolates from fermented mycelia for both parent and cured strains as described in previous 
studies (Partida-Martinez et al., 2007a, Partida-Martinez et al., 2008, Ibrahim et al., 2008b).   
 
As shown in Figure 54, a 1.5 kb band specific for the bacterial 16S rDNA was amplified from 
parent but not ciprofloxacin treated (cured) strains. Showing that bacterial 16s rDNA is present 
among mucoralean fungi and can be eliminated with ciprofloxacin treatment further agreeing 
with the above shown microscopic observation. The application of ciprofloxacin here was 
based on reports by Sugar et al, who reported that this antibiotic had no intrinsic effects on 
fungus (Sugar and Liu, 2000, Sugar et al., 1997, Chamilos et al., 2007). Other antibiotics such 














Figure 54: PCR screening reveals a band consistent with bacterial 16S rDNA among 
mucoralean fungi. 
Genomic DNA was isolated from both parent and cured strains of the indicated mucoralean 
fungi and screened by PCR for the amplification of a 1.5 kb band indicative of bacterial 16S 
rDNA. The image is representative of gel electrophoresis of PCR products from one of at least 














5.3.3 Transmission electron microscopy reveals the influence of the 
endobacteria on fungal cell wall organization  
Partida-Martinez et al (2007) has unequivocally proven that Burkholderia bacterial species are 
true endosymbionts residing in the fungal cytosol, where they can be distinguished from the 
fungal organelles. Using a similar approach, we attempted to demonstrate the presence or 
absence of the bacteria in swollen spores of both parent and cured strains of R. microsporus.  
 
Accordingly, the spores were harvested and metabolically activated for 4 has described before 
(section 2.3). Cells were then fixed by High Pressure Freezing and sectioned for Transmission 
Electron Microscopy (section 2.9) 
As shown in Figure 55, TEM micrographs showed patches of low electron density, similar to 
those described by Partida-Martinez et al (2007) that are distinct from the fungal organelles. 
However, the more pronounced finding we noted with this experiment was the changes in the 
cell wall organisation between the parent and cured strains of R. microsporus.  These findings 
point to influence of the endo-bacteria on cell wall organization but calls for more work in 












Figure 55: The Endobacterium influences fungal cell wall organisation. 
Effect of endosymbiont status on R. microsporus F469-12 fungal structure. The TEM 
micrographs represent cross-sectional structures of both the parent and cured swollen spores, 












5.3.4 Endo-hyphal bacterial can be isolated in pure culture  
The final approach to this was isolating the bacterium in pure culture, as has been done by 
others to definitively prove the presence of the endosymbiont and better characterise its effects 
((Scherlach et al., 2006, Partida-Martinez and Hertweck, 2005)). Here, a modified version of 
the protocol described by Partida-Martinez et al (2005) and Scherlach et al (2006) was used as 
is described (Sections 2.2, 2.3 and 2.5) Spores were fermented (Figure 53), mycelia digested 
with Lyticase enzyme, and centrifuged, and the supernatant aliquots inoculated and incubated 
for fungal or bacterial growth as described before.  
As shown in Figure 56 and Table 12, bacterial isolation was successful in the following 
strains: R. microsporus (CBS 631.82), R. microsporus (FP 469-12), M. circinelloides (CBS 
277940), M. circinelloides (NRRL 3631), and C. bertholletiae (NB2). Bacterial isolation failed 
in L. corymbifera, R. chenensis and R. delemar. However, supernatant aliquots from fungi 
where isolation was not possible also demonstrated presence of bacteria that failed to thrive in 
culture. This may be an example of an endosymbiotic bacteria demonstrating a reduced genome 
size and function due to loss of certain genes that would otherwise facilitate their survival when 
not living in a symbiotic association, as demonstrated by Uehling et al (Uehling et al., 2017).  
Table 12: Characterisation of isolated endosymbiotic bacteria. 
No. Fungal strain ID Isolated bacterial 
symbiont 
Family Colony and other 
description feature 





Bukholderiaceace Colorless, shiny colonies 
producing a strong foul 
smell on Nutrient Agar. 
2 R. microsporus  
(FP 469-12.6652333)  




Bukholderiaceace Colorless, shiny colonies 
producing a strong foul 
smell on Nutrient Agar 
3 Mucor circinelloides 
(CBS 277940) 
Micrococcus luteus  Micrococcaceae Yellowish odorless colonies 
on Nutrient Agar  
4 Mucor circinelloides 
(NRRL 3631) 
Micrococcus luteus  Micrococcaceae Cream-ish odorless colonies 





Sphingomonadaceae Orange pinkish odorless 





Figure 56: The endo-hyphal bacterium can be isolated in pure culture. 
Typical fermentation set up (a) with 250 mL of VK media and incubated at 30 oC with (80 
rpm) for 2-4 days. (b) Typical 4 day fermented mycelial fungal ball. (c) Typical initial isolation 
of the bacteria on a nutrient agar plate after 3-5 days of incubation at 30 oC and sub-cultured 
colonies of respective bacterial endosymbiont isolated from (d) C. bertholletiae (NB2), (e) M. 











Examination of the isolated bacteria demonstrated various features: colonies ranged from 
colourless to pigmented colonial appearances (Figure 56) and cells were mainly of a 
coccobacilli-rod shaped morphology. The bacteria were identified through genotyping and 
were demonstrated to belong to different families, as shown in Table 9. Genotyping identified 
them as Ralstonia pickettii from both R. microsporus strains, Micrococcus luteus from both 
Mucor strains and Sphingomonas wittichii from C. bertholletiae. Interestingly, R. pickettii 
belongs to the same family as the B. rhizoxinica and B. endofungorum endosymbionts and16S 
amplicons of isolated bacteria here in comparison to the fungal Isolated DNA reveals similar 
results as before, demonstrated in Figure 57.  
 
Finally, an attempt was made to re-introduce the endosymbiont to the fungal host. Bacteria and 
fungi were co-incubated following the protocol of Lackner et al (2011) (Lackner et al., 2011a). 
However, although uptake of the endosymbiont was observed at a low-level, we should note 
that the complemented (re-infected) fungal phenotype was not taken forward in this project 
because a stable mutualism could not be re-established in the time available. It is possible that 
the bacterium requires enough time or specific environmental conditions to adapt and re-










Figure 57: PCR amplicons from isolated endobacterium reveal 16S rDNA. 
Genomic DNA was isolated from fungal and isolated bacteria strains as indicated and screened 
by PCR for the amplification of a 1.5 kb band indicative of presence of a bacterial 16S rDNA. 
The image is representative of gel electrophoresis of PCR products from one of at least three 










1 2 3 4 5 6 H2O
1. R. microsporus (CBS 631.82)
2. R. microsporus (CBS631.82) + ciprofloxacin
3. Ralstonia pickettii from (CBS 631.82)
4. R. microsporus (469-12.6652333)
5. R. microsporus (469-12.665233) + ciprofloxacin




5.4 Effect of Bacterial elimination on Fungal Phenotype 
Bacterial-fungal interactions (BFI) have a significant impact on phenotypes such as gene 
transfer, substrate consumption, virulence, sexuality and metabolism (Araldi-Brondolo et al., 
2017, Moebius et al., 2014b, Husnik and McCutcheon, 2018, Mondo et al., 2017). Our data 
have now demonstrated the presence of bacteria symbionts among mucoralean fungi, including 
in the strain of interest here. Most importantly, we are able to eliminate the bacteria from the 
fungus and also isolate the endosymbiont in pure culture. This way interface mechanisms of 
BFI can now be studied together and separately. 
 
Thus, using elimination and isolation as tools, the influence of the bacteria on modulation of 
fungal phenotype, particularly metabolism, was considered and investigated. We hypothesised 
that if the bacterium is the force behind the anti-phagocytic attributes described so far, then its 
elimination would abolish the effects demonstrated by the spores during infection. In addition, 
a similar loss of functional peaks would be reflected in the chemistry profiling described before 
(Sections 2.5 and 2.11).   
 
5.4.1 Elimination of the bacteria reduces fungal sporulation  
We have preliminarily investigated the impact of the bacteria on fungal sporulation. 
Accordingly, both parent and cured strains of R. microsporus were passaged on respective 
plates of SDA with or without ciprofloxacin as described before (Sections 2.4 and 2.5) 
As shown in Figure 58, when continuously passaged on ciprofloxacin plates, sporulation 
significantly decreased with time. These findings are similar to what has been reported 
elsewhere, that bacterial symbionts influence sexuality in R. microsporus by B. rhizoxinica 
where the endosymbiont has been characterized to control fungal transcription through RAS2 




Figure 58: Elimination of bacterial endosymbiont reduces fungal sporulation. 
The parent strain of R. microsporus was passaged on SDA plates with or without ciprofloxacin 
at room temperature every 2 weeks, spores harvested and counted. The data are presented as 












5.4.2 Elimination of the bacteria restores phagocytosis of pre-germinated 
spores  
We have already shown in Chapter 3 that metabolically active spores are not as readily 
phagocytosed by macrophages. To determine the impact of the endosymbiont bacteria on this 
outcome, endosymbiont free spores were pre-germinated and phagocytic uptake determined as 
described previously (Sections 2.3, 2.7 and 2.11).  
As demonstrated in Figure 60, there are significant differences in the uptake rate of parent 
spores as opposed to endosymbiont free strain. For instance, dormant spores of the cured strain 
demonstrated an increased uptake form 76% by parent strain to 87% (p<0.01), while swollen 
spores also demonstrated increased uptake rate from 25% by parent to 79% by cured 
(p<0.0001) at 2 h; and from 15% by parent to 78% by cured (p<0.0001) at 4 h (Figure 60). 
This reversal in phagocytic uptake of cured swollen spores’ points to the influence of bacterial 













Figure 59: The bacterial endosymbiont influences fungal secretome and interaction with 
mammalian cells in vitro. 
Phagocytosis of parent or cured resting or swollen (2 and 4 h) spores of R. microsporus FP469-
12 by J774A.1 macrophages (n=3 biological replicates, One-way ANOVA with Tukey’s 
correction for multiple comparisons) and for the examined repeats errors bars represent s.e.m. 
(*= p< 0.01, ***=p< 0.0001). 
 
 197 
5.4.3 Supernatant from cured spores demonstrates loss of activity  
To determine the effect of bacterial elimination on expression of the supernatant (SN) factors, 
cured strain (endosymbiont free) supernatants were collected and their activity against 
phagocytosis, cytoskeleton, and phagosome maturation determined as described before 
(Sections 2.3, 2.5, 2.7 and 2.9) As shown in Figures 61-63, treatment of macrophages with the 
two (+/- endosymbiont) supernatant types variably impacts macrophage phenotypic functions. 
For instance, phagocytosis is inhibited from an average percentage uptake of 85% (± 6 SEM) 
by the control to on average 35% (± 5 SEM) upon treatment with the parent supernatant (p < 
0.00001) but no significant difference was noted between the control and cured strain 
supernatant registering a reduction from 85% to 63 (± 7 SEM) (p=0.725) (Figure 61).   
Regarding phagosome maturation: Both spore categories (+/- endosymbiont) significantly 
inhibit phagosome maturation when compared with control (p < 0.05) (Figure 62a). Inhibition 
by parent spores is significantly lower than by endosymbiont free spores (p < 0.001) (Figure 
62a); and there is no difference in phagosome inhibition between resting and swollen spores 
of both strains (p > 0.05) (Figure 62a).  
Regarding supernatants, treatment with parent SN (p<0.0001) significantly inhibits phagosome 
maturation compared to endosymbiont free SN (p> 0.05) (Figure 62b) 
Previously, we demonstrated that treatment of phagocytes with R. microsporus swollen spore 
supernatant reduces overall staining with Phalloidin dye and anti-beta tubulin immunostaining, 
indicative of reduced cytoskeletal integrity. This was also reflected in the rounding of cells 
(chapter 4 Figures 33 (actin) and 34 (beta-tubulin)) (Section 4.6.2) Here we also investigated 
the impact of bacterial symbiosis on cytotoxic effects. As shown in Figure 63, it was   
interesting to see that whilst parent SN significantly inhibited both actin and beta tubulin (p < 
0.0001) respectively. This activity was lost following treatment with endosymbiont free SN (p 
> 0.05). Indeed, there were significant differences in the activity parent vs cured supernatants 
 
 198 
against actin or beta tubulin polymerisation. These findings further show that the bacterial 



















Figure 60: The bacterial endosymbiont influences fungal secretome and interaction with 
mammalian cells. 
Effect of bacterial endosymbiont supernatants isolated from indicated fungal hosts on 
phagocytosis of R. microsporus resting spores. For both conditions, the number of phagocytes 
containing at least one spore were counted after 1 hour (n=9000, One way ANOVA with 
Tukey’s correction for multiple comparisons). In each graph, three biological replicates were 





Figure 61: The bacterial endosymbiont influences phagosome maturation in vitro. 
Harvested (a) parent and cured spores resting or pre-germinated spores (in SDA at 30o C for 4 
h) were co-incubated with J774 phagocytes for 1 h and phagosome maturation assessed using 
LysoTracker staining. (b) Supernatants were collected from both parent and cured strains of R. 
microsporus. These were then used to treat J774 phagocytes which were co-incubated with R. 
microsporus swollen fixed killed spores for 2 h, phagosome maturation determined with 
LysoTracker staining and quantified with image J. (n=300 (three biological repeats), one way 
ANOVA with Turkeys correction for multiple comparisons and error bars represent s.d 









Figure 62: The bacterial endosymbiont influences cytoskeletal organisation in vitro. 
Supernatants were collected from parent and cured strains of R. microsporus. These were then 
used to treat J774 phagocytes for 1 h. (a) phagocytes were then stained for F-actin with 
phalloidin for 15 min. (b) Phagocyte were stained for Beta- tubulin with anti-beta tubulin 
antibodies for 2 h. Stain quantification was scored with image J.  Both assays, n=450, Statistical 
significance was assessed via one-way ANOVA with Turkey’s correction for multiple 
comparisons. In each graph, three biological repeats were examined and error bars represents 









5.4.3 Endosymbiont free spores are more susceptible to macrophage killing 
and stress 
We previously shown that R. microsporus parent spores are resistant to both macrophages 
killing and environmental stress factors (Section 3.3.2). Here, the impact of the bacterial 
symbiosis on the spore’s ability to resist macrophage killing and other stresses was also 
determined as before (Sections 2.5, 2.6 and 2.7).  
 
As demonstrated in Figures 63-64; when compared with survival of parent spores, we saw 
that, after treatment with ciprofloxacin to cure the endosymbiont, both resting and swollen 
spores’ ability to resist macrophage killing was compromised. There was no difference in the 
survival of parent and endosymbiont free spores at 0 h (p > 0.05). But then spore survival 
significantly declined from 100 % to 80 % after 6 h (p < 0.01), to 50 % after 24 h (p < 0.0001) 
for resting spores; and from 98 % to 60 % after 6 h (p < 0.001), to 45% after 24 h (p < 0.0001) 
for swollen spores (Figure 63). These data demonstrate that bacterial symbiosis may play a 
key role in fungal survival and evasion of innate immunity during infection.  
In regard to response to other stress factors, endosymbiont free spores were generally 
susceptible to individual stresses including cell wall damage due to osmotic and SDS (p<0.05), 
nitrosative stress by sodium nitroxide (p<0.05), oxidative stress by hydrogen peroxide 
p<0.00001) and antifungal stress by AmB treatments p<0.05) (Figure 64). The findings here 
demonstrate that in spite of the state of the spores, losing the endosymbiont compromises the 
ability of the fungus to survive against stress factors. These findings are similar to those 
obtained from the macrophage killing assay. These findings point to how crucial the 
endosymbiont might be for fungal survival and flexibility, both in the wider environments and 





Figure 63: Loss of a bacterial endosymbiont compromises fungal survival following 
phagocytic uptake. 
Impact of bacterial endosymbionts on fungal (R. microsporus F469-12) parent or cured spore’s 
survival following co-culture with J774 macrophage for the indicated time points. Three 
biological repeats were examined and error bars represent s.e.m. Statistical significance was 
assessed via One way ANOVA with Tukey’s correction for multiple comparisons (ns=p>0.05, 





Figure 64: Endosymbiont free spores show increased susceptibility to environmental stress 
factors. 
Impact of bacterial endosymbionts on fungal (R. microsporus F469-12) parent or cured resting 
spores’ susceptibility to stress factors include cell wall, nitrosative, oxidative and antifungal 
stresses at the indicated concentrations. Three biological repeats were examined and error bars 
represent s.e.m. Statistical significance was assessed via One way ANOVA with Tukey’s 











5.5 Chemistry based evidence of bacterial symbiosis  
5.5.1 Elimination of the bacteria abolishes expression of active HPLC peaks  
HPLC profiling of R. microsporus parent SN revealed several peaks, particularly peaks 3, 5 
and 8, as being the most active against phagocytosis. Furthermore, MS analysis of these peaks 
also revealed masses consistent with rhizo-toxins, particularly from peaks 5 and 8 (refer to 
chapter 4 (Section 4.9; Figures 46-48). 
 
Given the fact that rhizo-toxins are secreted by the endosymbionts, as mentioned earlier 
(Section 1.4.5.4), the effect of eliminating the bacteria on expression of these peaks was also 
investigated here. We hypothesised that the supernatant factors are either secreted by a bacterial 
endosymbiont or by the fungus but only when in association with the bacteria.  
 
Accordingly, both supernatant types (+/- endosymbiont) were extracted, and profiled by HPLC 
as described before (Sections 2.11). As shown in Figure 65, we saw that all active peaks 3, 5 
and 8 are abolished following elimination of the bacteria. Further highlighting the loss of 
activity demonstrated in the endosymbiont free supernatant as shown earlier, most importantly 
confirming that bacterial symbiosis may significantly impact on fungal metabolism and 








Figure 65: Elimination of the endobacterium abolishes all active HPLC peaks. 
R. microsporus (parent and cured) strains were fermented in sfDMEM at 30oC, 80 rpm for 2-4 
days. Supernatant was collected, extracted with chloroform and HPLC profiled using C18 
column. A medium control is included. The Chromatograms shown are from one of at least 





5.6 Bacterial derived supernatants  
5.6.1 Bacterial supernatants show reduced activity 
We have so far explored the effect of spore metabolism through examining supernatants from 
parent and endosymbiont knockout spores. This way, we established a correlation between 
spore metabolism and bacterial symbiosis. Therefore, following isolation of the bacteria in pure 
culture, we sought to explore the biological activity in three different strains: wildtype (parent), 
cured (endosymbiont free) fungal strains, and the isolated bacteria in pure culture both 
separately and co-cultured together with the endosymbiont-free fungal host (discussed later in 
Chapter 6).  
 
Given this background, we sought to examine activity of bacterial-derived supernatants against 
macrophage effector functions to establish if the bacteria are the producers of the supernatant 
factors in question. Accordingly, the bacteria were grown in sfDMEM, the supernatant was 
collected and activity against phagocytosis, phagosome maturation and cytoskeleton 
determined as described before (Sections 2.4, 2.5, 2.7 and 2.9)).  
As shown in Figure 66, supernatants of bacteria isolated from R. microsporus and other 
mucoralean fungi were all evaluated for activity against phagocytosis. In addition, supernatants 
from both parent and cured fungal categories (resting and swollen) and a wild type strain of 
Burkholderia cepacia, a close relative of R. pickettii, were evaluated as controls. While parent 
SN significantly reduces phagocytosis from 78% to 30% (p<0.00001), bacterial supernatants 
demonstrated reduced activity against phagocytosis to an average of 55% (p<0.001). There was 
however a significant difference in the activity of bacterial SN to that of the wildtype B. cepacia 




Figure 66: Bacterial endosymbiont culture supernatants show reduced activity against 
phagocytic uptake by J774 macrophages. 
Supernatants were collected from indicated fungal hosts and their respective isolated bacterial 
strains. These were then used to treat J774 phagocytes which were co-incubated with R. 
microsporus dormant spores for 1 h and uptake rate assessed. Three biological repeats were 
examined and error bars represent s.e.m. Statistical significance was assessed via One way 





Also stemming from cytotoxic effect demonstration already, the effect of bacterial 
endosymbiont supernatants on cytotoxic effects was tested. As shown in (Figure 68), 
significant and comparable levels of activity were seen by both R. pickettii and parent 
supernatants against phagosome maturation (p < 0.01) (Figure 67a); actin polymerisation (p < 
0.01) (Figure 67b) and no significant differences were noted for beta tubulin (p>0.05) (Figure 
67c). For all assays, there were significant differences between activity of the bacterial 
endosymbiont supernatants and endosymbiont free fungal supernatants (p<0.05) (Figure 67). 
Although the bacterial supernatant demonstrated reduced activity against phagocytosis (see 
figure 67), its activity against other macrophage effector functions was comparable to 
supernatant from parent swollen fungal supernatants. However, these findings can suggest 


















Figure 67: Bacterial endosymbiont culture supernatants show similar levels of activity against 
phagosome maturation and cellular cytoskeleton. 
Supernatants were collected from Ralstonia pickettii (isolated from R. microsporus). This was 
then used to treat J774 phagocytes for 1 h. (a) The phagocytes were then co-incubated with 
swollen fixed killed spores of R. microsporus and phagosome maturation determined with 
LysoTracker staining for 2 h. (b) Phagocytes were stained for F-actin with rhodamine-
conjugated phalloidin for 15 min. (c) Phagocyte were stained for Beta- tubulin with anti-beta 
tubulin antibodies for 2 h. For all tests staining intensity was scored with image J. For all assays, 
(a) n=100, (b and c) n=450, Statistical significance was assessed via one way ANOVA with 
Turkey’s correction for multiple comparisons. In each graph, three biological repeats were 
examined and error bars represents s.e.m.(ns=p>0.05, *=p<0.01, **=p<0.001), ***p<0.0001 









5.6.2 Bacterial endosymbiont supernatant shows loss of the most active peak (5) 
Reduced activity against phagocytosis by bacterial supernatant was rather intriguing, 
prompting further analysis and thus, was also profiled using HPLC, as previously described 
(Sections 2.5 and 2.11). As shown in Figure 68, it was quite interesting to see that of the active 
peaks present in the wildtype fungal supernatant, only peaks 3 and 8 are present in bacterial 
supernatant. The most active one, peak 5, is absent. Taken together with the observation that 
endosymbiont supernatant has reduced anti-phagocytic activity compared to wildtype fungal 
supernatant, this could mean that peaks 8 and 3 have some limited activity. These data also 
further confirm that peak 5 is the most active against phagocytosis, as demonstrated before 
(Section 4.9). Whether peaks 3 and 8 are metabolites of the same product remains to be 
determined. This finding also highlights the potential role of different growth conditions on 
expression of the metabolic factors, and this is explored below. Specifically, we investigate 















Figure 68: The bacterial endosymbiont supernatant shows loss of HPLC peak 5. 
R. microsporus (parent and cured) and R. pickettii strains were fermented in sfDMEM at 30oC, 
80 rpm for 2-4 days. The Supernatant was collected, extracted with chloroform and HPLC 
profiled using C18 column. A medium control is included. Chromatograms shown are from 




5.6.3 Growth conditions significantly impact metabolism of both the 
bacterium and fungus 
The above findings pointed to differences in metabolic process by both the fungus and 
bacterium while living in symbiotic association or separate. Thus, to examine this aspect, we 
used a chemistry approach to profile the impact of substrate availability on metabolism of the 
parent, cured fungal and isolated bacterial strains. Accordingly, the strains were grown in 
sfDMEM, VK or HL5 medium, supernatants collected, extracted and HPLC profiled as 
described before (Sections 2.2 and 2.11). The host-relevant medium DMEM is a nutrient-poor 
medium for bacterial and fungal culture and supports limited growth. We therefore asked 
whether other nutrient-rich media would support expression of peak 5, the most active peak. 
HL-5 is a common medium for the cultivation of the mini-host model organism Dictyostelium 
discoideum a natural predator of the mucorales 
 
As shown in Figure 69, it was interesting to see that there were significant changes in the 
HPLC profiles by both fungi and bacteria under the different medium growth conditions. Both 
the fungus and bacteria produced a larger range of products in HL5 and VK than in DMEM 
medium, indicating that production of the active compounds could be significantly affected by 
the growth conditions. These conditions may reflect those that the bacteria experiences during 
symbiosis but perhaps not while cultured in DMEM medium. However, more work is needed 






Figure 69: Different growth conditions influence both bacterial and fungal metabolism. 
R. microsporus (parent and cured) and R. pickettii strains were fermented in different culture 
medium as indicated at 30oC, 80 rpm for 2-4 days. Supernatants were collected, extracted with 
chloroform and HPLC profiled using C18 column. Medium controls were also included. 












5.7 Genetical evidence  
Loss of peak 5 from bacterial supernatant was an unexpected finding if we are to refer to the 
rhizo-toxins which are produced by Paraburkholderia rhizoxinica or Paraburkholderia 
endofungorum (Partida-Martinez et al., 2007b, Partida-Martinez et al., 2007a). Thus, genetic 
analysis of the bacteria was also performed. The isolate in our case is R. pickettii, a 
phylogenetically close relative of Paraburkholderia species belonging to same 
Bukholderiaceace family (Figure 70). The question at this stage was whether R. pickettii also 
produced the likes of rhizo-toxins. This was done by examining the metabolic cluster in the 

















Figure 70: R. pickettii is phylogenetically related to Paraburkholderia. 
Genomic DNA was isolated from bacterial endosymbionts and whole genome sequence 
performed to determine identity and phylogenetic relations. The tree shows the phylogenetic 



















5.7.1 Genome sequence of R. pickettii shows no evidence of rhi gene cluster 
for rhizoxin  
We ought to elucidate both the molecular and genetic properties of R. pickettii to specifically 
characterize and identify the supernatant factors in question. Stemming from the similarities in 
function to the rhizo-toxins, comparisons between the two were drawn. Rhizoxin biosynthesis 
is driven by both a polyketide synthase (PKS) and a single non-ribosomal peptide synthetase 
(NRPS). Several reports have shown the existence of type I PKS gene clusters among 
metagenomes of rhizoxin producing fungi and isolated endosymbionts (Partida-Martinez and 
Hertweck, 2007). The rhi gene cluster has also been identified and encodes rhizoxin (rhi) mega 
synthase and some accessory enzymes. It is an 81 kb in size with 10 open reading frames 
(ORFs) A-J flanked by two transposase genes. Five of these ORFs (rhi A-F) encode proteins 
that represent a giant PKS-NRPS thio-template system with domains organized into modules 
(Partida-Martinez and Hertweck, 2007, Scherlach et al., 2006). 
Given this background prediction, a search for similar domains was performed on the Ralstonia 
genome using BLAST, Anti-smash and Pfam tools.  
 
However, all searches failed to return matches for rhi homologs in R. pickettii. Interestingly 
though, Pfam prediction yielded a series of domains with similar function to some of the 
individual genes in the rhi cluster (Figure 71). The anti-smash search for PKS and NRPS on 
the other hand returned mainly unidentified gene clusters, with one possible type 1 PKS cluster 
(Figure 72a). The prediction for this was based on an assumed PKS/NRPS collinearity rather 
than the actual structure (Figure 72b) giving similar findings as identified by Pfam. It was also 
interesting to note that R. pickettii shared homologs with other species of Ralstonia and 





Figure 71: Pfam based prediction for rhi homologs. 
Genomic sequence data was used to search for homologs of the rhi gene cluster (PKS) or 
(NRPS) in R. pickettii using the pfam domain data base. The cartoon shows domains in R. 














Figure 72: Anti-smash search for polyketide synthetase (PKS) or non-ribosomal polyketide 
synthase (NRPS) gene clusters. 
Genomic sequence data was used to search for homologs of the rhi gene cluster (PKS) or 
(NRPS) in R. pickettii using the Anti-Smash data base for gene clusters. The cartoons represent 
location of gene, annotation and homologs in other organisms. Anti-smash search reveals (i) a 
possible type 1 PKS with (ii) co-linearity and similar functional domains to those predicted by 




Whilst the findings here showed that R. pickettii lacks the explicit rhi gene cluster previously 
reported, it did indicate that domains with similar predicted functions to some of those by rhi 
individual genes may exist. Whether this alludes to the existence of an alternative pathway for 
rhizo-toxin biosynthesis remains to be explored. Therefore, we can at this stage state that the 
supernatant factor in question might be similar to the rhizo-toxins in function but perhaps 
different in the structural signature. This thus remains to be fully identified and characterized. 
 
5.8 Impact of bacterial symbiosis in vivo 
In vivo dynamics of mucormycete infections and disease progression are poorly understood. 
Several in vivo lab systems are being created to address this concern, and studies by Chamilos 
et al (2008), Ibrahim et al (2008), Voelz et al (2015) and Inglesfield et al (2018) have all 
pioneered this in different systems including the fly, mouse and zebrafish models (Chamilos et 
al., 2008a, Voelz et al., 2015, Inglesfield et al., 2018, Ibrahim et al., 2008b).  
 
In order to place our findings into a more physiologically relevant context, we used in vivo 
models of infection. We employed three systems: Zebrafish, Galleria mellonella wax moth, 
and Mouse models. Whilst fish and wax moth larvae work were done primarily at University 
of Birmingham, mouse studies were performed in collaborations with Ibrahim Ashraf at the 
University of California Los Angeles (UCLA) (Section 2.13). 
 
5.8.1 Why these particular models? 
The zebrafish (Danio rerio) model is extensively used in biomedical research mainly to study 
embryonic development and haematopoiesis. However, its application has expanded to other 
fields including immunology. Our application of the model here is based on the fact that 
following fertilization, the larva survives with only the innate immune system in the early 
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stages of development. Adaptive immunity in the fish develops morphological and functionally 
in the later stages post fertilization. 
This somewhat temporary separation enables an independent in vivo study of innate immunity 
without interruption of the adaptive system. However, in addition to this there are several other 
advantages of the zebrafish system that make it suitable for a multitude of vertebrate based 
studies. These include but are not limited to transparency, which enables real-time visual 
imaging, its small size, its rapid life cycle, and the fact that it can be easily manipulated 
genetically (Benard et al., 2012, Brothers and Wheeler, 2012, Ellett and Lieschke, 2010, Harvie 
and Huttenlocher, 2015, Meeker and Trede, 2008, Novoa and Figueras, 2012, Voelz et al., 
2015). 
The mouse model was used here because it is more closely related to the human system and 
thus a more suited model to study human disease (Ibrahim et al., 2008b, Ibrahim et al., 2011). 
Other advantages of this model include but not limited to; genome has been sequenced, breed 
fast, relatively cost effective and smaller compared to humans.  
The application of the Galleria model here was mainly as an alternative system probing whether 
mucormycetes can be studied using this set up in future studies  (Huang et al., 2015, Maurer et 
al., 2015, Won et al., 2017, Andrejko et al., 2014, Tsai et al., 2016).  
 
5.8.2 Bacterial symbiosis promotes fungal pathogenicity in Galleria 
mellonella wax moth larvae model 
The Galleria mellonella wax moth is extensively used for the study of bacterial pathogenesis, 
and is used for fungal studies with growing frequency, most commonly as an alternative in vivo 
model. It offers an alternative to reduce the number of animals used, as recommended by the 
National Centre for the Reduction, Replacement and Refinement of animals in Research 
(NC3Rs) (Tsai et al., 2016). Previously the model has been tried with several filamentous and 
dimorphic fungi including Candida albicans, Penicillium marneffei and Aspergillus in addition 
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to bacteria studies (Huang et al., 2015, Maurer et al., 2015, Won et al., 2017, Andrejko et al., 
2014, Tsai et al., 2016).  Thus, application of this model system here was also considered as a 
possible future alternative system for studying mucoralean fungi in vivo. Accordingly, the 
larvae were injected with two separate doses (low (104) and high (106)) of resting or pre-
germinated spores (+/- endosymbiont) and survival of the larvae determined as described 
(Section 2.11)  
As shown in Figure 73, for low dose (LD) infections there were significant differences in 
mortality of the larvae between parent and cured spores (p<0.05). Similar patterns were seen 
with high dose (HD) infections for swollen spores (p = 0.0012). For HD resting spores, there 
was no statistically significant difference (p > 0.05). These findings also show how important 
bacterial symbiosis could be for fungal pathogenicity. Although the findings here are similar 















Figure 73: Bacterial symbiosis promotes virulence of R. microsporus FP-469-12in Galleria 
mellonella. 
Spores were harvested, pre-germinated or maintained in a resting state and stained before 
infections were made. Wild type Galleria larva were infected with parent or cured strains of R. 
microsporus by injecting with low (104/10L) or high (106/L) doses of the spores as indicated 
into pro-limbs of the larvae. Three biological replicates of populations of 5 larva each were 
examined (n=15). Statistical differences were determined using Mantel-Cox with Bonferroni’s 











5.8.3 Bacterial symbiosis enables fungal pathogenicity in zebrafish  
Based on previous reports by Voelz et al (2015) and recently Inglesfield et al (2018) that M. 
circinelloides induces early tissue-specific innate immune responses by rapid recruitment of 
phagocytes, the impact of bacterial symbiosis on both fish and fungal survival was examined. 
Accordingly, ~24 h old embryos of wildtype (AB) zebrafish were inoculated in the hindbrain 
ventricle as shown in Figure 74a with resting or swollen Rhizopus spores (+/- endosymbiont), 
and survival rates of both fish and the fungus determined. Also, the impact of ciprofloxacin 
treatment of the fish on both host and pathogen survival was evaluated as described (Section 
2.13).  
Notably, there was no statistical significance in the rate of mortality due to PVP control and by 
either resting or swollen endosymbiont free spores (p > 0.05). However, significant differences 
in mortality were seen between parent vs cured resting spores (p = 0.0006); and between parent 
vs cured swollen spores (p = 0.00323) (Figure 74b). Fungal survival reveals a similar pattern, 
with significantly more fish clearing cured as opposed to parent spores of both categories. 
However, as already shown in vitro, swollen spores survived better than resting spores (Figure 
74c). Interestingly, following treatment with ciprofloxacin, we also saw significant differences 
in mortality of the fish for both + Cipro and – Cipro for resting spores (p < 0.0001); and for 
swollen spores (p = 0.0393). A similar pattern is reflected in fungal survival, although the 
difference was larger with resting spore, where fungal CFUs are reduced in the treated as 
opposed to the untreated fish cohort infected with resting spores. Survival of the swollen spores 
was not significantly affected (Figure 75).  
 
It possible that although survival is not as affected, perhaps treatment halted other metabolic 
processes of the spores, thus slowing down their growth rate and thus the progression of 
infection. These findings further highlight the importance of the endosymbiont in vivo, 
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particularly in facilitating an infection. They also point to the importance of ciprofloxacin in 
improving survival of the host. Whether this can be extrapolated clinically for prophylactic 



























Figure 74: Bacterial symbiosis enables fungal survival in vivo. 
Spores were harvested, pre-germinated or maintained in a resting state and stained with 
calcofluor white. (a) AB wild type zebrafish were infected with parent or cured strains of R. 
microsporus by injecting into the hindbrain. (b) Injected fish were then cultivated in E3 
medium and monitored every 24 h.p.i for total of 96 h.p.i with mortality rates assessed every 
24 h.p.i. (c) Infected fish were sacrificed and homogenized in E3 containing antibiotics every 
24 h.p.i for a total of 96 h.p.i, homogenate plated on SDA and incubated at room temperature 
for colony forming units (CFUs). For (b) Three biological replicates of populations of 10 fish 
each were examined (n=30). Statistical differences were determined using Mantel-Cox with 
Bonferroni’s correction for multiple comparisons (5% family-wise significance threshold = 
0.025). For (c) Statistical significance was assessed by Two-way ANOVA with Tukey’s 




Figure 75: Treatment with ciprofloxacin is protective against infection by R. microsporus FP-
469-12. 
Spores were harvested, pre-germinated or maintained in a resting state and stained with 
calcofluor white. AB wild type zebrafish were infected with parent or cured strains of R. 
microsporus by injecting into the hindbrain. (a) Injected fish were then cultivated in E3 
medium with or without 60 ug/ml of ciprofloxacin and monitored every 24 h.p.i for total of 96 
h.p.i with mortality rates assessed every 24 h.p.i. (b) Infected fish were sacrificed and 
homogenized in E3 containing antibiotics (penicillin, streptomycin and gentamycin) every 24 
h.p.i for a total of 96 h.p.i, homogenate plated on SDA and incubated at room temperature for 
colony forming units (CFUs). (a) Three biological replicates of populations of 10 fish each 
were examined (n=30). Statistical differences were determined using Mantel-Cox with 
Bonferroni’s correction for multiple comparisons (5% family-wise significance threshold = 
0.025). (c) Statistical significance was assessed by Two-way ANOVA with Tukey’s correction 








5.8.4 Phagocytes are readily recruited and crucial for containing the 
infection  
We have learned that defective phagocytic effector functions predispose one to mucormycosis 
(Riley et al., 2016, Ibrahim and Voelz, 2017). However, it also appears that even with a 
competent phagocyte system one is not entirely free from an infection by mucoralean fungi 
because of their ability to evade phagocyte killing and possibly establish latency. Inglesfield et 
al (2018) attests to this by showing formation of granulomas where spores are kept dormant, 
facilitating a latent infection that is activated when conducive immunosuppressive conditions 
manifest (Inglesfield et al., 2018). Further, these data suggested that whilst phagocytes are able 
to recognize and control fungal spores, they can also serve as a reservoir for dormant infection 
in at risk individuals.  
 
Thus, the impact of bacterial symbiosis on the dynamics of phagocyte recruitment was 
examined, building on the hypothesis that bacterial symbiosis may prevent phagocyte 
recruitment. To answer this question, transgenic zebrafish lines with fluorescently tagged 
macrophages [Tg (mpeg1: G/U: Nfs B-mCherry)] or neutrophils [Tg (mpx: GFP)] were 
employed as described by Inglesfield et al (2018) to determine 1) survival of transgenic fish 
and 2) phagocyte recruitment following infection. Recruitment was determined and registered 
both in fish that survived throughout the entire experimental time line (survivors) and those 
that succumbed to the infection during the experiment (the non-survivors).  
 
As shown in Figures 76-78, a similar and comparable pattern in mortality was observed in 
transgenic and wild type fish. In all models, parent spores killed significantly more fish than 
cured spores of either category (p < 0.05) (Figures 76a and 76b). Regarding phagocyte 
recruitment, it was interesting to see that macrophages (Figure 77) and neutrophils (Figure 
78) are both rapidly recruited to the hindbrain following infection by either category of spores, 
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with an average cell count of about 20 macrophages and 25 neutrophils after 6 h.p.i post 
infection (p < 0.05) (Figures 77a, 77b, 78a and 78b). At this point, however, the data begin 
to stratify by survival outcome: survivors exhibit distinct patterns of phagocyte recruitment 
























Figure 76: Bacterial symbiosis enables fungal survival following infection of transgenic fish. 
Spores were harvested, pre-germinated or maintained in a resting state and stained with 
calcofluor white before infections were made. Transgenic zebrafish were infected with parent 
or cured strains of R. microsporus by injecting into the hindbrain. Injected fish were then 
cultivated in E3 medium monitored every 24 h.p.i for total of 96 h.p.i with mortality rates 
assessed every 24 h.p.i. (a) Mpeg fish expressed mCherry labelled macrophages while (b) 
MPOs expressed GFP labelled neutrophils. (a) Three biological replicates of populations of 10 
fish each were examined (n=30). Statistical differences were determined using Mantel-Cox 














Figure 77: Effect of bacterial symbiosis on macrophage recruitment. 
Spores were harvested, pre-germinated or maintained in a resting state and stained with 
calcofluor white before infections were made. MPEG transgenic zebrafish expressing mCherry 
macrophages were infected with parent or cured strains of R. microsporus by injecting into the 
hindbrain. The injected fish were then cultivated in E3 medium evaluated for macrophage 
recruitment. (a) fish surviving throughout the entire experiment and (b) those that succumbed 
to the infection during the course of the experiment was recorded. Three biological replicates 
of populations of 4 fish per condition were examined (n=12). Statistical significance was 
assessed by Two-way ANOVA with Tukey’s correction for multiple comparisons or pairwise 
t-tests where sample number was unequal due to fish death (ns=p>0.05, *=p<0.05; 
**=p<0.001; ***=p<0.0001 and ****=p<0.00001). (c) Representative micrographs showing 




In the surviving fish, we note a significant and steady increase in recruitment of both cell types 
from 6 h.p.i to an average count of about 40 macrophages and 55 neutrophils after 24 h.p.i (p 
< 0.05); this was more pronounced for both cell types upon infection with cured spores rather 
than parent spores (Figures 77a and 78a).  
For infections with both cured and parent resting spore types, after 48 and 72 h.p.i there is a 
significant decline in macrophage recruitment, to about 30 and 20 macrophages respectively 
(p < 0.05) (Figure 77a). A similar decline was not observed for parent swollen spores.  
Neutrophil recruitment significantly increases after 48 h.p.i (p < 0.05) and drops after 72 h.p.i 
for both cured spore types and more significantly with swollen cured spores (p < 0.05) (Figure 
78a). However, neutrophil recruitment for parent spores significantly increased after 48 (p < 
0.05) and 72 h.p.i. This effect was more pronounced with swollen spores (p < 0.00001) 
compared to resting spores (p > 0.05) (Figures 77a, 77b, 78a and 78b).  
Additionally, among the survivors, macrophage recruitment variably and significantly (p < 
0.05) increases in first 24 h.p.i, but then significantly drops after 48 and 72 h.p.i for both 
endosymbiont free and parent spore metabolic category (Figure 77a). Whereas, neutrophil 
recruitment variably and significantly (p < 0.05) increases in the first 24 h.p.i for all spore 
category, and significantly (p < 0.05) drops after 48 and 72 h.p.i for endosymbiont free spores; 
recruitment is maintained is respectively maintained for parent resting and significantly (p< 
0.05) increased for parent swollen spores after 48 and 72 h.p.i (Figure 78a).  A similar pattern 
is observed among the non-survivors, with significant (p< 0.05) increase in both macrophage 
and neutrophil recruitment but followed with only a significant (p < 0.05) decrease in 








Figure 78: Effect of bacterial symbiosis on neutrophil recruitment. 
Spores were harvested, pre-germinated or maintained in a resting state and stained with 
calcofluor white before infections were made. Transgenic zebrafish expressing GFP 
neutrophils were infected with parent or cured strains of R. microsporus by injecting into the 
hindbrain. The injected fish were then cultivated in E3 medium evaluated for macrophage 
recruitment for the indicated time points. (a) fish surviving throughout the entire experiment 
and (b) those that succumbed to the infection during the course of the experiment was recorded. 
Three biological replicates of populations of 4 fish per condition were examined (n=12). 
Statistical significance was assessed by Two-way ANOVA with Tukey’s correction for 
multiple comparisons or pairwise t-tests where sample number was unequal due to fish death 
(ns=p>0.05, *=p<0.05; **=p<0.001; ****=p<0.00001). (c) Representative micrographs 
showing recruitment following infection with swollen parent spores are shown. 
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It would appear that recruitment of both macrophages and neutrophils is key but fish survival 
seems depend more on neutrophil recruitment following infection. This was better 
demonstrated during infection with parent swollen spores where neutrophils are recruited 
continually in the surviving fish, while an impairment in their recruitment leads to mortality of 
the fish as in the non-surviving fish. Indeed, phagocyte recruitment in the non-survivors was 
the opposite of that observed in the survivors: most of non-survivors demonstrating a defect in 
recruitment of phagocytes to combat the infection (Figures 77b and 78b). 
Thus, the findings here clearly highlight the importance of innate immunity, particularly 
phagocytes, in containing the infections, especially in early stages of infection. Most 
importantly the impact of bacterial symbiosis on disease outcome is again significantly shown 
here. With a bacteria endosymbiont, the fungus may still evade host immunity, even with a 
competent phagocytic system. However, the evasion may not necessarily be solely through 
prevention of recruitment but also through inhibition of other phagocyte effector functions 
including phagocyte killing  
 
5.8.5 Bacterial symbiosis promotes fungal pathogenicity in an 
immunocompetent mouse model 
Both the zebrafish larvae and wax moth larvae models have limitations compared to the mouse 
model. The mouse is a close relative of humans and thus making it physiologically suitable for 
systemic studies. Thus, to establish the role of bacterial symbiosis in R. microsporus virulence 
during mammalian infection, a mouse mode was employed.  
 
As already mention this part of the project was performed in collaborated with Ibrahim Ashraf, 
University of California Los Angeles. Accordingly, 10 immunocompetent mice per category 
were inoculated with resting or pre-germinated spores (+/- endosymbiont). The mice were 




 As demonstrated in Figure 80, it was interesting to see that parent spores generally survived 
better than cured spores. For instance, at both 4 and 48 h.p.i we see a significant drop in the 
recovery of cured spores from 4.3 for parent to 2 .0 CFUs /g for cured resting spores (p = 
0.00102); and even a further drop at 48 h.p.i from 2.9 for parent to 0.5 CFUs /g for cured resting 
spores (below the limit of detection) (p < 0.0001). A similar pattern is seen with swollen spores, 
with significant drops at 4 h.p.i from 3.5 for parent to 2.5 CFUs /g for cured swollen spores (p 
= 0.01384); and from 2.0 for parent 1.0 CFUs /g for cured swollen spores (p = 0.012).  
 
Generally, there was a significant decline in survival of the fungus from 4 to 48 h.p.i (p < 0.05) 
(Figure 79). However, these findings revealed a lack of efficient clearance of spores with the 
endosymbiont as opposed to ones without. Whether latency is a possible outcome here remains 
to be explored. The results here further affirm that bacterial symbiosis might play a key role 
during fungal survival in vivo. Whether this impacts on both disease progression remains to be 










Figure 79: Bacterial symbiosis influences fungal pathogenicity in a mouse model. 
Spores were harvested, pre-germinated or maintained in a resting state before infections were 
made. Immunocompetent CD-1 male mice were infected with 106/25 L with parent or cured 
strains of R. microsporus intratracheally. The mice were sacrificed at 4 and 48 h.p.i, lungs 
collected, homogenized and homogenate plated on PDA +0.1% triton at 37oC. Effect of 
endosymbiont status on fungal survival (CFUs) following intra-tracheal infection of mice at 4 
and 48 hours with resting and swollen spores (n=5). Statistical significance was assessed by 
Two-way ANOVA with Tukey’s correction for multiple comparisons (ns=p>0.05; *=p < 0.01).  
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5.9 Discussion  
In this work, we demonstrate that the human fungal pathogen R. microsporus harbours an 
endosymbiont capable of influencing fungal interactions with mammalian phagocytes and 
modulating fungal virulence. Our findings highlight an emerging theme in fungal pathogenesis 
that urges a broader view of fungal growth and virulence to encompass cross-kingdom 
interactions reflecting the ecological origins of infecting species. Recent work has shown that 
several fungi like Fusarium and Mycorrhizal fungal species harbour bacterial endosymbionts 
that influence fungal phenotypes (Shaffer et al., 2017, Husnik and McCutcheon, 2018, 
Hoffman et al., 2013, Frey-Klett et al., 2011, Araldi-Brondolo et al., 2017).   
The mucormycetes, particularly R. microsporus, one of the prevalent causative agents of fatal 
mucormycosis, has been reported to harbour bacterial endosymbionts including Burkholderia 
rhizoxinica and Burkholderia endofungorum species (Gee et al., 2011, Lackner et al., 2009b, 
Partida-Martinez et al., 2007a, Partida-Martinez et al., 2007b, Partida-Martinez and Hertweck, 
2005, Scherlach et al., 2006, Partida-Martinez et al., 2007c). It is becoming evident that 
Rhizopus and these endosymbionts form a highly specific and complex association that 
significantly influences the fungal host’s metabolic and sexual phenotypes (Moebius et al., 
2014a, Mondo et al., 2017). Additionally, endobacteria are a source of potent antimitotic and 
hepatotoxic mycotoxins such as rhizoxin and rhizonin and can influence fungal pathogenesis 
in plants (Scherlach et al., 2006, Partida-Martinez and Hertweck, 2007, Partida-Martinez and 
Hertweck, 2005, Partida-Martinez et al., 2007b, Partida-Martinez et al., 2007a, Lackner et al., 
2009b). However, the role of these endosymbionts in pathogenesis during mucormycosis has 
yet to be clinically defined. In this study, we report that a clinical isolate of R. microsporus, 
and other mucoralean fungi harbour bacterial endosymbionts that influence host–pathogen 
interactions including phagocytosis and macrophage killing.  
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We further show that R. microsporus spore survival following phagocytosis by macrophages 
is dependent on the presence of an endobacterium. Elimination of the bacterial endosymbiont 
by ciprofloxacin treatment facilitates macrophage killing and in vivo clearance of the fungal 
spore. In this study, we also observed that this is facilitated by the production of bacterial toxin 
consistent with rhizoxin. We further noted that this toxin exhibits several anti-phagocytic 
effects including impacting mammalian cell morphology and cytoskeleton organisation, 
particularly actin and beta tubulin polymerisation. These findings agree with reports that show 
that bacterial symbiosis facilitates plant pathogenesis by R. microsporus through production of 
the phytotoxin rhizoxin, an antimitotic agent that targets beta tubulin (Lackner et al., 2009b).  
Two groups recently reported that although bacterial endosymbionts are widely found among 
mucormycete clinical isolates and produce the toxins rhizoxin or rhizonin, they did not impact 
pathogenesis during mucormycosis in both mice and fly models (Ibrahim et al., 2008b, Partida-
Martinez et al., 2008).  Our findings differ from these reports because elimination of the 
endobacterium restores phagocytosis, and promotes macrophage killing.  
Several reports continue to report existance of endobacteria among fungi and their influence 
on fungal survival on several fronts, particularly on their metabolism, sexuality, antifungal 
reistance, and this is clearly being noticed across an array of fungal families (Shaffer et al., 
2017, Nazir et al., 2014, Mondo et al., 2017, Moebius et al., 2014a, Frey-Klett et al., 2011, 
Benoit et al., 2015, Zheng et al., 2017, Salvioli et al., 2016, Hoffman et al., 2013, Araldi-
Brondolo et al., 2017). From this stand point, it is early to write off the importance of bacterial 
symbiosis in the pathogenesis of mucormycosis. Furthermore, harnesing the role of bacterial 
symbiosis could prove key in revolutionalising mucormycotic management through 
combination therapy of anifungal and antibiotics.  
In summary, we have shown that R. microsporus and other mucormycetes harbour a bacterial 
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endosymbiont. In R. microsporus this endosymbiont secretes a hydrophobic compound that 
affects several phagocytic effector functions including cell morphology and its elimination 
reverses all the effects. Whilst these anti-phagocytic phenotypes are consistent with those 
established with rhizoxin here, it is too early to implicate rhizoxin but rather late to explore the 
role of bacterial endosymbiosis in the pathogenesis of mucormycosis.  
The data presented here describes ways of screening mucoralean fungi for bacterial 
endosymbionts using microscopy coupled with PCR and in vitro isolation; and the effects of 
endobacterium on fungal host phenotypes including phagocytosis, HPLC and in vivo studies. 
All these methods permit high through put screening for endobacterium among filamentous 
fungi. However, other more sensitive and specific techniques such as NMR, MS/LCS would 
be required to characterise this anti-phagocytic compound better. Furthermore, the effect of the 
factor on other cell lines such as PBMCs would be required to increase the relevance of the 
findings. On the other hand, in vivo model used in this study are adequate (Section 5.7.1) but 
our findings would require more repeats especially using the mouse to improve relevancy of 
the findings. In Future, the impact of the endo bacterium of cytokine profile can also be 
investigated and other infection models such the amoebae can also be employed.  Ciprofloxacin 
was the antibiotic employed here in comparison with other authors, but these a gap to try other 
antibiotics against endobacterium. Finally, the genetics findings presented here are superficial 




























We know now that R. microsporus spores secrete compounds with anti-phagocytic activity. 
Most importantly the compounds are secreted by a bacterial endosymbiont highlighting the 
role of the bacteria in fungal survival and metabolic attributes. Whether the secreted factor here 
is similar to what has been characterised such as rhizo-toxins remains unknown.  
 
Stemming from the data presented in this thesis, we have proposed three hypotheses based on 
the chemistry data particularly peak 5. 
1. That the fungus + endosymbiont make peak 5. 
2. The fungus is a signal for the endosymbiont to make peak 5. 
3. That the endosymbiont is a signal for the fungus to make peak 5.  
Firstly; we tried to establish which of the two (bacteria or fungus) is the signal for the other to 
produce the metabolic compounds in question. This mainly stems from the data that show 
bacteria as producers of a large range of products in HL5 and VK compared to DMEM medium. 
Indicating that production of the active compounds could be significantly affected by the 
growth conditions suggesting that perhaps these conditions reflect those when living in 
symbiosis with the fungus (Figure 82) 
So, to examine this, the bacteria were co-incubated with both live and heat killed mashed fungal 
substrate grown in under different conditions, supernatants collected and activity against 
phagocytosis determined as described before (Section 2.5) 
As shown in Figure 83, co-incubation with mashed but live fungal substrate showed relatively 
more activity as opposed to that with heat killed substrate. This may suggest that the fungus is 
the signal production of the active compound by the bacteria but requires the fungus to be live 






Figure 80: Growth conditions can influence bacterial metabolism. 
R. pickettii bacteria was fermented in different culture medium as indicated at 30oC, 80 rpm 
for 2-4 days. Supernatants were collected, extracted with chloroform and HPLC profiled using 
C18 column. Medium controls were also included. Chromatograms presented are from one of 









Figure 81: Effect of filtered supernatants from co-cultures of bacterial symbionts and different 
fungal substrates on phagocytosis by J774 macrophages. 
Both the parent and cured strains were grown in different media conditions, mycelia collected, 
processed as indicated and co-incubated with bacteria in sfDMEM. The resultant supernatants 
were collected and used to treat J774 macrophages for 1 h then co-incubated with dormant 
spores and phagocytosis determined. For all conditions, the number of phagocytes containing 
at least one spore were counted after 1 hour (n=9000, One way ANOVA with Tukey’s 
correction for multiple comparisons). In each graph, three biological replicates were examined 




























7.1 Final discussion  
This project has explored interaction mechanisms between the infecting particles of 
mucormycetes and the host cell lines in addition to utilising a series of animal models. Through 
employing a clinical isolate of R. microsporus, we have made vital observations, specifically 
that this pathogen and other mucoralean fungi harbour bacterial endosymbionts.  
The data presented herein shows that these bacterial endosymbionts can modulate host-fungal 
interactions. Yet this happens to be an emerging theme that has already been explored to some 
extent in plant pathology (Shaffer et al., 2017, Husnik and McCutcheon, 2018, Hoffman et al., 
2013, Frey-Klett et al., 2011, Araldi-Brondolo et al., 2017).  
Fungi appear to harbour a wide diversity of bacterial endosymbionts that are specifically 
adapted to colonize respective fungal hosts and significantly influence host-relevant fungal 
phenotypes, including metabolism, cell wall organization, development, and plant host 
colonization. Indeed, these endosymbionts can be a source of potent mycotoxins that can 
influence  fungal pathogenesis (Moebius et al., 2014a, Mondo et al., 2017, Shaffer et al., 2017, 
Hoffman et al., 2013, Araldi-Brondolo et al., 2017, Uehling et al., 2017, Ibrahim et al., 2008b, 
Takashima et al., 2018, Gee et al., 2011, Partida-Martinez et al., 2007b, Partida-Martinez and 
Hertweck, 2005, Scherlach et al., 2006, Nazir et al., 2014, Frey-Klett et al., 2011, Benoit et al., 
2015, Zheng et al., 2017, Salvioli et al., 2016). 
The role of these endosymbionts clinically is still un appreciated, representing a significant gap 
in our understanding of the pathogenicity of mucormycetes. Here we provide evidence that a 
bacterial endosymbiont may significantly influence its interaction with mammalian hosts. We 
show that during the early steps of spore-germination, the bacterium secretes a factor that 
inhibits phagocytosis. In addition, R. microsporus spore survival following phagocytosis by 
macrophages is dependent on the presence of the endobacterium. Elimination of the bacterial 
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endosymbiont by ciprofloxacin treatment facilitates macrophage killing and in vivo clearance 
of fungal spores.  
While previous work has mainly focused on Burkholderia-Rhizopus endosymbiosis, we 
identify a previously unappreciated niche for the related gram-negative bacterium Ralstonia 
pickettii as an endosymbiont of R. microsporus. Consistent with long-term mutualism, we 
observed an overall reduction in RNS/ROS stress resistance and virulence in a cured R. 
microsporus isolate. We also observed reduced sporulation and overall fitness in this strain 
after repeated passage of fungal growth on SDA plates with cirpofloxacin. Mondo et al., 
showed that bacterial endosymbionts can impact fungal sporulation and development through 
controlling RAS2, a key GTPase that regulates fungal sexual reproduction (Mondo et al., 2017).  
Additionally, consistent with a change in lipid biogenesis, we observe changes in the fungal 
plasma membrane in cured spores, as well as increased sensitivity to Amphotercin B, indicative 
of altered ergosterol content. Loss of the endosymbiont had profound impacts on R. 
microsporus response to phagocytosis. Together, our findings support a mutualistic lifestyle 
for R. pickettii and R. microsporus.   
In addition to supporting fungal development and stress resistance, we show that R. pickettii 
inhibits phagocytosis by macrophages during the initial steps of germination. We demonstrate 
that this is facilitated by the production of a unique bacterial factor. We further note that this 
factor exhibits several anti-phagocytic effects including impacting mammalian cell 
morphology and cytoskeleton organisation, particularly actin and -tubulin polymerization as 
well as phagosome maturation. These findings add to reports of bacterial endosymbionts that 
facilitate pathogenesis, first revealed by the finding that B. Rhizoxina increases R. microsporus 
pathogenesis through production of the phytotoxin Rhizoxin, an antimitotic agent that targets 
the cytoskeleton (Lackner et al., 2009b).  
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However, this factor appears to be distinct from the Rhizo-toxins in activity and biosynthesis, 
as evidenced by analysis of secondary metabolite clusters in the R. pickettii genome. Further, 
we show that the presence of the endosymbiont reduces fungal sensitivity to host phagocyte 
antimicrobial activity and that this can have implications for pathogenesis during the earliest 
stages of mammalian infection.   
Two groups recently reported that although bacterial endosymbionts, including Rhizoxin and 
Rhizonin producers, are widely found among mucormycete clinical isolates, these 
endosymbionts did not impact pathogenesis during mucormycosis in both mouse and fly 
models (Ibrahim et al., 2008b, Partida-Martinez et al., 2008). The influence of endosymbiont-
derived Rhizoxin on pathogenesis was assessed in a diabetic mouse model (Ibrahim et al., 
2008b). Diabetic mice were infected with Rhizopus isolates harbouring Rhizoxin-producing 
Burkholderia endosymbionts and then treated with either Amphotericin B antifungal or 
Ciprofloxacin antibacterial or both 24 hours post-infection. No impact for Ciprofloxacin 
treatment was observed in that work (Ibrahim et al., 2008b).  
 
In contrast, in our work, when immune-competent mice were infected with resting spores pre-
treated with Ciprofloxacin, CFUs were reduced compared to untreated within 4 hours and 
spores could no longer be recovered after 48 hours. It should be noted that the work here was 
performed in a small number of mice (5 per group) and therefore is prone to the challenges 
associated with underpowered models of infection. However, we observed similar patterns in 
the zebrafish model of infection, which simultaneously allows larger study populations and 
detailed dissection of mechanisms of innate immune defence. We again observed a profound 




 In both models, the endosymbiont appears to play a more significant role during the transition 
from resting to swollen spore, however direct infection with swollen cured spores was still 
associated with reduced host death. We hypothesize that in our model, the elimination of the 
endobacterium restores robust phagocyte recruitment and promotes macrophage killing of 
fungal spores, factors that remain defective in the diabetic or immune-suppressed host models.  
 
During in vivo infection of immunocompetent mice, the closely related fungus R. oryzae was 
shown to be phagocytosed but not killed by alveolar macrophages, while un engulfed spores 
were associated with neutrophil recruitment (Andrianaki et al., 2018a).  Swollen spore survival 
was linked to resistance to iron limitation and melanin-mediated arrest of phagosome 
maturation. These findings are consistent with observations in zebrafish showing the formation 
an early granuloma comprised of macrophages and neutrophils in response to M. circinelloides 
that likewise controlled but failed to kill spores and suggest a similar host response to a variety 
of infecting Mucorales species (Voelz et al., 2015, Inglesfield et al., 2018). Spore survival 
within macrophages in vitro and within early granuloma in immunocompetent mice indicate a 
potential reservoir for latent fungal infection. Indeed, an emerging trend in clinical reports of 
mucormycosis is the unappreciated burden of indolent or chronic mucormycosis (Rodriguez-
Lobato et al., 2017, Desoubeaux et al., 2014, Gamarra et al., 2018). The observation that 
elimination of bacterial endosymbionts impacts cell wall organization, resistance to host 
relevant stress, and resistance to macrophage-mediated killing raises questions on the 
possibility that modulation of fungal endosymbiont status may impact fungal latency and allow 
clearance.  
Together, our findings highlight the importance of bacterial symbiosis in the pathogenesis of 
mucormycosis. However, we urge caution in extending our findings to all Mucorales or fungal 
endosymbionts. While a number of studies have demonstrated general features common to 
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host-Mucorales interactions, there may be species-specific aspects that influence Mucorales 
pathogenesis.  In addition, not all clinical isolates profiled do harbour endosymbionts, 
suggesting that endosymbionts may augment, but are not constitutively required for, 
pathogenesis (Ibrahim et al., 2008b). Overall, our findings point to a role for the bacterial 
endosymbiont in fungal immune evasion during infection via a secreted factor and raise the 
possibility of a role in reactivation of latent infections with resting spores in patients 
undergoing immunosuppressive therapy (Brunet et al., 2018). Harnesing the role of bacterial 
symbiosis could prove key in revolutionalising mucormycotic management through 
combination therapy of anifungal and antibiotics.  
 
 






















Mucormycosis is a major health concern and its prevalence continues to grow among an array 
of at-risk individuals. Aetiology of the disease is mainly dominated by Rhizopus species and 
understanding their pathogenicity is key to our exploration of disease progression. In this 
regard, we also report here that metabolic spores of R. microsporus are able to evade phagocyte 
effector functions as recently shown in R. oryzae. Interestingly, our findings show that this 
metabolic process is attributed to bacterial symbiosis influencing pathogenicity of R. 
microsporus both in vivo and in vitro. Fascinatingly these findings come at the time when 
several studies exploring poly-microbial interactions including bacterial-fungal interactions 
have reported that bacteria are capable of networking with fungi at various levels, subsequently 
leading to modulations in substrate consumption, enzyme production, thermotolerance, 
sexuality, antifungal resistance, metabolism and virulence 
Although bacterial endosymbionts such as B. rhizoxinica and B. endofungorum have been 
implicated in plant pathology via rhizo-toxin production and studies have so far shown that 
these bacteria may not contribute towards human pathogenesis of mucormycosis. Here, we 
have shown that R. microsporus may harbour other symbionts such as R. pickettii, a close 
relative of B. rhizoxinica in the family Bukholderiaceace.  This is heavily involved fungal 
metabolism and promotes evasion of innate immunity by the fungus via production of a factor 
similar to the rhizo-toxins in function. To the best of our understanding this is the first report 
to show that bacterial symbiosis may contribute towards mucoralean pathogenicity and further 
examination of this concept can heavily contribute towards clinical management of 
mucormycosis. It has already been hypothesised before that endobacteria may contribute 
towards pathogenicity of mucoralean fungal hosts, and the evidence provided in this thesis 
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